10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

FOR ANNUAL AND TRANSITION REPORTS PURSUANT TO SECTIONS 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

(Mark One)

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended October 31, 2005

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

For the transition period from                          to                         

0-22366

(Commission file number)

CREDENCE SYSTEMS CORPORATION

(Exact name of registrant as specified in its charter)

Delaware	94-2878499
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
1421 California Circle, Milpitas, California	95035
(Address of principal executive office)	(Zip Code)

(408) 635-4300

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Name of each exchange on which registered
None	None

Securities registered pursuant to Section 12(g) of the Act:

Common Stock, $0.001 par value

Indicate by check mark if the registration is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes  ¨  No  x

Indicate by check mark if the registration is not registered to file reports pursuant to Section 13 or Section 15(d) of the Act.  Yes  ¨  No  x

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x  No  ¨

Indicate by a check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  x

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).  Yes  x  No  ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  ¨  No  x

The aggregate market value of voting stock held by non-affiliates of the Registrant, as of April 30, 2005 was approximately $573,350,538 (based upon the closing price for shares of the Registrant’s common stock as reported by the Nasdaq National Market for the last trading date prior to that date). Shares of common stock held by each officer, director and holder of 5% or more of the outstanding common stock have been excluded in that such persons may be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination for other purposes.

On December 31, 2005, approximately 99,488,400 shares of the Registrant’s common stock, $0.001 par value, were outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the Registrant’s Proxy Statement for the 2006 Annual Meeting of Stockholders to be held on March 21, 2006 are incorporated by reference into Part III of this report. Except as expressly incorporated by reference, the Registrant’s Proxy Statement shall not be deemed to be a part of this report.

FORM 10-K

TABLE OF CONTENTS

		Page
	PART I
Item 1.	Business	5
Item 1A.	Risk Factors	18
Item 1B.	Unresolved Staff Comments	31
Item 2.	Properties	31
Item 3.	Legal Proceedings	32
Item 4.	Submission of Matters to a Vote of Security Holders	32
	PART II
Item 5.	Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	35
Item 6.	Selected Financial Data	35
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	37
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	52
Item 8.	Financial Statements and Supplementary Data	54
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	95
Item 9A.	Controls and Procedures	95
Item 9B.	Other Information	97
	PART III
Item 10.	Directors and Executive Officers of the Registrant	99
Item 11.	Executive Compensation	99
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	99
Item 13.	Certain Relationships and Related Transactions	101
Item 14.	Principal Independent Registered Public Accounting Firm Fees and Services	101
	PART IV
Item 15.	Exhibits and Financial Statement Schedules	102
	Signatures	103

2

PART I

This Annual Report on Form 10-K contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements using terminology such as “believes,” “may,” “will,” “expects,” “plans,” “anticipates,” “goals,” “estimates,” “potential,” or “continue,” or the negative thereof or other comparable terminology regarding beliefs, plans, expectations or intentions regarding the future. The cautionary statements made in this Annual Report on Form 10-K should be read as being applicable to all related forward-looking statements whenever they appear in this Annual Report on Form 10-K. Forward-looking statements include statements regarding our objective to be the leading supplier of test solutions from design through to production test; the combining of NPTest technology with our traditional cost focus; the anticipated benefits of leveraging our technology portfolio and the scalability of our technology; keeping pace with rapid advances in IC design and test enhancing our existing systems; our goal to provide our customers with lower total cost alternative test solutions; our customers requiring increasing levels of sophisticated hardware tools; our belief that our cost effective test systems enables us to provide leading edges solutions to minimize time to market and extract the best yields from the manufacturing process; building close working relationships with integrated circuit manufacturers, EDA software vendors and wafer probe and device handler vendors to enhance our market position which allow us to design and offer more effective products; our intention to focus our ongoing high-end SoC test development on the Sapphire platform; anticipated cycle time, timing accuracy, the number and characteristics of the pins and the density of our products; the increasing importance of test service companies in the ATE market; our dependence upon the success of our major customers; our dependence on obtaining orders from new and current customers and the general global economy; international business continuing to account for a significant portion of our net sales; our belief that order cancellations and customer-requested shipment delays will occur in the future; seeking long-term relationships with major customers; our focus on increased cycle time, accuracy and pin counts of our tester products and co-development of technology between our product groups; our continued efforts to provide solutions that allow a more rapid, cost-effective development of ATE test programs; our dedication to continue to invest significant resources in the development of new products and enhancements; the possibility that litigation may be necessary to enforce our patents and other intellectual property rights; our manufacturing objective to produce engineering validation test systems and ATE that conform to our customers’ requirements at the lowest commercially practical manufacturing cost; managing our inventory through agreements with both suppliers and subcontractors; competing favorably with respect to throughput, tools for reducing customer product time-to-market, product performance and total cost of ownership; future results depending on attracting and retaining highly skilled workers; our dependence on continued significant expenditures related to new products, capital equipment purchases and worldwide training and customer service and support; our belief that our net sales and operating results will continue to fluctuate; our intention to introduce new products and product enhancements; our belief that our gross margin on systems sales will continue to vary significantly; our expectation that our top ten customers in the aggregate continue to account for a large portion of our net sales for the foreseeable future, and the loss of one or more of these customers will harm our business and operating results; our intent to continue to address the need to develop new products and enhance existing products through acquisitions of other companies, product lines, technologies and personnel; focus on product innovation and maintain a higher level of quality and customer service; existing cash and short-term investments being sufficient to meet our cash requirements for the foreseeable future; our dependence on the capital expenditures of manufacturers of semiconductors and other companies; a significant portion of new orders depending upon demand from semiconductor device manufacturers building or expanding fabrication facilities and new device testing requirements; dependence upon our obtaining orders for systems to be shipped in the same quarter in which the order is received; continued acceptance, volume production, timely delivery and customer satisfaction of our newer digital, mixed signal and non-volatile memory testers being of critical importance to our future financial results; investment of significant resources in the development and completion of new products and product enhancements; investing significant resources in property, plant and equipment, purchased and leased facilities, inventory and other cost; our plan to bring our IT functions in-house; the possibility that we may repatriate cash from our foreign subsidiaries; adoption of SFAS 123R will have a material impact on our consolidated financial statements, gross margins and operating expenses; the factors upon

3

which our ability to maintain or increase sales levels in Taiwan depend; our belief that the adoption of SFAS 123R will have a material effect on our results of operations; our anticipation that international sales will continue to account for a significant portion of our total net sales; our expectation that we will continue to receive notice of third party claims for infringement and that litigations expenses with respect to those claims may continue to be an expensive and time consuming process for us; our expectation that our expenses will increase as a result of our response to the new requirements of the Sarbanes-Oxley Act of 2002, including implementation of Section 404; our expectation that the Sarbanes-Oxley Act of 2002 will make it more difficult and more expensive for us to obtain director and officer liability insurance; our dependence on the continued service of our executive officers and key personnel; our dependence upon our ability to attract and retain qualified personnel; existing properties, including both owned and leased sites, are in good condition and adequate to meet our current and foreseeable future requirements; the belief that our tax positions are consistent with the tax positions in the jurisdictions in which we conduct business; our intention to vigorously defend claims brought by Roy Schmidt; our belief that claims brought in the ordinary course of business will not have a material adverse effect on our business, financial condition or results of operation; our anticipation that net sales will decrease by approximately 4% to 8% in the first quarter of fiscal year 2006 compared to fourth quarter of fiscal 2005; our belief that gross margins could be flat to slightly higher in the next several quarters; our anticipation that R&D expenses for fiscal 2006 will be flat in absolute dollars when compared to those recorded in fiscal 2005; our expectation that SG&A expenses for fiscal 2006 will be flat to down in absolute dollars when compared to those recorded in fiscal 2005; anticipated annual amortization for purchases intangible assets and deferred compensation is expected to be $18.8 million, $18.4 million, and $14.5 million for the fiscal years ending in 2006 through 2008, respectively, excluding the effect of FAS 123R adoption; our expectation to record a full valuation allowance on domestic tax benefits; our belief that investment in inventory will continue to represent a significant portion of our working capital; the highly cyclical semiconductor industry which experiences downturns; our expectation that a 10% change in the interest rate will not have any material effect on our interest income or expense; our belief that the adoption of SFAS 154, relating to retrospective changes in accounting principles, will not have a material effect on our consolidated financial position or results of operations; anticipated amortization of intangible assets as a result of the NPTest acquisition; our cautious outlook for future orders and sales levels; our revenue recognition practices regarding new products; our expectation that we will not recognize any significant tax benefits in our results of operations; our belief that our current cash and investment positions combined with the ability to borrow funds will be sufficient to meet our anticipated business requirements for the next 12 months; estimated future restructuring payments; our dependence on generating sufficient taxable income in future years to realize net deferred tax assets; future minimum lease payments; minimum contractual cash obligations and the effect of such obligations in future periods; our intention to continue to evaluate goodwill on an annual basis; our intention to evaluate other intangibles at such times as events and changes in circumstances suggest that the carrying amount may not be recoverable from its estimated future undiscounted cash flow; the highly competitive nature of the automatic test equipment industry which is subject to rapid technological change; the impact of the adoption of certain accounting pronouncements on the Company’s financial positions or results of operations; our need for continued significant expenditures for research and development, marketing and other expenses for new products; our expectation of continuing volatility in order activity; our belief that it is probable that orders will be canceled and delayed in the future; our intention to review and evaluate the design and effectiveness of our disclosure controls and procedures on an ongoing basis and to correct any material deficiencies that we may discover; our goal to ensure that our senior management has timely access to material information that could affect our business; and those described under the heading “Risk Factors” as well as risks described immediately prior to or following some forward-looking statements.

These forward-looking statements involve important factors that could cause our actual results to differ materially from those in the forward-looking statements. Such important factors involve risks and uncertainties including, but not limited to difficulties in utilizing different technologies; delays in bringing products to market due to development problems; difficulties in developing new engineering validation test systems; the possibility that our existing systems will become obsolete; excessively high costs in the future related to enhancing our existing systems; significant changes in customer preferences; difficulties in integrating acquired technology with our product lines; the possibility that competitors will introduce products faster than us; unanticipated difficulties

4

in building close working relationships with vendors; difficulties in developing the Sapphire platform; less sales of the Sapphire platform products than anticipated; product defects sustained during the manufacturing process; the risk that we may not be successful in obtaining new orders from major customers; unanticipated decreases in demand for our products in foreign countries; difficulties in providing extensive support to major customers; unanticipated difficulties in manufacturing and delivering new products, enhancement tools; unanticipated difficulties in integrating our products with customers’ operations; unanticipated difficulties in integrating developed technology; substantial technological changes in the semiconductor industry; a lack of the required resources to invest in the development of new products; uncertainties as to the current products provided by our competitors; unanticipated difficulties in locating and evaluating potential product lines, technologies and business to acquire; the viability of legal claims brought against us; our failure to accurately predict the effect of the ultimate outcome of claims on our business, financial condition or results of operations; lower than expected revenues; the risk that we may be required to expend more cash in the future than anticipated; difficulties in obtaining orders from manufacturers of semiconductors and companies that specialize in contract packaging and/or testing of semiconductors; underestimate of the expenses associated with implementation of the requirements of the Sarbanes-Oxley Act of 2002; the timing of orders; an unanticipated lack of resources to invest in property, plant and equipment, purchased and leased facilities, inventory, personnel and other costs; changing market conditions in Taiwan; inaccuracies in our assumptions regarding our tax positions; uncertainties as to the nature and extent of any potential cyclical downturn in the semiconductor industry; uncertainties of the assumptions regarding anticipated amortization of intangible assets as a result of the NPTest acquisition; uncertainties as to the prospect of future orders and sales levels; changes in laws applicable to us regarding revenue recognition practices relating to our new products; uncertainties as to the future level of sales and revenues; unanticipated budgetary constraints; uncertainties as to the assumptions underlying our calculations regarding estimated annual amortization expenses for purchased intangible assets and deferred compensation; uncertainties as to the effects of the adoption by us of certain accounting policies; the risk that our future working capital will not be sufficient to invest significant portions of such working capital in inventories; uncertainties as to the effect of the adoption of certain accounting pronouncements; unanticipated difficulties in the remediation of internal control deficiencies; ability of the Company to maintain the requisite level of assets under its deferred compensation plan; increased fragmentation in the ATE industry and other factors set forth in “Risk Factors” and elsewhere herein. Reference is made to the discussion of risk factors detailed in our filings with the Securities and Exchange Commission, including our reports on Form 10-K and 10-Q. All projections in this annual report on Form 10-K are based on limited information currently available to us, which is subject to change. Although any such projections and the factors influencing them will likely change, we will not necessarily update the information, since we are only to provide guidance at certain points during the year. Actual events or results could differ materially and no reader of this annual report on Form 10-K should assume that the information provided today will still be valid in the future. Such information speaks only as of the date of this annual report on Form 10-K.

Item 1. Business

We design, manufacture, sell and service engineering validation test equipment, diagnostics and failure analysis products and automatic test equipment, or ATE, used for testing semiconductor integrated circuits, or ICs. As part of our test equipment, we provide automation solutions in the IC design and test flow fields. We serve a broad spectrum of the semiconductor industry’s testing needs through a wide range of products that test digital logic, analog, mixed-signal, system-on-a-chip or SoC, radio frequency and non-volatile memory semiconductors. We utilize our proprietary technologies to design products which are intended to provide a lower total cost of ownership and improved yield optimization than competing products currently available while meeting the increasingly demanding performance requirements of today’s engineering validation test, characterization, emission-based optical diagnostics, failure analysis and production test markets. Our products are designed to test semiconductors; first, at the prototype stage, second, as they are produced in high volume, and third, during yield optimization and failure analysis. Our test products enable design and test engineers to develop and troubleshoot production test programs prior to fabrication of the device prototype. Collectively, our customers include major semiconductor manufacturers, fabless design houses, foundries and assembly and test services companies.

5

We were incorporated in California in March 1982 and were reincorporated in Delaware in October 1993. “Credence” or the “Company”, “we”, “us” and “our” refers to Credence Systems Corporation and our subsidiaries. Our principal executive offices are located at 1421 California Circle, Milpitas, California and our telephone number is (408) 635-4300. Our worldwide website address is www.credence.com. On our Investor Relations page on this web site we post the following filings as soon as reasonably practicable after they are electronically filed with or furnished to the Securities and Exchange Commission: our annual report on Form 10-K, our quarterly reports on Form 10-Q, our current reports on Form 8-K and any amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934. All such filings on our Investor Relations web page are available to be viewed on this page free of charge. Information contained on our web site is not part of this annual report on Form 10-K or our other filings with the Securities and Exchange Commission. We assume no obligation to update or revise any forward-looking statements in this annual report on Form 10-K, whether as a result of new information, future events or otherwise, unless we are required to do so by law. A copy of this annual report on Form 10-K is available without charge upon written request to: Mr. John Batty, the Company’s Senior Vice President, Chief Financial Officer and Secretary, at the Company’s headquarters at 1421 California Circle, Milpitas, California 95035. The SEC maintains an Internet site at www.sec.gov that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC. “Credence Systems Corporation,” “Credence,” “IMS,” “Fluence,” “SC,” “ValStar,” “Quartet,” “Octet,” “Sapphire,” “ITS9000,” “ASAP,” “SPP,” “Electra,” “Vanguard,” “Kalos,” “DUO,” “TMT,” “MVNA,” “Virtual Test,” “Optonics,” “Emiscope” and “SZ” are certain of our trademarks. This Annual Report on Form 10-K also includes trademarks of other companies.

Background

The semiconductor industry’s successful production of increasingly smaller, faster and more sophisticated ICs has made semiconductor devices available for a wide range of applications resulting in semiconductor content growth in almost all appliances ranging from dishwashers to automobiles, cell phones to PDAs and laptops to servers. At the same time, semiconductors have emerged as the building blocks of the communication, internet and telephony infrastructures. IC proliferation, together with a competitively driven reduction in device average selling prices or ASPs, compels IC manufacturers to continually strive to reduce manufacturing costs while improving their time to volume production and profit.

The process of designing and manufacturing ICs is complex and capital-intensive, involving stages of design, prototype manufacture, engineering validation test of the prototypes, device manufacture and production test and finally yield improvement. Each stage in this process has come under pressure as ICs have increased in complexity and speed while ASPs have declined. At the design stage, advances in electronic design automation, or EDA, software has allowed design engineers to work with IC designs at increasingly higher levels of abstraction, permitting engineers to design significantly more complex ICs in less time. The ability to design more complex and capable circuits, together with advances in manufacturing processes, has resulted in an approximate doubling of chip speed and complexity every two years. However, as ICs have become more complex and as device manufacturers have increasingly sought ways to introduce products to market more rapidly, critical limitations have become increasingly apparent in the IC design-to-production process flow.

The equipment used in the engineering validation test stage often has been unable to effectively verify and characterize increasingly complex ICs. To perform specialized tests on prototypes, engineers turned to ATE machines to verify and characterize prototypes. ATE machines, however, are designed for volume production testing and often lack the flexibility or versatility to efficiently test whether, and within what limits, a given part works, or to efficiently analyze why it fails.

Production testing is a principal element in the cost structure of semiconductors. Purchasers of production testers now examine more carefully the total cost of ownership of ATE comprised of the initial purchase price of the tester, as well as the tester’s reliability, flexibility, size, power and cooling requirements, ability to upgrade, maintenance and spare parts costs.

6

The semiconductor manufacturers have increasingly shifted performance testing towards wafer probe which imposes new requirements on ATE. Wafer probe testing requires that the device under test be located in close physical proximity to the measuring circuits of the tester in order to minimize potential signal distortions that can negatively impact testing yields. Smaller testers can more easily be placed in close physical proximity to the circuits. In addition, wafer probe testing typically occurs in a clean room where potential contaminants must be continually removed and temperatures kept constant. These special maintenance requirements make clean rooms expensive to operate. Smaller testers occupy less floor space and therefore assist in reducing clean room costs. In addition, smaller testers that consume less power generally have reduced air conditioning requirements.

Technical, economic and market trends have created a significant need for an integrated design to production test flow that includes photo emission based optical diagnostic tools, specialized engineering validation test products and high performance, cost effective ATE. Additionally, the market is requiring solutions that enable engineers to develop and debug production test software and ATE interface equipment, or fixtures, in parallel with the design and validation of IC prototypes to increase the process parallelism and improve device time to market.

The Credence Solution and Strategy

Our objective is to be the leading supplier of semiconductor test solutions from design through production test. This includes high performance IC engineering validation test systems, compelling silicon debug and diagnostic systems, and cost-effective ATE for production testing of ICs used in high volume applications.

We provide high performance IC engineering solutions that address the engineering, debug and validation requirements of increasingly complex devices. Our engineering validation test systems test logic devices, mixed-signal devices that combine both analog and digital functionality and memory devices. Our engineering validation test systems can also be used to test selected functions of highly integrated SoC devices. By keeping pace with the industry’s advances in speed and pin count requirements, our solutions enable customers to reduce the time required for verification, characterization and failure analysis. This generally results in lower cost of design, reduced time-to-market and increased competitiveness for the companies designing today’s increasingly complex ICs. Our validation systems give engineers a more flexible and cost-effective way to verify and characterize prototype ICs and to perform failure analysis. Each validation system integrates the functions of a variety of individual test instruments into a single system that offers increased verification and characterization performance with significant cost savings. Our engineering validation test technology allows our systems to send and receive data from an IC at the same speeds the circuit will experience in actual use. As a result, design and test engineers can better identify failures, assess areas of concern, run rapid diagnostic sequences to pinpoint the causes of failure and identify changes needed to correct design errors or weaknesses. We also provide unique solutions for advanced silicon debug, characterization and device failure analysis. Incorporating innovative time resolved emission technology for the backside timing measurement of a wide range of devices from complex multi-layer metal devices in flip-chip packages, to more traditional devices with conventional wire bond and tape automated bonding packaging technologies, this technology helps semiconductor manufacturers bring products to market faster with fewer mask re-designs and at a lower cost. Additionally, our engineering solutions accelerate failure analysis problem resolution with integrated test and diagnostic systems and integrated feedback to the major EDA products. Our solutions provide IC manufacturers shorter design cycles and faster failure resolution, improving profit opportunities and minimizing failure impact.

Cost of ownership is a critical parameter in choosing ATE platforms. Credence has traditionally excelled in this area, developing proprietary complementary metal oxide semiconductor, or CMOS, stabilization methods that minimize the drift characteristic of CMOS and enable us to produce ATE production test systems and instruments that are smaller and require less power than those based on emitter-coupled logic, or ECL, technology. These testers and instruments are intended to provide a lower total cost of ownership than many competing products currently available while meeting the performance demands of today’s ATE market. CMOS technology allows the circuits used in our testers to be reduced, or scaled down in size, as IC process technology

7

improves. This scalability enables us to develop and manufacture smaller circuits for use in our testers at what we believe to be a lower cost and with a potentially shorter development cycle, than traditional process technologies.

Although cost is critical in ATE, many high end applications require extreme stability and accuracy. With our acquisition of NPTest in 2004, we have increased our high-end test technology. NPTest was a leader in high performance bipolar ECL and Silicon Germanium, or SiGe, circuitry. We believe that this technology, combined with Credence’s traditional cost focus, will allow us to provide scalable solutions that can meet both the high performance requirements seen in SoC characterization and the strict cost goals of high volume production.

Our business strategy incorporates the following key elements:

• Maintain Technological Competitiveness.    Our broad and deep technology portfolio enables testing of high-speed digital, mixed signal, Radio Frequency, or RF, linear and automotive devices in high-volume production as well as the highly demanding engineering test areas. We believe that leverage of this technology portfolio and the scalability of our technology will allow us to offer new products and enhancements in a potentially shorter time and at a lower cost than many of our competitors.

• Provide Innovative Solutions to Test Increasingly Complex Devices.    We will continue to keep pace with rapid advances in IC circuit design and test by introducing new engineering and production test systems, optical debug and diagnostic systems and related solutions designed to test higher speed buses and more complex and higher pin count devices. We intend to continually enhance our existing systems to add valuable features and functions that meet our customers’ evolving needs.

• Lower Total Cost of Ownership.    We seek to provide test solutions to our customers at a significantly lower total cost of ownership than competing products currently available while meeting the performance requirements of our customers. We believe that the system price, reliability, flexibility, size, power consumption, upgradeability and maintenance costs, including spare parts, of our testers enable our customers to more cost effectively test ICs.

• Provide Solutions to Reduce Time-to-Market and Improve Yields.    We believe that our customers require increasing levels of sophisticated tools to integrate the design to production test flow, assist in the utilization of ATE, minimize time-to-market and improve device yields. We offer a unique silicon debug, diagnostic and failure analysis methodology that enables transistor-level failure location. Incorporating leading high-speed opto-electronic Infra Red, or IR, detection and imaging technology, our Emiscope product line provides critical information to rapidly locate timing problems in new or failing devices. We believe our cost effective test systems that integrate design and test enable us to provide leading edge solutions to minimize time to market and extract the best yields from the manufacturing process.

• Target Diverse, High-Volume Markets.    Our products target the testing of digital logic, analog mixed-signal, SoC, memory and radio frequency devices that are used in a broad range of growing end-user market segments. Our products are designed to test semiconductors that are manufactured in high volume and are used in a variety of applications such as automobiles, appliances, personal computers, personal communications products, networking products, digital televisions and multimedia hardware and communications infrastructure.

• Leverage Relationships with Industry Leaders to Enhance Market Position.    We will continue to build close working relationships with integrated circuit manufacturers, EDA software vendors and wafer probe and device handler vendors to enhance our market position. Working closely with integrated circuit manufacturers helps us anticipate their needs and incorporate specific value-added functionality into our products. We believe our relationships with leading EDA software vendors allow us to design and offer products that can effectively exchange data to perform validation tests and silicon debug and refine production test programs and perform yield optimization. Our relationships with several leading wafer probe and device handler vendors strengthen our ability to develop total solutions required to drive the cost of test significantly lower.

8

• Worldwide Technical Support and Customer Service.    As semiconductor manufacturers expand their operations worldwide, they require global support, service and training. To meet this requirement, we utilize a combination of direct sales, service and support personnel and a broad network of independent distributors located in close proximity to major customer sites. We currently maintain locations throughout the world to service and support our customers.

Products

We currently offer a wide variety of products that test digital logic, analog, mixed-signal, SoC, non-volatile or memory and RF wireless ICs. Digital logic semiconductors produce discrete on and off logical sequences that control functions, store data, retrieve data and move and manipulate data at high rates of speed. Analog semiconductors control external functions such as sound, graphics, power management and motor controls by producing continuous varying voltage or current signals. When these analog functions are combined onto a digital IC, the resulting device is considered a mixed-signal device and as the levels of integration increase, the circuit is termed as SoC device. Non-volatile memory, or NVM, semiconductors retain their data when the power is turned off. RF wireless ICs are the devices that receive, transmit and convert radio frequency signals typically used in cellular telephones and other communications devices.

During fiscal 2004, we acquired NPTest, headquartered in San Jose, California, USA. NPTest designed, developed and manufactured advanced semiconductor test and diagnostic systems and provided related services for the semiconductor industry. The NPTest business traced its history to 1965 when Fairchild Semiconductor established an automated test equipment division. In 2003, NPTest launched the Sapphire platform with initial shipments in December of 2003. This highly scalable platform competes in the mid/high end SoC test market, taking advantage of NPTest’s strength in high performance test along with superior test economics. Credence now intends to focus its ongoing high end SoC test development on the Sapphire platform.

We are organized into four application focused groups consisting of the SoC Products Group or SPG, the Analog and Mixed Signal Product Group or AMS, the Memory Product Group or MPG and the Diagnostics and Characterization Group or DCG.

9

The following table sets forth our current product offerings, their features and examples of typical devices tested by each product. Included in some of the basic features are the anticipated cycle speed in megahertz, timing accuracy in either picoseconds (ps) or nanoseconds (ns), the number and characteristics of the pins and the density, in megabits (Mb), of the device that can be tested:

Product Group	Series	Models	Basic Features	Typical Devices Tested
System on Chip	Sapphire	Sapphire	>1024 digital pins 200Mb/s to >6.4 Gb/s Better than +/- 50 ps accuracy >300A power Analog and Serial instruments for Audio, Video, Cellular baseband, xDSL, GigE, PCI Express, S-ATA, HDD read channel, OC-48. Compact, scalable infrastructure. Universal test head slots for maximum flexibility.	Microprocessors, graphics, chipsets, multimedia devices, mass storage, and complex high performance consumer devices
Analog and Mixed-Signal	Sapphire D	Sapphire D-10	200 Mbps with 96 channels per card 16 channels at 2A each, 4 quadrant Audio, video instruments Compact, scalable, air cooled Optimized multi-site test architecture	Microcontrollers, personal consumer devices, baseband, and display drivers
	ASL	ASL 3000	Up to 32 analog instruments with expansion for up to 64 pins of digital and DSP instruments. Up to 16 ports of 6GHz RF with Analog and digital instruments using MVNA technology.	Personal communications, A/D and D/A converters as well as multi-site test of traditional linear devices. Wireless communications IC such as PAs, low noise amplifiers, mixers and synthesizers. Bluetooth, CDMA, GSM and 802.11 WLAN compatible devices
		ASL 1000	Up to 19 analog instruments with 32 digital pins 25MHz	Analog or Linear IC such as battery power management IC. Traditional linear devices such as op-amps, comparators and regulators
	Falcon		Up to 32 analog instruments with expansion for up to 128 pins of digital and DSP instruments.	Automotive and mixed signal devices
	Piranha		Up to 64 pins 50 MHz digital	Automotive and mixed signal devices
Memory	KALOS 2	Personal K2 Kalos 2	192 pins 72 independent sites, 3456 pins 100/400 MHz Up to 2G fail memory +/-350 ps accuracy	Memories, EEPROM, EPROM, MROM, and NVM ASICs

10

Product	Series	Models	Basic Features	Typical Devices Tested
Diagnostics & Characterization Products	Complete lab design test solution	Complete Lab	Next generation debug and analysis: Expandable and configurable solution set includes NEXS framework software and frontside fixed probe technology	All flip chip devices and many wirebond-packaged devices using 65nm design rules
	Emission Based Optical Probers	EmiScope IIt	Debug and failure analysis: Expandable, configurable timing and logic optical probing system for advanced device analysis	All flip chip devices and many wirebond-packaged devices proven to below 90nm design rules
	Laser-Based Failure Localization	GlobalScan-I	Debug and failure analysis: Expandable system for localization and characterization of device failures and performance yield improvement	All flip-chip and many wirebond-packaged devices proven to below 90nm design rules
	Focused Ion Beam	P3X-II	Failure analysis, identify and repair circuit layout mainly in outer metal layers
		OptiFIB	Failure analysis, identify and repair circuit layout mainly in inner metal layers
	Emission Microscopy	IREM-1	Failure analysis, yield improvement and design debug. A fault localization system for both photo emission and thermal emission spectrums.	All device and package types
		IREM-II	Failure analysis, yield improvement and design debug. A fault localization system optimized for the photo emission spectrum. Extremely high sensitivity system.	All device types

System on Chip Products

Sapphire.    Sapphire is the first scalable platform to be brought to market for testing high performance microprocessors, chipsets and consumer devices. This high performance SoC configurable test platform first shipped in December 2003. It is designed to be a highly reconfigurable and scalable functional and structural tester for a wide range of ICs. All of Sapphire’s test electronics are integrated in the test head and interconnected by a proprietary high bandwidth bus, which results in a lower cost platform and a smaller footprint. Sapphire is used for silicon debug and validation, characterization, wafer sort and final test. The design supports a broad configuration range of up to 5,000 pins and a performance envelope that ranges from 200 Mb/s to >6.4 Gbps. Higher volume Sapphire instrument cards are the 4064 (64 channels at 400 Mbps), 1616 (16 channels at 1.6 Gbps), 3208 (8 channels at 3.2 Gbps), and QBIX (audio and video signal generation and capture). Delivery of 6.4 Gbps instrument cards has begun and the initial units have been accepted. The scalable platform allows these instruments as well as other announced instruments to then be easily configured to test devices demanding compelling performance (e.g. PCI Express 2 on graphics chips or very high-speed serial front side buses on state of the art microprocessors).

11

Analog and Mixed-Signal Products

Sapphire D.    Introduced in fiscal 2005, the Sapphire D extends the key attributes of the Sapphire into a cost effective test platform addressing the more cost driven markets such as personal consumer devices, micro-controllers, digital-baseband and display driver technologies. The Sapphire D architecture is highly configurable and focused on extending scalability into massive multi-site testing, which results in a superior cost of test model for our customers. The Sapphire D leverages electronics integration and air-cooling to produce a compact form factor. The Sapphire D is used for engineering as well as wafer sort and final production testing. Sapphire D initial introductory instruments are the DPIN 96 (96 channels at 200 Mbps) and mixed-signal instruments for video and audio testing. Initial Sapphire D production test systems have been shipped, installed and accepted.

ASL 3000.    Introduced in fiscal 2002, the ASL 3000 is an extension of the ASL product line featuring an increased number of mixed signal instruments, expansion to 64 pins of digital capability and DSP based mixed signal test. The ASL 3000 is capable of testing more complex devices and more devices in parallel and targets a wide range of ICs used in personal communications. Our RF wireless test products provide tools to IC manufacturers for use in characterization and production test of high performance, cost sensitive RF devices. Incorporating our proprietary Modulated Vector Network Analysis, or MVNA, technology to test RF devices, the ASL 3000RF is targeted at cost effective testing of RF front-end devices that are typically manufactured using Gallium Arsenide, or GaAs, Bi-polar or Bi-CMOS technology. The devices, power amplifiers, or PAs, low noise amplifiers, or LNAs, synthesizers, mixers and switches and integrated combinations of these, or base band chips, are used in both digital and analog cell phones. Providing capability to test devices compliant with Bluetooth and 802.11 standards, the ASL 3000RF delivers high performance, high throughput and leading cost of test economics.

ASL 1000.    The ASL 1000 product line tests the traditional analog function blocks such as amplifiers, regulators, switches and converters either as individual ICs or as larger function ICs such as battery power management devices in portable electronics devices. The ASL 1000 was introduced in fiscal 1996. This system is highly configurable and targeted at testing the traditional analog building block ICs. As the traditional analog or linear device producers move to more efficient manufacturing, the multi-site test capability of the ASL 1000 has proven to be very effective at reducing their cost of test.

Falcon.    The Falcon is a high-performance analog and mixed-signal test system that offers unique analog, Digital Signal Processing, or DSP, and other digital capabilities for automotive, smart power and consumer devices. Falcon delivers high throughput with a 200 MHz digital sequencer per channel architecture and reduces test costs through its high-speed computer/tester interface, and parallel, multi-site and concurrent test capabilities. The Falcon offers an innovative tester-per-pin technology for analog and digital applications, as well as special automotive pins offering a voltage swing up to a 30 V. The Falcon also features Gigalink, a new high-speed serial bus system and AWT, a new analog wave tool.

Piranha.    The Piranha is an analog and mixed-signal test system that provides a cost-effective solution for high volume devices with low and medium pin counts. The Piranha uses the same technology as the Falcon in a smaller housing without a test head. With frequencies up to 50 MHz digital and up to 64 pins, the Piranha also features multi-site and parallel test capabilities to lower test costs.

Memory Products

Kalos 2.    Kalos 2 was introduced in fiscal year 2003 and represents the next generation non-volatile memory testers. With industry leading speed and innovative tester on a chip, or ToC, architecture, the Kalos 2 products provide the highest level of parallel test capabilities. Coupled with minimal footprint and complete engineering to production test coverage, the Kalos 2 delivers the lowest overall cost of test for NVM devices. The Kalos 2 can support up to 32 test sites, enabling testing of high pin count NVM and memory core microcontroller devices.

Personal Kalos 2.    Personal Kalos 2 is a desktop engineering version of the high-throughput Kalos 2 tester.

12

Diagnostics & Characterization Products

Complete Lab for Device Analysis and Debug

Complete laboratory design test solution.    An industry-first, the complete lab assists integrated device manufacturers, or IDMs, and fabless semiconductor companies to reduce the time it takes to bring products to market. This next generation suite of products includes design debug, circuit editing, and advanced microscopy tools integrated with navigation software and a new frontside fixed probe technology. Specifically, the complete solution targets 65nm designs by combining the EmiScope-III, GlobalScan-III, OptiFIB-III and P3X-III, all third generation debug and Focused Ion Beam, or FIB, tools with the IREM-II and IREM-XP next generation advanced microscopy tools. The Navigation Exchange Server, or NEXS, framework provides full navigation and links to third-party schematic and layout tools. Finally, the new frontside probe solution allows low-cost and easy to use test setups.

Emission based optical probers

EmiScope-IIt.    A configurable, expandable platform for non-invasive, transistor-level internal signal probing of silicon ICs. The EmiScope-IIt is the industry-leading solution for debug of flip-chip packaged and multi-metal layer devices. Using innovative time-resolved photon emission detection technology, the system enables semiconductor manufacturers to perform debug and characterization more quickly and effectively, thus bringing products to market faster, with fewer design respins. The system’s high-bandwidth electronics, high-resolution imaging, and data management capabilities enable semiconductor manufacturers to perform timely design debug, failure analysis and characterization. The EmiScope-IIt offers multiple user options, including five lens sets for a variety of package types, high-power cooling, flexible fixturing and software data analysis modules. The EmiScope-IIt can also be field upgraded with GlobalScan technology as customer needs grow.

Laser-based failure localization

GlobalScan-I.    A configurable platform for fault and design marginality localization, the GlobalScan-I features innovative laser-scanning microscope or LSM technology. It supports the same options as the EmiScope-IIt, including five lens sets, a common software base, and flexible fixturing and cooling options. In its fault isolation mode, the GlobalScan system quickly pinpoints resistive metal interconnections, opens and other traditional manufacturing faults, allowing manufacturers to solve critical yield problems quickly and efficiently. In its performance marginality localization mode, the GlobalScan-I identifies regions of a circuit which are limiting performance at specific speeds, voltages, or temperature conditions, allowing device designers to implement design fixes efficiently and with fewer design respins. The GlobalScan-I system can also be field upgraded to EmiScope functionality as customer needs grow.

Focused Ion Beam Products

P3X-II.    The IDS P3X-II is the most advanced Focused Ion Beam product used for circuit edit and repair of devices that use 90nm and beyond process technology. The IDS P3X-II combines ion column with a CAD navigation interface, which enables the user to align FIB and CAD images simultaneously. In failure analysis, the IDS P3X-II can identify and repair circuit layout mainly in outer metal layers. The system can provide an option to edit 300mm wafers.

OptiFIB.    The IDS OptiFIB is a Focused Ion Beam product used for circuit edit and repair. The IDS OptiFIB is unique because it combines ion and photon optics in a single coaxial column with a CAD navigation interface, which enables the user to align FIB and CAD images simultaneously, increasing the accuracy of circuit modification. In failure analysis, the IDS OptiFIB can identify and repair circuit layout at inner metal layers. The system can provide option to edit 300mm wafers.

13

Emission Microscopy

IREM-I and II.    The IREM-I and II are advanced emission microscopes that provide unmatched sensitivity in fault identification and defect localization for developer’s of advanced, low-voltage, high-density semiconductor devices. The IREM-II with its high sensitivity InGaAs focal plane array and proprietary high numerical aperture optics, is optimized for photo emission applications. And while optimized for photo emissions applications, “swapping” to thermal emission microscopy applications, employing the IREM-I MCT detector, is easily accomplished.

Customers, Markets and Applications

We target digital logic, analog, mixed-signal, non-volatile memory, RF and SoC device manufacturers that serve a broad range of growing end-user market segments. Our customers design, manufacture and test semiconductors in high volume for use in applications such as automobiles, appliances, personal computers, personal communications products, networking products, digital televisions, wireless Local Area Network, or LAN, and multimedia hardware.

In addition to marketing our products to major semiconductor manufacturers, we have developed relationships with numerous assembly and test services companies. Semiconductor manufacturers and fabless semiconductor companies utilize these subcontractors as a means of lowering their fixed production costs, thus minimizing the effects of cyclicality inherent in the semiconductor industry. As a result, these assembly and test services companies are an increasingly important segment of the ATE market.

Intel Corporation, headquartered in the United States, accounted for 25% and 11% of our net sales in fiscal 2005 and 2004, respectively. Advanced Micro Devices, Inc., headquartered in the United States, accounted for 14% of our net sales in fiscal 2005. STMicroelectronics N.V., headquartered in Europe, accounted for 15% of our net sales in fiscal 2004.

We believe that our success depends in large part upon the success of our major customers. The loss of, or any reduction in, orders by a significant customer (including the potential for reductions in orders by assembly and test services companies which that customer may utilize), including reductions due to market, economic or competitive conditions in the semiconductor industry or in other industries that manufacture products utilizing semiconductors has materially adversely affected and may continue to materially adversely affect our business, financial condition and results of operations. Our ability to increase sales in the future will depend in part upon our ability to obtain orders from new customers as well as upon the financial condition and success of our customers and the general global economy. There can be no assurance that our sales will not decrease in the future or that we will be able to retain existing customers or to attract new ones.

For information on our geographic data and major customers, see Note 4—“Industry Segments and Concentration of Risks,” of the Notes to the Consolidated Financial Statements included elsewhere herein. Our international sales are primarily denominated in United States dollars. We anticipate that our international business will continue to account for a significant portion of net sales in the foreseeable future. See “Risk Factors—Our international business exposes us to additional risks.”

Backlog

We schedule production of our systems based upon order backlog and order forecast. We include in our backlog only those customer orders for systems (including upgrades) for which we have accepted purchase orders and assigned shipment dates in approximately the following six months. Substantially all of our orders are subject to cancellation or rescheduling by the customer with limited or no penalties. Our backlog at any particular date may not necessarily be representative of actual sales for any succeeding period due to orders received for systems to be shipped in the same quarter, possible changes in system delivery schedules, cancellation of orders and potential delays in system shipments. As of October 31, 2005, our order backlog for systems, exclusive of

14

orders for spare parts, service and support, was approximately $134.9 million plus an additional $8.8 million of deferred revenue under Staff Accounting Bulletin 104, “Revenue Recognition,” (SAB 104), as compared with $174.9 and $19.9 million, respectively, as of October 31, 2004. We have historically experienced order cancellations and customer-requested shipment delays in connection with cyclical downturns in the semiconductor industry. We believe it is probable that order cancellations and customer-requested shipment delays will continue to occur in the future.

Sales, Service and Support

We currently market and sell our products in the United States and Europe principally through our direct sales organization, with direct sales employees and representatives in over 14 locations. Outside the United States and Europe, we utilize both direct sales employees and a broad network of distributors, with direct sales employees and distributors in over 18 countries. Shipments through distributors represented approximately 20%, 35% and 28%, of net sales during fiscal years 2005, 2004 and 2003, respectively.

Our distributors and we have sales and support centers located in the United States, Europe, Israel, and Asia from which both direct Credence personnel and independent sales and service representatives sell and support our products. We believe that field support is critical to our customers. Support encompasses many of the components of the total cost of ownership for test equipment. We seek to develop long-term relationships with major customers through extensive support consisting of teams of professional sales, applications, training and service personnel. These personnel are located in close physical proximity to key customer sites in order to provide the required support in a timely fashion. The sales process includes consultations with customers to help them purchase the most cost-effective equipment for their needs, to help develop custom test programs to optimize production throughput, to assist in long-term self-sufficiency through training of customer test engineering personnel and to provide the service capacity and preventive maintenance to reduce downtime for customers’ systems. Customer support includes field personnel and in-house applications personnel who work closely with design engineering groups to modify existing equipment to meet the latest performance requirements.

Our standard policy is to warrant our new systems against defects in design, materials and workmanship for one year for parts and labor. We offer customers additional support after the warranty period in the form of maintenance contracts for specified time periods. Such contracts include various options such as board replacement, priority response, planned preventive maintenance, scheduled one-on-one training, daily on-site support and monthly system and performance analysis.

Research and Development

The engineering validation test, emission-based optical diagnostics, failure analysis and ATE markets are subject to rapid technological change and new product introductions. Our ability to be competitive in this market will depend in significant part upon our ability to successfully develop and introduce new products, enhancements and related tools on a timely and cost-effective basis. This will enable customers to integrate our products into their operations as they begin volume manufacturing of the next generation of semiconductors.

Historically we have pursued a technology acquisition strategy to complement our internal research and development efforts. This strategy has included the acquisitions of businesses, product lines, instruments and technology such as the NPTest and Optonics acquisitions. The NPTest acquisition introduced us to the Sapphire product which is a scalable platform for testing high performance microprocessors, chipsets and consumer devices. The Optonics acquisition added emission based optical diagnostics and failure analysis products to our product portfolio.

Our ongoing research and development efforts include focusing on increased cycle speed, accuracy, jitter and pin counts of our testers, as well as joint use of technology among our products group. We will continue to

15

focus efforts on providing solutions that allow more rapid, cost-effective development of ATE test programs that reduce time-to-market of customer integrated circuit designs. We will continue to invest significant resources in the development of new products and enhancements for the foreseeable future.

Research and development expenses were $92.5 million for fiscal 2005, $80.5 million in fiscal 2004 and $73.5 million in fiscal 2003 (excluding acquisition related charges for in-process research and development, or IPR&D).

Proprietary Rights

We attempt to protect our intellectual property rights through patents, copyrights, trademarks and maintenance of trade secrets and other measures. Our current patent portfolio includes approximately 272 United States patents plus foreign counterparts. Our patent portfolio growth was due to a combination of pursuing our ongoing patent filing and prosecution activities and the acquisition of patents as part of our merger activities. Our patents relate to a range of technologies including features of our products. From time to time we grant licenses under our patents and technology and receive licenses under patents and technology from others.

There can be no assurance that others will not independently develop equivalent intellectual property or that we can meaningfully protect our intellectual property. There can be no assurance that any patent we own will not be invalidated, circumvented or challenged, that the rights granted thereunder will provide competitive advantages to us or that any of our pending patent applications will be issued. Furthermore, there can be no assurance that others will not develop similar products, duplicate our products or design around the patents owned by us. In addition, litigation has been and may continue to be necessary to enforce our patents and other intellectual property rights, to protect our trade secrets, to determine the validity and scope of the proprietary rights of others, or to defend against claims of infringement or invalidity. In addition, from time to time we encounter disputes over rights and obligations concerning intellectual property. We cannot assume that we will prevail in any such intellectual property disputes. For additional information with respect to our intellectual property, review the information set forth under “Risk Factors—If the protection of proprietary rights is inadequate, our business could be harmed” and “—Our business may be harmed if we are found to infringe proprietary rights of others.”

Manufacturing and Suppliers

Our manufacturing objective is to produce engineering validation test systems and ATE that conform to our customers’ requirements at the lowest commercially practical manufacturing cost. We rely on outside vendors to manufacture certain components and subassemblies including several custom ICs. We seek to manage our inventory levels through agreements with both suppliers and subcontractors that provide just-in-time delivery of these components and subassemblies. We assemble these components and subassemblies to create finished testers in the configurations specified by our customers. In general, we use standard components and prefabricated parts available from numerous suppliers. However, some components and subassemblies necessary for the manufacture of our testers are obtained from a sole supplier or a limited group of suppliers. Our reliance on a sole or a limited group of suppliers and on outside subcontractors involves certain risks, including a potential inability to obtain an adequate supply of required components, and reduced control over pricing and timely delivery of components. See “Risk Factors—There are limitations on our ability to find the supplies and services necessary to run our business.”

Competition

The ATE industry is intensely competitive. We face substantial competition throughout the world, primarily from ATE manufacturers located in the United States and Japan, as well as from some of our customers. These competitors include, among others, Teradyne Inc., Agilent Technologies, Inc., Advantest Corporation, Eagle Test Systems, Inc., Nextest Systems Corporation and LTX Corporation and, with respect to certain of our diagnostics and characterization products, Hamamatsu Corporation and FEI Company.

16

The principal elements of competition in our markets and the basis upon which our customers select engineering validation testers and ATE include throughput, tools for reducing customer product time-to-market, product performance and total cost of ownership. We believe that we compete favorably with respect to these factors. See Risk Factors—“The ATE industry is intensely competitive which can adversely affect our ability to maintain our current net sales and revenue growth.”

Employees

As of October 31, 2005, we had a total of 1,631 direct employees and 179 temporary or contract employees. Of the 1,631 direct employees, 572 employees are in manufacturing and customer service, 480 employees are in research and development and 579 employees are in selling, general and administrative functions. Our employees are highly skilled, and we believe our future results of operations will depend in large part on our ability to attract and retain such employees. None of our domestic employees are represented by a labor union, and we have not experienced any work stoppages. We consider our employee relations to be good.

17

Item 1A. Risk Factors

Our operating results have fluctuated significantly which has adversely affected and may continue to adversely affect our stock price.

A variety of factors affect our results of operations. The above graph illustrates that our quarterly net sales and operating results have fluctuated significantly. We believe they will continue to fluctuate for several reasons, including:

• worldwide economic conditions in the semiconductor industry in general and capital equipment industry specifically;

• loss of certain key customers who account for large portions of our revenue;

• patterns of capital spending by our customers, delays, cancellations or reschedulings of customer orders due to customer financial difficulties or otherwise;

• market acceptance of our new products and enhanced versions of existing products;

• changes in overhead absorption levels due to changes in the number of systems manufactured, the timing and shipment of orders, availability of components including custom integrated circuits, or ICs, subassemblies and services, customization and reconfiguration of our systems and product reliability;

• our manufacturing capacity and ability to volume produce systems, including our newest systems, and to meet customer requirements;

• manufacturing inefficiencies associated with the start-up of our new products, changes in our pricing or payment terms and cycles, and those of our competitors, customers and suppliers;

• our ability to attract and retain qualified employees in a competitive market;

• timing of new product announcements and new product releases by us or our competitors;

18

• write-offs of excess and obsolete inventories and accounts receivable that are not collectible;

• labor and materials supply constraints;

• expenses associated with acquisitions and alliances, including expenses charged for any impaired acquired intangible assets and goodwill;

• operating expense reductions associated with cyclical industry downturns, including costs relating to facilities consolidations and related expenses;

• the proportion of our direct sales and sales through third parties, including distributors and OEMs, the mix of products sold, the length of manufacturing and sales cycles, and product discounts; and

• natural disasters, political and economic instability, currency fluctuations, regulatory changes and outbreaks of hostilities, especially in Asia.

We intend to introduce new products and product enhancements in the future, the timing and success of which will affect our business, financial condition and results of operations. Our gross margins on systems sales have varied significantly and will continue to vary significantly based on a variety of factors including:

• long-term pricing decreases by us and our competitors and pricing by our suppliers;

• manufacturing volumes;

• manufacturing inefficiencies;

• hardware product sales mix;

• absorption levels and the rate of capacity utilization;

• inventory write-downs;

• new product introductions;

• product reliability;

• customization and reconfiguration of systems;

• the possible sale of inventory previously written-off;

• international and domestic sales mix and field service margins; and

• ceasing investment in underperforming or redundant product lines.

New and enhanced products typically have lower gross margins in their early stages of commercial introduction and production, and we may build substantial finished goods inventories of such new products. If delays in or cancellations of orders for those products occur, it may require future inventory write-offs, which would negatively affect our future financial performance. Although we have recorded and continue to record inventory write-offs, product warranty costs, and deferred revenue, we cannot be certain that our estimates will be adequate.

We cannot forecast with any certainty the impact of these and other factors on our sales and operating results in any future period. Results of operations in any period, therefore, should not be considered indicative of the results to be expected for any future period. Because of this difficulty in predicting future performance, our operating results may fall below the expectations of securities analysts or investors in some future quarter or quarters. Our failure in the past to meet these expectations has adversely affected the market price of our common stock and may continue to do so. In addition, our need for continued significant expenditures for research and development, marketing and other expenses for new products, capital equipment purchases and worldwide training and customer service and support will impact our sales and operations results in the future. Other significant expenditures may make it difficult for us to reduce our significant fixed expenses in a particular

19

period if we do not meet our net sales goals for that period. Many of these expenses are fixed and will be difficult to reduce in a particular period if our net sales goal for that period is not met. As a result, we cannot be certain that we will be profitable in the future.

The semiconductor industry is cyclical.

The semiconductor equipment industry is highly cyclical. Our business and results of operations depend largely upon the capital expenditures of manufacturers of semiconductors and companies that specialize in contract packaging and/or testing of semiconductors. This includes manufacturers and contractors that are opening new or expanding existing fabrication facilities or upgrading existing equipment, which in turn depends upon the current and anticipated market demand for semiconductors and products incorporating semiconductors. The timing, length and severity of the up-and-down cycles in the semiconductor equipment industry are difficult to predict. This cyclical nature of the industry in which we operate affects our ability to accurately predict future revenue and, thus, future expense levels. When cyclical fluctuations result in lower than expected revenue levels, operating results may be adversely affected and cost reduction measures may be necessary in order for us to remain competitive and financially sound. During a down cycle, we must be in a position to adjust our cost and expense structure to prevailing market conditions and to continue to motivate and retain our key employees. In addition, during periods of rapid growth, we must be able to increase manufacturing capacity and personnel to meet customer demand. We can provide no assurance that these objectives can be met in a timely manner in response to industry cycles. If we fail to respond to industry cycles, our business could be seriously harmed.

As a result of the cyclical nature of the semiconductor industry, we have experienced shipment delays, delays in commitments and restructured purchase orders by customers and we expect this activity to continue. Accordingly, we cannot be certain that we will be able to achieve or maintain our current or prior level of sales or rate of growth. We anticipate that a significant portion of new orders may depend upon demand from semiconductor device manufacturers building or expanding fabrication facilities and new device testing requirements that are not addressable by currently installed test equipment, and there can be no assurance that such demand will develop to a significant degree, or at all. In addition, our business, financial condition or results of operations may continue to be materially adversely affected by any factor materially adversely affecting the semiconductor industry in general or particular segments within the semiconductor industry.

Some of our revenue is generated from a small number of key customers and the loss of a key customer could substantially reduce our revenues and be perceived as a loss of momentum in our business.

Over time, we have expanded our base of customers; however, a large portion of our revenues are generated from a small number of key customers. In particular, two customers, Intel Corporation and Advanced Micro Devices, Inc., accounted for 25% and 14% of our net sales for fiscal 2005, respectively. Our top ten customers accounted for 66%, 55% and 45% of our net sales for fiscal 2005, 2004 and 2003, respectively. We expect that our top ten customers in the aggregate will continue to account for a large portion of our net sales for the foreseeable future, and the loss of one or more of these customers or collaborative partners would harm our business and operating results. The loss of a significant customer could also be perceived as a loss of momentum in our business and an adverse impact on our financial results, and this may cause the market price of our common stock to fall.

Implementation or changes to our enterprise resource planning system and other related systems may affect our business.

We may experience difficulties in implementing, making changes or enhancements to our enterprise resource planning (“ERP”) system and other related systems that could disrupt our ability to timely and accurately process and report key components of the results of our consolidated operations, our financial position and cash flows. Any disruptions or difficulties that may occur in connection with implementing, making changes or enhancements to our ERP system or any future systems could also adversely affect our ability to complete the

20

evaluation of our internal controls and attestation activities pursuant to Section 404 of the Sarbanes-Oxley Act of 2002. System failure or malfunctioning may result in disruption of operations and the inability to process transactions and could adversely affect our financial results.

Our ability to successfully bring our information technology functions in-house may affect our operations.

We are planning to bring our information technology, or IT, functions in-house, which is currently being administered by a third party vendor. This requires us to hire qualified individuals, implement appropriate additional IT controls and assume all responsibilities that are currently being handled by the third party vendor. Failure to successfully complete the transition may result in disruption of our operations and may have an adverse impact on our financial results.

Changes to financial accounting standards may affect our reported results of operations.

A change in accounting standards or practices can have a significant effect on our reported results and may even affect our reporting of transactions completed before the change is effective. New accounting pronouncements and varying interpretations of accounting pronouncements have occurred and may occur in the future. Changes to existing standards or the questioning of current practices may adversely affect our reported financial results or the way we conduct our business.

For example, the adoption of Statement on Financial Accounting Standard No. 123R “Share-Based Payment” which requires us to measure all employee stock-based compensation awards using a fair value method beginning in fiscal year 2006 and record such expense in our consolidated financial statements will have a material adverse impact on our consolidated financial statements as reported under generally accepted accounting principles in the United States. The adoption of this statement will adversely impact on our gross margin as well as operating expenses.

We have a limited backlog and obtain most of our net sales from products that typically range in price from $200,000 to $5.0 million and we generally ship products generating most of our net sales near the end of each quarter, which can result in fluctuations of quarterly results.

Other than certain memory products, for which the price range is typically below $50,000, we obtain most of our net sales from the sale of a relatively few number of systems that typically range in selling price from $200,000 to $5.0 million. This has resulted and could continue to result in our net sales and operating results for a particular period being significantly impacted by the timing of recognition of revenue from a single transaction. Our net sales and operating results for a particular period could also be materially adversely affected if an anticipated order from just one customer is not received in time to permit shipment during that period. Backlog at the beginning of a quarter typically does not include all orders necessary to achieve our sales objectives for that quarter. Orders in backlog are subject to cancellation, delay, deferral or rescheduling by customers with limited or no penalties. Throughout the recent fiscal years, we have experienced customer-requested shipment delays and order cancellations, and we believe it is probable that orders will be canceled and delayed in the future. Consequently, our quarterly net sales and operating results have in the past, and will in the future, depend upon our obtaining orders for systems to be shipped in the same quarter in which the order is received.

In the past, some of our customers have placed orders with us for more systems than they ultimately required. We believe that in the future some of our customers may, from time to time, place orders with us for more systems than they will ultimately require, or they will order a more rapid delivery than they will ultimately require. For this reason, our backlog may include customer orders in excess of those that will actually be delivered.

Furthermore, we generally ship products generating most of our net sales near the end of each quarter. Accordingly, our failure to receive an anticipated order or a delay or rescheduling in a shipment near the end of a particular period or a delay in receiving customer acceptance from a customer may cause net sales in a particular

21

period to fall significantly below expectations, which could have a material adverse effect on our business, financial condition or results of operations. The relatively long manufacturing cycle of many of our testers has caused and could continue to cause future shipments of testers to be delayed from one quarter to the next. Furthermore, as our competitors announce new products and technologies, and as we complete acquisitions of similar technologies, customers may defer or cancel purchases of our existing systems. We cannot forecast the impact of these and other factors on our sales and operating results.

We may continue to experience delays in development, introduction, production in volume, and recognition of revenue from sales of our products.

We have in the past experienced significant delays in the development, introduction, volume production and sales of our new systems and related feature enhancements. These delays related to our inability to successfully complete product hardware engineering within the time frame originally anticipated, including design errors and redesigns of ICs. As a result, some customers have experienced significant delays in receiving and using our testers in production. Delays in introducing a product or delays in our ability to obtain customer acceptance, if they occur in the future, will delay the recognition of revenue and gross profit by us. We cannot be certain that these or additional difficulties will not continue to arise or that delays will not continue to materially adversely affect customer relationships and future sales. Moreover, we cannot be certain that we will not encounter these or other difficulties that could delay future introductions or volume production or sales of our systems or enhancements. In the past, we have incurred and we may continue to incur substantial unanticipated costs to increase feature sets in our systems. If our systems experience reliability, quality or other problems, or the market perceives our products to be feature deficient, we may continue to suffer reduced orders, higher manufacturing costs, delay in collecting accounts receivable and higher service, support and warranty expenses, and/or inventory write-offs, among other effects. Our failure to have a competitive test system available when required by a customer could make it substantially more difficult for us to sell testers to that customer for a number of years. We believe that the continued acceptance, volume production, timely delivery and customer satisfaction of our newer digital, mixed signal and non-volatile memory testers are of critical importance to our future financial results. As a result, our inability to correct any technical, reliability, parts shortages or other difficulties associated with our systems or to manufacture and ship the systems on a timely basis to meet customer requirements could damage our relationships with current and prospective customers and would continue to materially adversely affect our business, financial condition and results of operations. In addition, the consolidation of our manufacturing operations in a single site exposes us to the increased risk of manufacturing delays or disruption in the event of natural disasters or other calamities at the site. Any delays or disruptions could materially adversely affect our business, financial condition and results of operations.

Competition in the ATE market requires rapid technological enhancements and new products and services.

Our ability to compete in the automatic test equipment or ATE market depends upon our ability to successfully develop and introduce new products and enhancements with enhanced features on a timely and cost-effective basis, including products under development internally as well as products obtained in acquisitions. Our customers require test systems with additional features, higher performance and other capabilities. Therefore, it is necessary for us to develop new systems and/or enhance the performance and other capabilities of our existing systems to adequately address these requirements. Any success we may have in developing new and enhanced systems and new features to our existing systems will depend upon a variety of factors, including:

• product selection;

• timely and efficient completion of product design;

• implementation of manufacturing and assembly processes;

• product performance;

• reliability in the field;

22

• effective worldwide sales and marketing; and

• labor and supply constraints.

Because we must make new product development commitments well in advance of sales, new product decisions must anticipate both future demand and the availability of technology to satisfy that demand. We cannot be certain that we will be successful in selecting, developing, manufacturing and marketing new hardware products or enhancements. Our inability to introduce new products that contribute significantly to net sales, gross margins and net income would have a material adverse effect on our business, financial condition and results of operations. New product or technology introductions by our competitors could cause a decline in sales or loss of market acceptance of our existing products. If we introduce new products, existing customers may curtail purchases of the older products resulting in inventory write-offs and they may delay new product purchases. In addition, capacity utilization at outsourced assembly and test houses continues at low levels which is likely to depress our non-integrated device manufacturers, or IDM business until such time that demand and supply conditions improve. Any decline in demand for our hardware products could have a materially adverse effect on our business, financial condition or results of operations.

We are continuing to invest significant resources in the expansion of our product lines and there is no certainty that our net sales will increase or remain at historical levels or that new products will contribute to revenue growth.

We are currently devoting and intend to continue to devote significant resources to the development, enhancement, production and commercialization of new products and technologies. During fiscal 2005, we introduced several enhancements as well as new products that are evolutions or derivatives of existing products as well as products that were largely new. Under our revenue recognition policy adopted in accordance with Staff Accounting Bulletin No. 104, “Revenue Recognition,” (SAB 104), we defer revenue for transactions that involve newly introduced products or when customers specify acceptance criteria that cannot be demonstrated prior to the shipment. This results in a delay in the recognition of revenue as compared to the historic norm of recognizing revenue upon shipment. Product introduction delays, if they occur in the future, will delay the recognition of revenue and gross profit and may result in delayed cash receipts by us that could materially adversely affect our business, financial condition and results of operations. We invested and continue to invest significant resources in property, plant and equipment, purchased and leased facilities, inventory, personnel and other costs to begin or prepare to increase production of these products. A significant portion of these investments will provide the marketing, administration and after-sales service and support required for these new products. Accordingly, we cannot be certain that gross profit margin and inventory levels will not continue to be materially adversely affected by delays in new product introductions or start-up costs associated with the initial production and installation of these new product lines. We also cannot be certain that we can manufacture these systems per the time and quantity required by our customers. The start-up costs include additional manufacturing overhead, additional inventory and warranty reserve requirements and the enhancement of after-sales service and support organizations. In addition, the increases in inventory on hand for new product development and customer support requirements have increased and will continue to increase the risk of significant inventory write-offs. We cannot be certain that our net sales will increase or remain at historical levels or that any new products will be successfully commercialized or contribute to revenue growth or that any of our additional costs will be covered.

The ATE industry is intensely competitive which can adversely affect our ability to maintain our current net sales and our revenue growth.

With the substantial investment required to develop test application and interfaces, we believe that once a semiconductor manufacturer has selected a particular ATE vendor’s tester, the manufacturer is likely to use that tester for a majority of its testing requirements for the market life of that semiconductor and, to the extent possible, subsequent generations of similar products. As a result, once an ATE customer chooses a system for the testing of a particular device, it is difficult for competing vendors to achieve significant ATE sales to such customer for similar use. Our inability to penetrate any particular large ATE customer or achieve significant sales to any ATE customer could have a material adverse effect on our business, financial condition or results of operations.

23

We face substantial competition from ATE manufacturers throughout the world. A substantial portion of our net sales is derived from sales of mixed-signal testers. We face in some cases five and in other cases seven competitors in our primary market segments of digital, mixed signal, and RF wireless ATE. We believe that the ATE industry in total has not been profitable for the last three years, indicating a very competitive and volatile marketplace. Several of these competitors have substantially greater financial and other resources with which to pursue engineering, manufacturing, marketing and distribution of their products. Certain competitors have introduced or announced new products with certain performance or price characteristics equal or superior to products we currently offer. These competitors have introduced products that compete directly against our products. We believe that if the ATE industry continues to consolidate through strategic alliances or acquisitions, we will continue to face significant additional competition from larger competitors that may offer product lines and services more complete than ours. Our competitors are continuing to improve the performance of their current products and to introduce new products, enhancements and new technologies that provide improved cost of ownership and performance characteristics. New product introductions by our competitors could cause a decline in our sales or loss of market acceptance of our existing products.

Moreover, our business, financial condition or results of operations will continue to be materially adversely affected by continuing competitive pressure and continued intense price-based competition. We have experienced and continue to experience significant price competition in the sale of our products. In addition, pricing pressures typically have become more intense during cyclical downturns when competitors seek to maintain or increase market share, at the end of a product’s life cycle and as competitors introduce more technologically advanced products. We believe that, to be competitive, we must continue to expend significant financial resources in order to, among other things, invest in new product development and enhancements and to maintain customer service and support centers worldwide. We cannot be certain that we will be able to compete successfully in the future.

We may not be able to deliver custom hardware options to satisfy specific customer needs in a timely manner.

We must develop and deliver customized hardware to meet our customers’ specific test requirements. The market requires us to manufacture these systems on a timely basis. Our test equipment may fail to meet our customers’ technical or cost requirements and may be replaced by competitive equipment or an alternative technology solution. Our inability to meet such hardware requirements could impact our ability to recognize revenue on the related equipment. Our inability to provide a test system that meets requested performance criteria when required by a device manufacturer would severely damage our reputation with that customer. This loss of reputation may make it substantially more difficult for us to sell test systems to that manufacturer for a number of years, which could have a material adverse effect on our business, financial condition or results of operations.

We rely on Spirox Corporation and customers in Taiwan for a significant portion of our revenues and the termination of this distribution relationship would materially adversely affect our business.

Spirox Corporation, a distributor in Taiwan that sells to end-user customers in Taiwan and China, accounted for approximately 14%, 23% and 19% of our net sales in fiscal years ended October 31, 2005, 2004 and 2003, respectively. Our agreement with Spirox has no minimum purchase commitment and can be terminated for any reason on 180 days prior written notice. On May 31, 2005, we entered into an agreement with Spirox to combine our Taiwan operation with Spirox’s T1 division into a corporation named Credence Spirox, an operation owned 90% by Spirox and 10% by us. This new corporation is dedicated to support our products in the Taiwan region. Consequently, our business, financial condition and results of operations could be materially adversely affected by the loss of or any reduction in orders by Spirox, any termination of the Spirox relationship, or the loss of any significant Spirox customer, including the potential for reductions in orders by assembly and tester service companies due to technical, manufacturing or reliability problems with our products or continued slow-downs in the semiconductor industry or in other industries that manufacture products utilizing semiconductors. Our ability to maintain or increase sales levels in Taiwan will depend upon:

• our ability with Spirox to obtain orders from existing and new customers;

24

• our ability to manufacture systems on a timely and cost-effective basis;

• our ability to timely complete the development of our new hardware products;

• Spirox and its end-user customers’ financial condition and success;

• general economic conditions; and

• our ability to meet increasingly stringent customer performance and other requirements and shipment delivery dates.

We have substantial indebtedness and if we need additional financing, it could be difficult to obtain.

We have $180 million principal amount of 1.5% Convertible Subordinated Notes, (Notes), due in 2008. We may incur substantial additional indebtedness in the future. The level of indebtedness, among other things, could:

• make it difficult for us to make payments on our debt and other obligations, particularly upon maturity of the Notes in 2008 if we were unable to cause the conversion of this debt into equity;

• make it difficult for us to obtain any necessary future financing for working capital, capital expenditures, debt service requirements or other purposes;

• require the dedication of a substantial portion of any cash flow from operations to service the indebtedness, thereby reducing the amount of cash flow available for other purposes, including capital expenditures;

• limit our flexibility in planning for, or reacting to changes in our business and the industries in which we compete;

• place us at a possible competitive disadvantage with respect to less leveraged competitors and competitors that have better access to capital resources; and

• make us more vulnerable in the event of a further downturn in our business.

There can be no assurance that we will be able to meet our debt service obligations, including our obligations under the Notes.

We expect that our existing cash and short-term investments will be sufficient to meet our cash requirements to fund operations and expected capital expenditures for the next twelve months. In the event we may need to raise additional funds, we cannot be certain that we will be able to obtain such additional financing on favorable terms if at all. Further, if we issue additional equity securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of common stock. Future financings may place restrictions on how we operate our business. If we cannot raise funds on acceptable terms, if and when needed, we may not be able to develop or enhance our products and services, take advantage of future business opportunities, grow our business or respond to competitive pressures, which could seriously harm our business.

We require a significant amount of cash, and our ability to generate cash may be affected by factors beyond our control.

Our business may not generate cash flow in an amount sufficient to enable us to fund our liquidity needs, including payment of the principal of, or interest on, our indebtedness, working capital, capital expenditures, product development efforts, strategic acquisitions, investments and alliances and other general corporate requirements. Our ability to generate cash is subject to general economic, financial, competitive, legislative, regulatory and other factors that are beyond our control. We cannot be assured that our business will generate sufficient cash flow from operations or that future borrowings or other sources of funding will be available to us, in amounts sufficient to enable us to fund our liquidity needs or with terms that are favorable to us.

25

We may repatriate cash from our foreign subsidiaries, which could result in additional income taxes that could negatively impact our results of operations and financial position. In addition, if foreign countries’ currency policies limit our ability to repatriate the needed funds, our business and results of operations could be adversely impacted.

One or more of our foreign subsidiaries hold a portion of our cash and cash equivalents. If we need additional cash to acquire assets or technology, or to support our operations in the U.S., and if the currency policies of these foreign countries allow us, we may repatriate some of our cash from these foreign subsidiaries to the U.S. Depending on our financial results and the financial results of our subsidiaries at the time that the cash is repatriated, we may incur additional income taxes from the repatriation, which could negatively affect our results of operations and financial position. In addition, if the currency policies of these foreign countries prohibit or limit our ability to repatriate the needed funds, our business and results of operations could be adversely impacted.

Our long and variable sales cycle depends upon factors outside of our control and could cause us to expend significant time and resources prior to earning associated revenues.

Sales of our systems depend in part upon the decision of semiconductor manufacturers to develop and manufacture new semiconductor devices or to increase manufacturing capacity. As a result, sales of our products are subject to a variety of factors we cannot control. The decision to purchase our products generally involves a significant commitment of capital, with the attendant delays frequently associated with significant capital expenditures. For these and other reasons, our systems have lengthy sales cycles during which we may expend substantial funds and management effort to secure a sale, subjecting us to a number of significant risks, including a risk that our competitors may compete for the sale, a further downturn in the economy or other economic factors causing our customers to withdraw or delay their orders or a change in technological requirements of the customer. As a result, our business, financial condition and results of operations would be materially adversely affected by our long and variable sales cycle and the uncertainty associated with expending substantial funds and effort with no guarantee that a sale will be made.

There are limitations on our ability to find the supplies and services necessary to run our business.

We obtain certain components, subassemblies and services necessary for the manufacture of our testers from a limited group of suppliers. We do not maintain long-term supply agreements with most of our vendors, and we purchase most of our components and subassemblies through individual purchase orders. The manufacture of certain of our components and subassemblies is an extremely complex process. We also rely on outside vendors to manufacture certain components and subassemblies and to provide certain services. We have experienced and continue to experience significant reliability, quality and timeliness problems with several critical components including certain custom ICs. We cannot be certain that these or other problems will not continue to occur in the future with our suppliers or outside subcontractors. Our reliance on a limited group of suppliers and on outside subcontractors involves several risks, including an inability to obtain an adequate supply of required components, subassemblies and services and reduced control over the price, timely delivery, reliability and quality of components, subassemblies and services. Shortages, delays, disruptions or terminations of the sources for these components and subassemblies have delayed and in the future may delay shipments of our systems and new products and could have a material adverse effect on our business. Our continuing inability to obtain adequate yields or timely deliveries or any other circumstance that would require us to seek alternative sources of supply or to manufacture such components internally could also have a material adverse effect on our business, financial condition or results of operations. Such delays, shortages and disruptions would also damage relationships with current and prospective customers and have and could continue to allow competitors to penetrate our customer accounts. We cannot be certain that our internal manufacturing capacity or that of our suppliers and subcontractors will be sufficient to meet customer requirements.

26

Our international business exposes us to additional risks.

International sales accounted for approximately 69%, 72% and 64% of our total net sales in fiscal years 2005, 2004 and 2003, respectively. We anticipate that international sales will continue to account for a significant portion of our total net sales in the foreseeable future. These international sales will continue to be subject to certain risks, including:

• changes in regulatory requirements;

• tariffs and other barriers;

• political and economic instability;

• the adverse effect of fears surrounding any health risks on our business and sales and that of our customers, especially in Taiwan, Hong Kong and China;

• an outbreak of hostilities in markets where we sell our products, including Korea and Israel;

• integration and management of foreign operations of acquired businesses;

• foreign currency exchange rate fluctuations;

• difficulties with distributors, joint venture partners, original equipment manufacturers, foreign subsidiaries and branch operations;

• potentially adverse tax consequences;

• the possibility of difficulty in accounts receivable collection;

• greater difficulty in maintaining U.S. accounting standards; and

• greater difficulty in protecting intellectual property rights.

We are also subject to the risks associated with the imposition of domestic and foreign legislation and regulations relating to the import or export of semiconductor equipment products. We cannot predict whether the import and export of our products will be adversely affected by changes in or new quotas, duties, taxes or other charges or restrictions imposed by the United States or any other country in the future. Any of these factors or the adoption of restrictive policies could have a material adverse effect on our business, financial condition or results of operations. Net sales to the Asia-Pacific region accounted for approximately 47%, 52% and 38% of our total net sales in fiscal years 2005, 2004 and 2003, respectively, and thus demand for our products is subject to the risk of economic instability in that region and health risks. Countries in the Asia-Pacific region, including Korea and Japan, have experienced weaknesses in their currency, banking and equity markets in the recent past. These weaknesses could continue to adversely affect demand for our products, the availability and supply of our product components and our consolidated results of operations.

No single Asian end-user customer accounted for more than 10% of our net sales during 2005 and 2004 or 2003. However, one end-user customer headquartered in Europe, STMicroelectronics N.V., accounted for 15% and 10% of our net sales in fiscal 2004 and 2003, respectively. No single European end-user customer accounted for more than 10% of our net sales during fiscal 2005. Two customers headquartered in the U.S., Intel Corporation and Advanced Micro Devices, accounted for 25% and 14% of our net sales in fiscal 2005, respectively. One customer headquartered in the U.S. accounted for 11% of our net sales in fiscal 2004.

In addition, one of our major distributors, Spirox Corporation, which accounted for 14%, 23% and 19% of our net sales in fiscal 2005, 2004 and 2003, respectively, is a Taiwan-based company. This subjects a significant portion of our receivables and future revenues to the risks associated with doing business in a foreign country, including political and economic instability, currency exchange rate fluctuations, fears related to health risks and regulatory changes. Disruption of business in Asia caused by the previously mentioned factors could continue to have a material impact on our business, financial condition or results of operations.

27

We operate in a volatile industry—indicators of goodwill and other long-lived assets impairment under SFAS 142 and SFAS 144 may be present from time to time.

Effective November 1, 2002, we adopted Statement of Financial Accounting Standard No. 142, “Goodwill and Other Intangible Assets” (SFAS 142), which was issued by the FASB in July 2001. Under this standard, we ceased amortizing goodwill and acquired workforce effective November 1, 2002. During fiscal 2005 and 2004, goodwill increased by approximately $1.1 million and $384.9 million, respectively, due to our acquisition of NPTest.

We test goodwill for possible impairment on an annual basis and at any other time if events occur or circumstances indicate that the carrying amount of goodwill may not be recoverable. Circumstances that could trigger an impairment test include but are not limited to: our market value falling below our net book value for a significant period of time, a significant adverse change in the business climate or legal factors; unanticipated competition; loss of key personnel; a significant change in direction with respect to investment in a product or market segment; the likelihood that a significant portion of the business will be sold or disposed of; or the results of testing for recoverability of a significant asset group within a reporting unit determined in accordance with SFAS 142.

As mandated by SFAS 142, we completed our annual goodwill impairment test as of July 31, 2005 during the fourth quarter of the fiscal 2005 year. We determined that the sum of the expected future discounted cash flows from the assets exceeded the carrying value of those assets; therefore, no impairment of goodwill was recognized. However, no assurances can be given that future evaluations of goodwill will not result in future impairment charges. We will continue to evaluate goodwill on an annual basis and at such other times as events and changes in circumstances suggest that the carrying amount may not be recoverable from its estimated future discounted cash flow. If we determine our goodwill or intangible assets to be impaired, the result of non-cash charges could be substantial.

During 2005, we did not note any impairment for our other intangible assets. However, no assurances can be given that future evaluations of other intangibles will not result in future impairment charges. We will continue to evaluate other intangibles at such times as events and changes in circumstances suggest that the carrying amount may not be recoverable from its estimated future undiscounted cash flow.

Future acquisitions may be difficult to integrate, disrupt our business, dilute stockholder value or divert management attention.

Our growth depends upon market growth, our ability to enhance our existing products, and our ability to introduce new products on a timely basis. We intend to continue to address the need to develop new products and enhance existing products through acquisitions of other companies, product lines, technologies, and personnel. Acquisitions involve numerous risks, including the following:

• Difficulties in integrating the operations, technologies, products, and personnel of the acquired companies;

• Diversion of management’s attention from normal daily operations of the business;

• Potential difficulties in completing projects associated with in-process research and development;

• Difficulties in entering markets in which we may have no or limited direct prior experience and where competitors in such markets may have stronger market positions;

• Initial dependence on unfamiliar supply chains or relatively small supply partners;

• Insufficient revenue to offset increased expenses associated with acquisitions; and

• The potential loss of key employees of the acquired companies.

28

Acquisitions may also cause us to:

• Issue common stock that would dilute our current shareholders’ percentage ownership;

• Assume liabilities;

• Record goodwill and non-amortizable intangible assets that will be subject to impairment testing on a regular basis and potential periodic impairment charges;

• Incur amortization expenses related to certain intangible assets;

• Incur large and immediate write-offs and restructuring and other related expenses; and

• Become subject to intellectual property or other litigation.

Mergers and acquisitions of high-technology companies are inherently risky, and no assurance can be given that our previous or future acquisitions will be successful and will not materially adversely affect our business, operating results, or financial condition. Failure to manage and successfully integrate acquisitions could materially harm our business and operating results. Prior acquisitions have resulted in a wide range of outcomes, from successful introduction of new products and technologies to an inability to do so. Even when an acquired company has already developed and marketed products, there can be no assurance that product enhancements will be made in a timely fashion or that pre-acquisition due diligence will have identified all possible issues that might arise with respect to such products.

From time-to-time, we have made acquisitions that resulted in in-process research and development expenses being charged in a single quarter. These charges may occur in any quarter, contributing to variability in our quarterly earnings. Risks related to new product development also apply to acquisitions.

Our executive officers and certain key personnel are critical to our business.

Our future operating results depend substantially upon the continued service of our executive officers and key personnel. Our future operating results also depend in significant part upon our ability to attract and retain qualified management, manufacturing, technical, engineering, marketing, sales and support personnel. Competition for qualified personnel is intense, and we cannot ensure success in attracting or retaining qualified personnel. There may be only a limited number of persons with the requisite skills to serve in these positions and it may be increasingly difficult for us to hire personnel over time. Our business, financial condition and results of operations could be materially adversely affected by the loss of any of our key employees, by the failure of any key employee to perform in his or her current position, or by our inability to attract and retain skilled employees.

If the protection of our proprietary rights is inadequate, our business could be harmed.

We attempt to protect our intellectual property rights through patents, copyrights, trademarks, maintenance of trade secrets and other measures, including entering into confidentiality agreements. However, we cannot be certain that others will not independently develop substantially equivalent intellectual property or that we can meaningfully protect our intellectual property. Nor can we be certain that our patents will not be invalidated, deemed unenforceable, circumvented or challenged, or that the rights granted thereunder will provide us with competitive advantages, or that any of our pending or future patent applications will be issued with claims of the scope we seek, if at all. Furthermore, we cannot be certain that others will not develop similar products, duplicate our products or design around our patents, or that foreign intellectual property laws, or agreements into which we have entered will protect our intellectual property rights. Inability or failure to protect our intellectual property rights could have a material adverse effect upon our business, financial condition and results of operations. In addition, from time to time we encounter disputes over rights and obligations concerning intellectual property, including disputes with parties with whom we have licensed technologies. We cannot assume that we will prevail in any such intellectual property disputes. We have been involved in extensive, expensive and time-consuming reviews of, and litigation concerning, patent infringement claims.

29

Our business may be harmed if we are found to infringe proprietary rights of others.

We have at times been notified that we may be infringing intellectual property rights of third parties and we have litigated patent infringement claims in the past. We expect to continue to receive notice of such claims in the future. We cannot be certain of the success in defending patent infringement claims or claims for indemnification resulting from infringement claims.

We cannot be certain of success in defending current or future patent or other infringement claims or claims for indemnification resulting from infringement claims. Our business, financial condition and results of operations could be materially adversely affected if we must pay damages to a third party or suffer an injunction or if we expend significant amounts in defending any such action, regardless of the outcome. With respect to any claims, we may seek to obtain a license under the third party’s intellectual property rights. We cannot be certain, however, that the third party will grant us a license on reasonable terms or at all. We could decide, in the alternative, to continue litigating such claims. Litigation has been and could continue to be extremely expensive and time consuming, and could materially adversely affect our business, financial condition or results of operations, regardless of the outcome.

We may be materially adversely affected by legal proceedings.

We have been and may in the future be subject to various legal proceedings, including claims that involve possible infringement of patent or other intellectual property rights of third parties. It is inherently difficult to assess the outcome of litigation matters, and there can be no assurance that we will prevail in any litigation. Any such litigation could result in substantial cost and diversion of our efforts, which by itself could have a material adverse effect on our financial condition and operating results. Further, adverse determinations in such litigation could result in loss of our property rights, subject us to significant liabilities to third parties, require us to seek licenses from third parties or prevent us from manufacturing or selling our products, any of which could materially adversely affect our business, financial condition or results of operations.

Recently enacted and proposed changes in securities laws and regulations are likely to increase our costs.

Recently enacted and proposed changes in the laws and regulations affecting public companies, including the provisions of the Sarbanes-Oxley Act of 2002, have increased and will continue to increase our expenses as we evaluate the implications of new rules and devote resources to respond to the new requirements. Sarbanes-Oxley Act mandates, among other things, that companies adopt new corporate governance measures and imposes comprehensive reporting and disclosure requirements, sets stricter independence and financial expertise standards for audit committee members and imposes increased civil and criminal penalties for companies, their chief executive officers and chief financial officers and directors for securities law violations. In particular, we incurred and expect to incur additional administrative expense as we implement Section 404 of the Sarbanes-Oxley Act, which requires management to report on, and our Independent Registered Public Accounting Firm to attest to, our internal control over financial reporting. In addition, The Nasdaq National Market, on which our common stock is listed, has also adopted comprehensive rules and regulations relating to corporate governance. These laws, rules and regulations have increased and will continue to increase the scope, complexity and cost of our corporate governance, reporting and disclosure practices, which could harm our results of operations and divert management’s attention from business operations. We also expect these developments to make it more difficult and more expensive for us to obtain director and officer liability insurance in the future, and we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. Further, our board members, Chief Executive Officer and Chief Financial Officer could face an increased risk of personal liability in connection with the performance of their duties. As a result, we may have difficultly attracting and retaining qualified board members and executive officers, which would adversely affect our business.

30

We are subject to the internal control evaluation and attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002.

Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, we are required, beginning with our fiscal year ended October 31, 2005, to include in our annual report our assessment of the effectiveness of our internal control over financial reporting and our audited financial statements as of the end of each fiscal year. Furthermore, our independent registered public accounting firm (Firm) is required to attest to whether our assessment of the effectiveness of our internal control over financial reporting is fairly stated in all material respects and separately report on whether it believes we maintained, in all material respects, effective internal control over financial reporting as of the end of each fiscal year. We have successfully completed our assessment and obtained our Firm’s attestation as to the effectiveness of our internal control over financial reporting as of October 31, 2005. In future years, if we fail to timely complete this assessment, or if our Firm cannot timely attest to our assessment, we could be subject to regulatory sanctions and a loss of public confidence in our internal control. In addition, any failure to implement required new or improved controls, or difficulties encountered in their implementation, could harm our operating results or cause us to fail to timely meet our regulatory reporting obligations.

Terrorist attacks, terrorist threats, geopolitical instability and government responses thereto, may negatively impact all aspects of our operations, revenues, costs and stock price.

The terrorist attacks in September 2001 in the United States and ensuing events and the resulting decline in consumer confidence has had a material adverse effect on the economy.

In addition, any similar future events may disrupt our operations or those of our customers and suppliers. Our markets currently include Taiwan, Korea and Israel, which are experiencing political instability. In addition, these events have had and may continue to have an adverse impact on the U.S. and world economy in general and consumer confidence and spending in particular, which could harm our sales. Any of these events could increase volatility in the U.S. and world financial markets, which could harm our stock price and may limit the capital resources available to us and our customers or suppliers. This could have a significant impact on our operating results, revenues and costs and may result in increased volatility in the market price of our common stock.

We are subject to anti-takeover provisions that could delay or prevent an acquisition of our company.

Provisions of our amended and restated certificate of incorporation, equity incentive plans, bylaws and Delaware law may discourage transactions involving a change in corporate control. In addition to the foregoing, our classified board of directors and the ability of our board of directors to issue preferred stock without further stockholder approval could have the effect of delaying, deferring or preventing a third party from acquiring us and may adversely affect the voting and other rights of holders of our common stock.

Item 1B. Unresolved Staff Comments.

None.

Item 2. Properties

Our headquarters are located on an owned site in Milpitas, California. This headquarters facility consists of 180,000 square feet on approximately 14 acres of land. We also own our manufacturing facilities, which are primarily test and assembly operations, in Hillsboro, Oregon in the U.S. and in Amerang, Germany. Our manufacturing facility in Hillsboro, Oregon is located in a 180,000 square foot facilities, comprised of two buildings and are on approximately twenty-nine acres of land. In addition, we also lease offices and facilities in several U.S. and international locations, including the United Kingdom, France, Singapore and Japan.

31

We believe our existing properties, including both owned and leased sites, are in good condition and are adequate to meet our current and foreseeable future requirements.

For additional information regarding obligations under leases, see Note 5—“Commitments and Contingencies,” of the Consolidated Financial Statements.

Item 3. Legal Proceedings

In March 2005, Roy Schmidt, a former employee, filed a complaint in the Superior Court of Santa Clara County, California against the Company, alleging fraud and various other contractual and tort claims in connection with the termination of his employment by the Company. Mr. Schmidt alleges damages in excess of $3.0 million and seeks in addition punitive damages. Formal discovery has begun in this litigation. The Company intends to vigorously defend these claims and believe it possesses meritorious defenses to the claims.

We are involved in various claims arising in the ordinary course of business. We currently believe that the ultimate amount of liability, if any, for any pending claims of any type (either alone or combined) will not materially affect our financial position, results of operations or liquidity. However, the ultimate outcome of any litigation is uncertain, and either unfavorable or favorable outcomes could have a material negative impact. Regardless of outcome, litigation can have an adverse impact on us because of defense costs, diversion of management resources and other factors.

Item 4. Submission of Matters to a Vote of Security Holders

There were no matters submitted to a vote of stockholders during the fourth quarter of fiscal 2005.

32

EXECUTIVE OFFICERS AND KEY EMPLOYEES

Our executive officers and key employees and their ages and positions as of December 31, 2005, are as follows:

	Name	Age		Position
Executive Officers
Dave House		62	Executive Chairman of the Board and Director
David A. Ranhoff		50	President and Chief Executive Officer
John C. Batty		50	Senior Vice President, Chief Financial Officer and Secretary
Brett Hooper		42	Senior Vice President, Human Resources
Byron W. Milstead		49	Senior Vice President and General Counsel
Key Employees
Fred Hall		56	Senior Vice President, Corporate Controller
Carlos Lazalde		48	Senior Vice President, Analog Mixed Signal and Memory Products Group
Dr. Jean-Luc Pelissier		43	Senior Vice President, Worldwide Field Operations and Sapphire Platform Group
Dr. David Karpenske		52	Senior Vice President, Sapphire Platform Group
William Dillon		47	Senior Vice President, Manufacturing Operations
Ofir Baharav		37	Senior Vice President, Diagnostics & Characterization Group

Dave House has served as Executive Chairman of the Board and a Director since December 2005. Mr. House served as Chairman, President, and CEO of Allegro Networks from 2001 to 2003. From 1998 until 2001, he served as President of Nortel Networks. He served as Chairman and Chief Executive Officer of Bay Networks from 1996 until its merger with Nortel Networks in 1998. Prior to 1996, Mr. House served in a number of senior managerial positions with Intel Corporation for 22 years.

David A. Ranhoff has served as President and Chief Executive Officer since January 2005. From September 1986 through January 2005 he served in several key management positions including President and Chief Operating Officer, Executive Vice President Sales and Marketing, Senior Vice President Sales, Marketing and Service, Vice President Sales, Managing Director of European Operations and National Sales Manager. Prior to joining the Company, Mr. Ranhoff served for eight years in various sales and management positions for GenRad, Inc.

John C. Batty has served as Senior Vice President and Chief Financial Officer since joining the Company in December 2004. Prior to joining Credence, Mr. Batty served as Chief Financial Officer, Secretary and Chief Operating Officer at Network Equipment Technologies from December 1999. Mr. Batty served as Vice President of Finance and Chief Financial Officer at Verilink Corporation from 1997 to 1999. Prior to joining Verilink, Mr. Batty spent over 10 years at VLSI as Controller, Director of Corporate Financial Planning and Vice President and Treasurer prior to its acquisition by Phillips Semiconductor. From 1982 to 1986, Mr. Batty held various finance positions with Intel Corporation.

Brett Hooper has served as Senior Vice President, Human Resources since June 2004. Mr. Hooper joined us in June 2004 through the acquisition of NPTest where he was the Vice President, Human Resources and Communications since June 2003. From 1999 through June 2003, Mr. Hooper held several senior Human Resources management positions in Schlumberger Semiconductor Solutions. Previously, Mr. Hooper held key management positions in Marketing Communication and Investor Relations. Mr. Hooper joined Schlumberger in 1987.

Byron W. Milstead has served as Senior Vice President and General Counsel since December 2005. Prior to that, he was Vice President and General Counsel from November 2000. Prior to that Mr. Milstead was a partner with the Portland, Oregon law firm of Ater Wynne LLP. Prior to joining Ater Wynne LLP in 1996, Mr. Milstead was an associate and partner in the Portland, Oregon office of Bogle & Gates PLLC. Mr. Milstead has practiced law since 1982.

33

Fred Hall has served as Senior Vice President, Corporate Controller since August 2004. Mr. Hall spent several months in an integration role, prior to that he was Senior Vice President, Human Resources from October 2001 to May 2004. From 1998 to October 2001, he was the Chief Financial Officer, Secretary and Treasurer of IMS. Mr. Hall was Vice President, Finance and CFO of Naiad Technologies, Inc., a biotechnology start-up company from 1997 until joining IMS in 1998. From October 1994 until 1997, Mr. Hall served as Vice President, CFO, Treasurer and Assistant Secretary for CFI ProServices, Inc., a provider of integrated, PC-based software for financial institutions. From June 1992 until October 1994, Mr. Hall served as Vice President, Finance and CFO, Secretary and Treasurer of Itronix Corporation, a manufacturer of hand held computers. Mr. Hall will be leaving the Company in January 2006.

Carlos Lazalde has served as Senior Vice President, Analog Mixed Signal and Memory Products Group, or MPG since August 2002. Mr. Lazalde joined us in July 2002 as the Vice President, General Manager of the Memory Products Division, or MPD. Prior to joining us from 1979 to July 2002, Mr. Lazalde held a variety of senior level positions, including President of the Automatic Test Equipment Division of Schlumberger. Mr. Lazalde has over 24 years of experience in the semiconductor equipment industry.

Dr. Jean-Luc Pelissier has served as Senior Vice President, World Wide Field Operations and Sapphire Platform Group since August 2005. Previously, Dr. Pelissier served as Senior Vice President, Sapphire Products Group since June 2004. Prior to that Dr. Pelissier was the President, Products of NPTest since September 2003. Dr. Pelissier served as the Vice President and General Manager, Test Systems prior to that and previously held an equivalent position with Schlumberger Semiconductor Solutions from October 2001. Dr. Pelissier was appointed Vice President Business Development for Schlumberger Semiconductor Solutions in September 2000. For a period of four months in 2000, Dr. Pelissier left Schlumberger to pursue other business interests. From January 1998 to April 2000 he held the position of Vice President and General Manager, SABER Services. Dr. Pelissier joined Schlumberger in 1987.

Dr. David Karpenske has served as Senior Vice President, Sapphire Platform Group since August 2005. Dr. Karpenske served as Senior Vice President, Technical Marketing since June 2004. Prior to that, he was the Vice President, SoC Products Group since August 2003. Prior to joining us, Dr. Karpenske spent 25 years with Schlumberger where he held positions in sales management, product development, marketing and business development. In 2000 his position was President Schlumberger Test & Transactions – North and Central America where he was responsible for businesses in the Telecommunication, Semiconductor Test Equipment, Smart Card, and IT Outsourcing industries. In 1997 he was Vice President of Business Development for Schlumberger.

William Dillon has served as Senior Vice President, Manufacturing Operations since June 2004. Mr. Dillon joined us in June 2004 through the acquisition of NPTest where he was the Vice President and General Manager, Operations since June 2003. Prior to that Mr. Dillon held an equivalent position with Schlumberger Semiconductor Solutions from late 2001. Mr. Dillon was appointed Vice President Customer Service for Schlumberger Semiconductor Solutions in May 1998 and Director of Field Operations for Schlumberger Semiconductor Solutions in February 1997. Mr. Dillon joined Schlumberger in 1979.

Ofir Baharav has served as Senior Vice President, Diagnostics & Characterization Group, or DCG since February 2005. Prior to that, he was Senior Director, General Manager EmiScope Products since January 2004. Mr. Baharav held the position of Sr. Director, Diagnostics & Characterization Group from January 2003 to January 2004. Mr. Baharav joined us in January 2003 through the acquisition of Optonics, Inc., where he acted as President since beginning of 2001. Before joining Optonics, Mr. Baharav led and participated in a variety of early stage technology companies spanning the fields of computer security systems, healthcare informatics, rapid modeling and digital printing. Mr. Baharav has also served in the Israeli Air Force as an officer and an aviator.

Officers serve at the discretion of the Board of Directors, until their successors are appointed. There are no family relationships among our executive officers or directors.

34

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Our common stock is traded on the Nasdaq National Market under the symbol CMOS. High and low closing stock prices for the last two fiscal years were:

	2005				2004
Quarter Ended	High		Low		High		Low
January 31	$	9.65	$	7.20	$	17.05	$	11.45
April 30	$	9.35	$	6.16	$	13.75	$	10.55
July 31	$	10.94	$	5.83	$	14.20	$	8.31
October 31	$	10.50	$	7.36	$	8.66	$	6.43

There were approximately 221 stockholders of record at December 31, 2005. To date, we have not declared or paid any cash dividends on our common stock. We do not anticipate paying any dividends on our common stock in the foreseeable future.

The information required by this item regarding equity compensation plans is incorporated by reference to the information set forth in Item 12 of this Form 10-K.

Item 6. Selected Financial Data

The selected consolidated financial data below should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our consolidated financial statements and the related notes. The selected consolidated statements of operations data for the years ended October 31, 2005, 2004 and 2003 and the selected consolidated balance sheet data as of October 31, 2005 and 2004, are derived from, and are qualified by reference to, the audited consolidated financial statements included elsewhere in this annual report on Form 10-K. The financial information for fiscal year 2004 included results of operations of NPTest beginning on May 29, 2004. The financial information for fiscal year 2003 included results of operations of Optonics beginning on January 23, 2003. The historical financial information for all periods includes the operations of Integrated Measurement Systems, Inc., which we acquired in August 2001. The transaction was accounted for using the pooling-of-interests method. The selected consolidated statement of operations data for the fiscal years ending prior to October 31, 2003, and the selected consolidated balance sheet data prior to October 31, 2004, are derived from our audited consolidated financial statements that are not included in this annual report on Form 10-K. The historical results presented below are not necessarily indicative of future results.

	Year Ended October 31,
	2005			2004			2003			2002			2001
	(in thousands, except per share amounts)
Consolidated Statement of Operations Data:
Net sales	$	429,320		$	439,803		$	182,414		$	164,209		$	301,718
Operating loss		(110,160	)		(79,788	)		(114,278	)		(173,194	)		(172,942	)
Loss before taxes		(108,543	)		(60,415	)		(112,059	)		(163,632	)		(155,587	)
Net loss		(119,932	)		(64,478	)		(113,112	)		(170,481	)		(98,676	)
Net loss per basic share	$	(1.28	)	$	(0.88	)	$	(1.80	)	$	(2.81	)	$	(1.65	)
Net loss per diluted share	$	(1.28	)	$	(0.88	)	$	(1.80	)	$	(2.81	)	$	(1.65	)
Consolidated Balance Sheet Data:
Working capital (a)	$	207,086		$	277,887		$	349,260		$	224,694		$	313,377
Total assets		1,046,305			1,173,106			698,493			582,249			757,419
Long-term debt		180,000			180,000			181,058			—			—
Retained earnings (accumulated deficits)		(369,251	)		(249,319	)		(184,841	)		(71,728	)		98,752
Stockholders’ equity	$	682,029		$	788,208		$	430,627		$	519,237		$	680,940

(a) Effective in the second quarter of fiscal 2005, the Company reclassified consigned inventory from inventory to long-term assets on the consolidated balance sheets. The reclassification has been reflected in the above table.

35

Supplementary Consolidated Financial Information (Unaudited)

Quarterly 2005

	2005 Quarter Ended
	January 31,			April 30,			July 31,			October 31,
	(in thousands, except per share amounts)
Net sales	$	93,883		$	101,944		$	111,925		$	121,568
Gross margin *		29,114			43,145			29,743			48,274
Research and development		22,328			22,728			23,849			23,633
Selling, general and administrative		31,356			31,844			31,317			32,306
Amortization of purchased intangibles and deferred stock compensation		6,696			6,340			5,663			4,771
Restructuring		1,351			440			9,654			6,160
Operating loss		(32,617	)		(18,207	)		(40,740	)		(18,596	)
Loss before taxes		(32,850	)		(16,298	)		(39,702	)		(19,693	)
Net loss		(36,302	)		(19,473	)		(41,677	)		(22,480	)
Net loss per basic share	$	(0.41	)	$	(0.21	)	$	(0.43	)	$	(0.23	)
Net loss per diluted share	$	(0.41	)	$	(0.21	)	$	(0.43	)	$	(0.23	)

* During the first, second and third quarter of fiscal 2005, there were approximately $5.5 million, $0.6 million and $23.0 million of special charges included in the cost of goods sold, respectively.

Quarterly 2004

	2004 Quarter Ended
	January 31,			April 30,		July 31,			October 31,
	(in thousands, except per share amounts)
Net sales	$	68,125		$	95,136	$	163,718		$	112,824
Gross margin *		31,903			49,481		31,982			40,169
Research and development		15,239			15,850		23,856			25,590
Selling, general and administrative		23,716			26,982		36,977			33,551
Amortization of purchased intangible assets		2,622			2,622		5,345			6,764
In-process research and development		—			—		7,900			—
Restructuring		653			—		2,969			2,687
Operating income (loss)		(10,327	)		4,027		(45,065	)		(28,423	)
Income (loss) before taxes		(10,033	)		5,317		(31,687	)		(24,012	)
Net income (loss)		(11,469	)		4,253		(33,165	)		(24,097	)
Net income (loss) per basic share	$	(0.18	)	$	0.07	$	(0.42	)	$	(0.28	)
Net income (loss) per diluted share	$	(0.18	)	$	0.06	$	(0.42	)	$	(0.28	)

* During the third and fourth quarter of fiscal 2004, there were approximately $46.2 million and $3.4 million of special charges included in the cost of goods sold.

36

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

We design, manufacture, sell and service engineering validation test equipment, diagnostics and failure analysis products and automatic test equipment, or ATE, used for testing semiconductor integrated circuits, or ICs. We serve a broad spectrum of the semiconductor industry’s testing needs through a wide range of products that test digital logic, mixed-signal, system-on-a-chip, radio frequency and non-volatile memory semiconductors. We utilize our proprietary technologies to design products which are intended to provide a lower total cost of ownership than many competing products currently available while meeting the increasingly demanding performance requirements of today’s engineering validation test, diagnostics and failure analysis and ATE markets. Our hardware products are designed to test semiconductors at two stages of their lifecycle; first, at the prototype stage, and, second, as they are produced in high volume. Collectively, our customers include major semiconductor manufacturers, fabless design houses, foundries and assembly and test services companies.

Major business developments during and subsequent to the fiscal year 2005 include:

• Improvement in revenue of our SoC test products, our design and characterization business; and towards the end of the year our analog and mixed signal products;

• Delivery of the first high speed, high pin count, Sapphire systems (3208/1616) to major Integrated Device Manufacturers.

• Appointment of a new Chief Executive Officer, effective January 1, 2005;

• Appointment of a new Chief Financial Officer, effective December 31, 2004;

• Completion of the transfer of our manufacturing from the Milpitas, California and Simi Valley, California facilities to Hillsboro, Oregon;

• Completion of the move of personnel from the former NPTest headquarters in San Jose to our Milpitas facilities;

• Settlement of a liability with Schlumberger for $4.0 million in cash and 615,157 shares of our common stock, which were valued at $5.0 million for a total settlement value of $9.0 million;

• Execution of an agreement to combine the Company’s Taiwan operations with Spirox’s T1 test division (our Taiwan distributor) into Credence Spirox Integration Corporation, an operation owned 90% by Spirox and 10% by us;

• Write down of Memory (Kalos II) and Sapphire inventories in the amount of $23.0 million;

• Incurred significant development costs on our next generation memory tester; and

• Incurred significant Sarbanes-Oxley related costs.

Our sales, gross margins and operating results have in the past fluctuated significantly and will, in the future, fluctuate significantly depending upon a variety of factors. The factors that have caused and will continue to cause our results to fluctuate include cyclicality or downturns in the semiconductor market and the markets served by our customers, the timing of new product announcements and releases by us or our competitors, market acceptance of new products and enhanced versions of our products, manufacturing inefficiencies associated with the start up of new products, changes in pricing by us, our competitors, customers or suppliers, the ability to volume produce systems and meet customer requirements, excess and obsolete inventory, patterns of capital spending by customers, delays, cancellations or rescheduling of orders due to customer financial difficulties or otherwise, expenses associated with acquisitions and alliances, our ability to effectively integrate acquisitions, product discounts, product reliability, the proportion of direct sales and sales through third parties, including distributors and original equipment manufacturers, the mix of products sold, the length of manufacturing and sales cycles, natural disasters, political and economic instability, new accounting pronouncements (e.g., FAS 123R), regulatory changes and outbreaks of hostilities. Due to these and additional factors, historical results and

37

percentage relationships discussed in this annual report on Form 10-K will not necessarily be indicative of the results of operations for any future period. For a further discussion of our business, and risk factors affecting our results of operations, please refer to the section entitled “Risk Factors” included elsewhere herein.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, as well as the disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to revenue recognition, accounts receivable factoring without recourse, allowance for doubtful accounts, inventory valuation and residual values related to leased products, long-lived assets valuation, warranty accrual, deferred taxes, restructuring and special charges and stock-based compensation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We discuss the development and selection of the critical accounting estimates with the audit committee of our board of directors on a quarterly basis, and the audit committee has reviewed our disclosure relating to them in this annual report on Form 10-K.

We believe the following critical accounting policies affect our more significant judgments and estimates used in the preparation of our consolidated financial statements.

Revenue Recognition:

Under Securities and Exchange Commission’s Staff Accounting Bulletin No. 104, “Revenue Recognition,” (SAB 104), we recognize revenue on the sale of semiconductor manufacturing equipment when title and risk of loss have passed to the customer, there is persuasive evidence of an arrangement, delivery has occurred or services have been rendered, the sales price is fixed or determinable, collectibility is reasonably assured and customer acceptance criteria have been successfully demonstrated. Revenue recognition policies are applied consistently among our semiconductor manufacturing equipment product lines. Product revenue is recognized upon shipment only when achieving the customer acceptance criteria can be demonstrated prior to shipment, which generally occurs with mature products. Revenue related to the fair value of the installation obligation is recognized upon completion of the installation. Service revenue are generally recognized upon performance of the activities requested by the customers. Products are classified as mature after several different customers have accepted similar systems. When the customer acceptance criteria cannot be demonstrated prior to shipment, revenue and the related cost of goods sold are deferred until customer acceptance. For some customers in certain countries where collection may be an issue, we may require a letter of credit to be established or cash receipt in advance before revenue can be recognized. Lease revenue is recorded in accordance with Statement of Financial Accounting Standard No. 13, “Accounting for Leases,” (SFAS No. 13), which requires that a lessor accounts for each lease by either the direct financing, sales-type or operating method. Revenue from sales-type leases is recognized at the net present value of future lease payments. Revenue from operating leases is recognized over the lease period.

During fiscal 2005, 2004 and 2003, we introduced several new enhancements, systems and products. Certain revenues from sales of these new enhancements, systems and products during these years were deferred until the revenue recognition requirements of our revenue recognition policy are satisfied. This practice will continue in the future. In the past, we experienced significant delays in the introduction and acceptance of new testers as well as certain enhancements to our existing testers. Delays in introducing a product or delays in our ability to obtain customer acceptance, if they occur in the future, will delay the recognition of revenue and gross profit by us.

38

With respect to arrangements with multiple deliverables, we follow the guidance in EITF 00-21, “Revenue Arrangements with Multiple Deliverables,” to determine whether there is more than one unit of accounting. To the extent that the deliverables are separable into multiple units of accounting, we then allocate the total fee on such arrangements to the individual units of accounting using the residual method. We then recognize revenue for each unit of accounting depending on the nature of the deliverable(s) comprising the unit of accounting (principally following SAB 104).

Sales in the United States are principally through our direct sales organization consisting of direct sales employees and representatives. Sales outside the United States utilize both direct sales employees and distributors. There are no significant differences in revenue recognition policies based on the sales channel, due to the business practices that have been adopted with our distributor relationships. Because of these business practices, we do not use “price protection,” “stock rotation” or similar programs with its distributors. We do not typically sell inventory into our distributors for eventual sale to end-users, but rather we sell product to the distributors on the basis of a purchase order received from an end-user. We evaluate any revenue recognition issues based on the characterization of the end customer in light of our revenue recognition policy.

Our semiconductor manufacturing equipment includes embedded software. We believe this embedded software is incidental to our products and therefore it is excluded from the scope of Statement of Position 97-2, “Software Revenue Recognition,” (SOP 97-2). Also, the embedded software in our products is not sold separately, cannot be used on another vendor’s products, and we cannot fundamentally enhance or expand the capability of the equipment with new or revised embedded software. In addition, the equipment’s principal performance characteristics are governed by digital speed and pin count which are primarily a function of the hardware.

Deferred revenue includes deferred revenue related to maintenance contracts (and other undelivered services) and to extended warranties where products were sold with more than the standard one-year warranty. Deferred profit is related to equipment that was shipped to certain customers, but the revenue and cost of goods sold were not recognized because the customer-specified acceptance criteria has not been met as of the fiscal period end or because the customer is deemed to be a high credit risk and payment has not been received as of the fiscal period end.

We warrant our products to our customers generally for one year from the date of shipment. In addition to the provision of standard warranties, we may offer customer paid extended warranty services with a fixed fee. The fixed fees are recognized as revenue on a straight-line basis over the applicable term of the contract. Related costs are recorded either as incurred or when related liabilities are determined to be probable and estimable.

For certain customers, typically those with whom we have long-term relationships, we may grant extended payment terms. Certain of our receivables have due dates in excess of 90 days, and we have a history of successfully collecting these extended payment term accounts receivable.

Accounts Receivable Factoring Without Recourse:

In July 2004, we entered into a non-recourse receivables purchase agreement with a commercial bank to sell certain of our trade receivables in non-recourse transactions. These receivables were not included in our consolidated balance sheet as the criteria for sale treatment established by Statement of Financial Accounting Standard No. 140, “Accounting for Transfers and Servicing of Financial Assets and Extinguishments of Liabilities,” (SFAS 140) had been met. Under SFAS 140, after a transfer of financial assets, an entity stops recognizing the financial assets when the control has been surrendered. We believe our factoring agreement met the criteria of a true sale of these assets since the acquiring party retained the title to these receivables and had assumed the risk that the receivables will be collectible. The trade receivables were sold at a discount plus administrative and other fees. The discount amount, administrative and other fees were accounted for in other income and expenses, net in the consolidated statements of operations. The proceeds received are included as cash in the accompanying consolidated balance sheets and as operating activities in the consolidated statements of cash flows. The facility was terminated in the quarter ended July 31, 2005.

39

Allowance for Doubtful Accounts:

We, along with our sales and distribution partners, perform ongoing credit evaluations of our customers’ financial condition. We maintain allowances for doubtful accounts for estimated losses resulting from the inability or unwillingness of our customers to make required payments. We record our bad debt expenses as selling, general and administrative expenses. When we become aware that a specific customer is unable to meet its financial obligations to us, generally because of bankruptcy or deterioration in the customer’s operating results or financial position, we record a specific allowance to reflect the level of credit risk in the customer’s outstanding receivable balance. In addition, we record additional allowances based on certain percentages of our aged receivable balances. These percentages are determined by a variety of factors including, but not limited to, current economic trends, historical payment and bad debt write-off experience. We are not able to predict changes in the financial condition of our customers or changes in general economic conditions, and if circumstances related to our customers deteriorate, our estimates of the recoverability of our trade receivables could be materially affected and we may be required to record additional allowances. Alternatively, if we provide more allowances than we need, we may reverse a portion of such provisions in future periods based on our actual collection experience.

Inventory Valuation and Residual Values Related to Leased Products:

We evaluate our inventory levels and valuations based on our estimates and forecasts of the next cyclical period in our industry. These forecasts require us to estimate our ability to sell current and future products in the next cyclical industry period and compare those estimates with our current inventory levels. If these forecasts or estimates change, or our product roadmaps change, then we would need to adjust our assessment of the inventory valuations. Once inventories are written down, we carry that inventory at its reduced value until it is scrapped or otherwise disposed of.

We monitor our inventory levels in light of product development changes and expectations of the cyclical period ahead. For the three years ended October 31, 2005, we have recorded a total of $80.6 million in special charges for the write-off of excess and obsolete inventories. We do not as a matter of course scrap all inventory that is identified as excess or obsolete. Our products are capital goods with potentially long economic lives and, historically, the opportunity to sell these products has both arisen and fallen unexpectedly. We have occasionally encountered unexpected demand for old products as well as the inability to transition customers to newer products. We closely monitor the inventories that have been written down but not scrapped, so that if any sales of these items occur and affect our reported gross margins, the effect, if material, is disclosed. We may be required to take additional charges for excess and obsolete inventory if a downturn causes further reductions to our current inventory valuations or if our current product development plans change.

We consign a portion of our finished goods to both external and internal customers primarily for the purpose of customer demonstration or applications development. This inventory is categorized as other long-term assets on our consolidated balance sheets. We depreciate all consigned inventories during the period that they are held on consignment over periods ranging from 18 months to 36 months. The depreciation expense for consigned inventory is charged to selling, general and administrative expense.

Residual values assigned to our products that are leased to customers are based on their remaining economic life at the end of the lease terms. The amounts assigned to the residual values are evaluated periodically based on technological change and the forecasted business cycle.

Long-Lived Asset Valuation:

Our long-lived assets consist of property and equipment, goodwill and identified intangible assets.

Effective November 1, 2002, we adopted Statement of Financial Accounting Standard No. 142, “Goodwill and Other Intangible Assets,” (SFAS 142) which was issued by the FASB in July 2001. Under this standard, we ceased amortizing goodwill and acquired workforce effective November 1, 2002.

40

We test goodwill for possible impairment on an annual basis and at any other time events occur or circumstances indicate that the carrying amount of goodwill may not be recoverable. Circumstances that could trigger an impairment test include but are not limited to: our market value falling below our net book value for a significant period of time; a significant adverse change in the business climate or legal factors; unanticipated competition; loss of key personnel; a significant change in direction with respect to investment in a product or market segment; the likelihood that a significant portion of the business will be sold or disposed of; or the results of testing for recoverability of a significant asset group within a reporting unit determined in accordance with SFAS 142.

The impairment test for goodwill involves a two-step process: step one consists of a comparison of the fair value of a reporting unit with its carrying amount, including the goodwill allocated to each reporting unit. If the carrying amount is in excess of the fair value, step two requires the comparison of the implied fair value of the reporting unit goodwill with the carrying amount of the reporting unit goodwill. Any excess of the carrying value of the reporting unit goodwill over the implied fair value of the reporting unit goodwill will be recorded as an impairment loss.

As mandated by SFAS 142, we completed our annual goodwill impairment test as of July 31, 2005. Based on the test, we determined that the sum of the expected future discounted cash flows from the assets exceeded the carrying value of those assets; therefore, no impairment of goodwill was recognized. However, no assurance can be given that future evaluations of goodwill will not result in future impairment charges. We will continue to evaluate goodwill on an annual basis and at such other times as events and changes in circumstances suggest that the carrying amount may not be recoverable from its estimated future discounted cash flow.

The determination as to whether a write down of goodwill is necessary involves significant judgment based on the short-term and long-term projections of our future performance. The assumptions supporting the estimated future cash flows of the reporting unit, including the discount rate used and estimated terminal value, reflect our best estimates.

We evaluate the carrying value of our long-lived assets, consisting primarily of purchased intangible assets, and property and equipment, whenever certain events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable, or at least annually, in accordance with Statement of Financial Accounting Standard No. 144, “Accounting for the Impairment or Disposal of Long-lived Assets,” (SFAS 144). Such events or circumstances include, but are not limited to, a prolonged industry downturn, a significant decline in our market value, or significant reductions in projected future cash flows. In assessing the recoverability of our long-lived assets, we compare the carrying value to the undiscounted future cash flows the assets are expected to generate. If the total of the undiscounted future cash flows is less than the carrying amount of the assets, we write down such assets based on the excess of the carrying amount over the fair value of the assets. Fair value is generally determined by calculating the discounted future cash flows using a discount rate based upon our weighted average cost of capital. Significant judgments and assumptions are required in the forecast of future operating results used in the preparation of the estimated future cash flows, including profit margins, long-term forecasts of the amounts and timing of overall market growth and our percentage of that market, groupings of assets, discount rates and terminal growth rates. In addition, significant estimates and assumptions are required in the determination of the fair value of our tangible long-lived assets, including replacement cost, economic obsolescence, and the value that could be realized in liquidation. Changes in these estimates could have a material adverse effect on the assessment of our long-lived assets, thereby requiring us to write down the assets. We make certain assessments with respect to the determination of all identifiable assets to be used in the business as well as research and development activities as of an acquisition date. Each of these activities was evaluated by both interviews and data analysis to determine our state of development and related fair value. The purchased intangibles consist of purchased technology, customer relations, trademarks, patents and non-compete agreements, and they typically have estimated useful lives of one to ten years.

41

Warranty Accrual:

We provide reserves for the estimated costs of product warranties at the time revenue is recognized. We estimate the costs of our warranty obligations based on our historical experience of known product failure rates, use of materials to repair or replace defective products and service delivery costs incurred in correcting product failures. In addition, from time to time, specific warranty accruals may be made if unforeseen technical problems arise. Should our actual experience relative to these factors differ from our estimates, we may be required to record additional warranty reserves. Alternatively, if we provide more reserves than we need, we may reverse a portion of such provisions in future periods.

Deferred Taxes:

When we prepare our consolidated financial statements, we calculate our income taxes based on the various jurisdictions where we conduct business. This requires us to calculate our actual current tax exposure and to assess temporary differences that result from different treatment of certain items for tax and accounting purposes. These differences result in deferred tax assets and liabilities, which we show on our consolidated balance sheets. The net deferred tax assets are reduced by a valuation allowance if, based upon weighted available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.

Our net deferred tax asset balance at the end of fiscal year 2005 was zero reflecting a full valuation allowance due to uncertainties surrounding our ability to generate future taxable income and our corresponding ability to utilize our deferred tax assets.

We are a U.S.-based multinational company subject to tax in multiple U.S. and foreign tax jurisdictions. Our effective tax rate is based on expected income, statutory rates and enacted tax rules, including transfer pricing. Significant judgment is required in determining our effective tax rate and in evaluating our tax positions on a worldwide basis. We believe our tax positions, including intercompany transfer pricing policies are consistent with the tax laws in the jurisdictions in which we conduct our business. It is possible that these positions may be challenged which may have an impact on our effective tax rate.

Restructuring and Special Charges:

Over the past years, we have recorded restructuring charges as we rationalized operations in light of customer demand declines and the economic downturn. These measures, which included major changes in senior management, workforce reduction, facilities consolidation and changes to the strategic focus of a number of sites, were largely intended to align our capacity and infrastructure to anticipate customer demand and to transition our operations to lower cost regions. The restructuring charges include employee severance and benefit costs, write-offs of property and equipment and costs related to leased facilities vacated and subleased. Severance and benefit costs and other costs associated with restructuring activities were recorded in accordance with Statement of Financial Accounting Standard No. 146, “Accounting for Costs Associated with Exit or Disposal Activities,” (SFAS 146). We also record severance and benefit costs in accordance with Statement of Financial Accounting Standard No. 112, “Employer’s Accounting for Post Employment Benefits,” (SFAS 112), as we conclude that (a) we have a substantive post employment benefit obligation that is attributed to prior services rendered, (b) rights to those benefits have vested, and (c) payment is probable and the amount can be reasonably estimated. The current accounting for restructuring costs requires us to record provisions and charges when we have a formal and committed restructuring plan.

Given the significance of, and the timing of the execution of such activities, this process is complex and involves periodic reassessments of original estimates. We continually evaluate the adequacy of the remaining liabilities under our restructuring initiatives and other special charges. Although we believe that these estimates accurately reflect the costs of our restructuring and other plans, actual results may differ, thereby requiring us to record additional provisions or reverse a portion of such provisions.

42

Stock-Based Compensation:

In December 2004, the FASB issued Statement of Financial Accounting Standard No. 123R, “Share Based Payment: An Amendment of FASB Statements No. 123 and 95,” (SFAS 123R). This statement requires that the cost resulting from all share-based payment transactions be recognized in the consolidated financial statements. In March 2005, the Securities and Exchange Commission (“SEC”) released SEC Staff Accounting Bulletin No. 107, “Share-Based Payment” (“SAB No. 107”). SAB No. 107 provides the SEC’s staff’s position regarding the application of SFAS No. 123R and certain SEC rules and regulations, and also provides the staff’s views regarding the valuation of share-based payment arrangements for public companies. We will adopt SFAS 123R, utilizing the modified prospective method, in the first quarter of fiscal 2006 and will continue to evaluate the impact of SFAS 123R on our operating results and financial condition. Our assessment of the estimated compensation charges is affected by our stock price as well as assumptions regarding a number of complex and subjective variables and the related tax impacts. These variables include, but are not limited to, our stock price volatility and employee stock option exercise behaviors.

Results of Operations

The following table sets forth certain operating data as a percentage of net sales for the fiscal years indicated:

	Fiscal Years Ended October 31,
	2005		2004		2003
Net sales	100	%	100	%	100	%
Cost of goods sold—on net sales	58		54		63
Cost of goods sold—special charges	7		11		1
Gross margin	35		35		36
Operating expenses:
Research and development	22		18		40
Selling, general and administrative	30		28		50
Amortization of purchased intangible assets	5		4		5
In-process research and development	—		2		1
Restructuring and special charges	4		1		2
Total operating expenses	61		53		98
Operating loss	(26	)%	(18	)%	(62	)%
Net loss	(28	)%	(15	)%	(62	)%

2005 vs. 2004

Net sales.    Net sales consist of revenues from systems sales, upgrades, spare parts sales, maintenance contracts, lease and rental income. Net sales decreased 2% to $429.3 million in fiscal 2005 from $439.8 million in fiscal 2004. For the fiscal year ended October 31, 2005, net sales from our SoC, Design Characterization product line and Service increased 62% to $323.5 million from $199.3 million in fiscal 2004. This increase resulted primarily from the May 2004 acquisition of NPTest, but also represented the increasing acceptance of the Sapphire and Diagnostics and Characterization tools as well as an increase in our installed base of systems. Net sales from our analog mixed signal and memory products declined 56% to $105.8 million during the fiscal year ended October 31, 2005 from $240.5 million during the same period of fiscal 2004. The decline results from the cyclically low demand in these markets, particularly for the memory products which are directed at the NOR memory group. The decline was softened somewhat by improving volumes for the analog mixed signal products in the second half of fiscal 2005. Sustainability of the revenue levels is dependent upon the economic and geopolitical climate as well as other risks described under the title “Risk Factors” herein. We anticipate net sales will decrease by approximately 4% to 8% for the first quarter of fiscal year 2006 compared to the fourth quarter of fiscal 2005.

43

International net sales accounted for approximately 69% and 72% of total net sales in fiscal 2005 and 2004, respectively. Our net sales to the Asia Pacific region accounted for approximately 47% and 52% of total net sales in fiscal 2005 and 2004, respectively. Capital markets in Asia historically have been highly volatile and in some Asian regions there have been geopolitical unrest, both of which have resulted in economic instabilities. These potential economic instabilities could materially adversely affect demand for our products.

Our net sales by product line in fiscal 2005 and 2004 consisted of:

	2005		2004
SoC	37	%	22	%
Analog Mixed Signal	22		32
Memory	3		23
Diagnostics and Characterization Group	11		4
Service and Other	27		19
Total	100	%	100	%

Gross Margin.    Our gross margin has been and will continue to be affected by a variety of factors, including manufacturing efficiencies, excess and obsolete inventory write-offs, sell through of previously written down inventory, pricing by competitors or suppliers, new product introductions, product sales mix, production volume, customization and reconfiguration of systems, international and domestic sales mix, special charges, and field service margins. Our gross margin as a percentage of net sales remained at 35% for fiscal 2004 and 2005. Excluding the effect of special charges, the gross margin as a percentage of net sales was 42% and 46% in fiscal 2005 and 2004, respectively. The special charges in 2005 were for the write down of Kalos II inventory due to our decision to invest in the next generation memory product as well as to lack of demand, obsolete revisions of Sapphire inventory resulting from our decision to market Sapphire as our sole solution for the high end SoC market and excess and obsolete Octet and Vanguard II inventory and assets due to our decision to discontinue significant future investment in these redundant product lines stemming from the acquisition of NPTest. Special charges in 2004 related primarily to obsolete Octet and Quartet inventory and assets, again due to our decision to discontinue significant future investment in these redundant product lines stemming from the acquisition of NPTest. Gross margin excluding special charges declined from 2004 to 2005 principally because we replaced higher margin analog mixed signal and memory revenues with somewhat lower margin Sapphire revenues. The decline was less than it otherwise might have been because of the efficiencies gained when we consolidated our three principal manufacturing facilities into one in the second and third quarter of 2005. In addition, during the fiscal year ended October 31, 2005 and 2004, our gross margin benefited by approximately 4.3% and 1.1%, respectively, from the sale of fully reserved inventory. Excluding the effect of the special charges, we believe gross margins could be flat to slightly higher in the next several quarters.

Research and Development.    Research and development, or R&D, expenses were $92.5 million in fiscal year 2005, compared to $80.5 million in the prior fiscal year, an increase of 15%. The increase in spending in fiscal 2005 resulted primarily from the significant resources invested in the development of new products and product enhancements of approximately $14.7 million offset by a $2.2 million decrease in bonuses earned and a $0.5 million decline in licenses fees. R&D expenses as a percentage of net sales were 21.6% and 18.3% in fiscal 2005 and fiscal 2004, respectively. The increase in R&D expenses as a percentage of net sales is primarily attributable to higher R&D expenses as well as lower net sales during 2005 as compared to fiscal 2004. We anticipate that R&D expenses for fiscal 2006 will be flat in absolute dollars when compared to those recorded in fiscal 2005.

Selling, General and Administrative.    Selling, general and administrative, or SG&A, expenses were $126.8 million in fiscal 2005, compared to $121.2 million in the prior fiscal year, an increase of 5%. The increase was primarily due to activities resulting from the acquisition of NPTest in May 2004, including an increase in integration expense of $5.1 million, an increase in product consignment expense of $4.9 million due to the number of Sapphire systems consigned and an increase in compensation costs of $2.8 million. In addition, we incurred approximately

44

$6.4 million of costs associated with our Sarbanes-Oxley compliance program, expenses related to salaries, consulting and audit fees. These increases were offset by a decrease in marketing spending of $1.2 million, a decrease in distributors and sales person commissions of $8.2 million, a decrease in other variable compensation of $2.4 million and decrease in fringe benefits costs of $2.1 million. These decreases were caused by the decrease in net sales as well as a focused effort to decrease spending. As a percentage of net sales, SG&A expenses were 29.5% and 27.6% in fiscal 2005 and fiscal 2004, respectively. The increase in SG&A expenses as a percentage of net sales is primarily attributable to a full year of NPTest and associated integration spending in 2005 versus five months in 2004 as well as lower sales levels during 2005 as compared to fiscal 2004. We expect SG&A expenses in fiscal 2006 to be flat to down in absolute dollars when compared to those recorded in fiscal 2005.

Amortization of Purchased Intangible Assets and Deferred Compensation.    Amortization of purchased intangible assets and deferred compensation expenses were $23.5 million in fiscal 2005, compared to $17.4 million in the prior fiscal year, an increase of 35%. Amortization of purchased intangible assets was higher in fiscal 2005 due primarily to the acquisition of NPTest in May 2004. Remaining estimated annual amortization expense for purchased intangible assets and deferred compensation is expected to be $18.8 million, $18.4 million, and $14.5 million, in the fiscal years ending in 2006 through 2008, respectively.

Restructuring Charges.    In fiscal year 2005, we recorded total restructuring charges of approximately $17.6 million. Of the $17.6 million, $5.0 million was for severance and other related charges which accounted for a headcount reduction of 110 employees. Of the $5.0 million, the amount recorded under FAS 112 at October 31, 2005 was $1.5 million. The affected employees were primarily in research and development and selling general and administrative functions throughout the world. Write-off of property and equipment amounted to $1.1 million, resulted from our decision to halt additional research and development investment in one of our products that was rendered redundant by the acquisition of NPTest. Operating lease and leasehold restoration charges of $11.5 million, which are net of expected sublease rentals, resulted from vacating the former NPTest headquarters facilities in San Jose. Outsource IT contract cancellation charges amounted to $1.4 million. These charges were offset by deferred rent write-off of $0.7 million and prior accrual adjustment of $0.6 million, primarily related to severance and related charges. See Note 3—“Special Charges and Restructuring,” of the notes to the Consolidated Financial Statements for further discussion.

Interest Income.    We generated interest income of $2.8 million and $3.3 million in fiscal 2005 and 2004, respectively. The decline from fiscal 2004 was primarily due to lower average investment balances in fiscal 2005 as compared to fiscal 2004 offset by a higher average interest rate.

Interest Expense.    Interest expenses were $3.2 million and $3.2 million in fiscal year 2005 and 2004, respectively. The interest expense in fiscal 2005 and 2004 was primarily attributable to interest expense related to the convertible subordinated notes that we issued in June 2003.

Other Income and Expenses, Net.    Other income, net was $2.1 million and $19.3 million in fiscal year 2005 and 2004, respectively, a decline of $17.2 million. The decrease in other income, net, from 2004 to 2005 was primarily due to the fair value adjustment of an acquired liability owed to the former parent of NPTest, Schlumberger Limited (Schlumberger). This liability was settled during the third quarter of fiscal 2005 for a total settlement value of $9.0 million. As of October 31, 2004, this liability was $10.3 million. See Note 2—“Acquisitions,” of the Notes to the Consolidated Financial Statements for further discussion.

Income Taxes.    We recorded an income tax provision of $11.4 million and $4.0 million in fiscal years 2005 and 2004, respectively. The income tax expense for the period consisted of net U.S. current income tax expense of $0.1 million and foreign tax expense on earnings and foreign withholding taxes of $11.3 million generated from our foreign operations.

At October 31, 2005, we had unused net operating loss and research tax credit carryforwards for federal income tax purposes of approximately $396.2 million and $8.8 million, respectively, which expire in 2012

45

through 2025. Utilization of the net operating loss and tax credit carryforwards will be subject to annual limitations due to the ownership change limitations provided by the Internal Revenue Code of 1986, as amended, and similar state provisions. The annual limitations may result in expiration of net operating loss and tax credit carryforwards before full utilization.

Realization of the net deferred tax assets is dependent on our generating sufficient taxable income in future years in appropriate tax jurisdictions to obtain reversals of temporary differences, net operating loss and tax credit carryforwards. Due to uncertainties in the timing and amount of such realization of our deferred tax assets, we have provided a valuation allowance equal to the net deferred assets at October 31, 2005 and October 31, 2004. We expect to record a full valuation allowance on domestic tax benefits until we can sustain a consistent level of profitability. Until such time, we would not expect to recognize any significant tax benefits in our results of operations.

2004 vs. 2003

Net sales.    Net sales increased 141% to $439.8 million in fiscal 2004 from $182.4 million in fiscal 2003. These improvements in net sales were due primarily to a general upturn in the industry during the first three quarters of 2004 and to our purchase of NPTest in the third quarter of fiscal 2004. For the fiscal years ended October 31, 2004 and 2003, net sales from our digital and mixed signal products was $232.6 million and $93.5 million, respectively. Net sales from our memory products increased from $30.8 million during fiscal 2003 to $103.0 million during fiscal 2004. In addition, our service revenue increased from $41.2 million in fiscal 2003 to $81.6 million in fiscal 2004. The acquisition of NPTest brought an additional $45.3 million of digital and mixed signal revenues, $2.7 million of diagnostic system revenues, and $34.6 million of service revenues. Sustainability of these revenue levels is dependent upon the economic and geopolitical climate, as well as other risks described under the heading “Risk Factors” herein.

International net sales accounted for approximately 72% and 64% of total net sales in fiscal 2004 and 2003, respectively. During fiscal 2004, international net sales for NPTest represented 53% of NPTest’s product and services net sales. Our net sales to the Asia Pacific region accounted for approximately 52% and 38% of total net sales in fiscal 2004 and 2003, respectively.

Our net sales by product line in fiscal 2004 and 2003 consisted of:

	2004		2003
SoC	22	%	27	%
Analog Mixed Signal	32		28
Memory	23		16
Design Characterization Group	4		4
Service and Other	19		25
Total	100	%	100	%

Operating lease and rental revenues were 2% and 4% of our net sales in fiscal 2004 and 2003, respectively.

Gross Margin.    Gross margin as a percentage of net sales decreased from 35.6% in fiscal 2003 to 35.0% in fiscal 2004. The decrease in fiscal 2004 gross margins from fiscal 2003 levels primarily reflected the benefits of a higher operating efficiencies and other factors described below, offset by the effect of special charges in fiscal 2004 cost of sales of $49.6 million related to excess and obsolete inventory and other charges due to our decision to discontinue significant future investment in our redundant product lines stemming from the acquisition of NPTest. In fiscal 2003 the special charges to cost of goods sold consisted of $1.3 million for a legal settlement with an inventory supplier and $0.6 million in spare part write-offs in our Valstar product line. Excluding the effect of these special charges, the gross margin as a percentage of net sales was 46.2% and 36.6% in fiscal 2004 and 2003, respectively. This increase was primarily attributable to better manufacturing

46

efficiencies stemming from higher production volumes as well as better product mix of newer products with higher gross margins. In addition, during fiscal year 2004, our gross margin benefited by approximately 1.1% from the sale of fully reserved inventory and the sale of Kalos ASIC devices previously written-down in a lower of cost or market provision.

Research and Development.    Research and development, or R&D, expenses were $80.5 million in the fiscal year 2004, compared to $73.5 million in the prior fiscal year, an increase of 9.5%. The increase in spending during fiscal 2004 resulted primarily from the acquisition of NPTest, in which contributed an additional $16.8 million of R&D expenses. Excluding NPTest, R&D expense decreased for the fiscal year 2004 primarily due to the reduction in our headcount of 163 people in the third quarter of fiscal 2003, of which 77 were in R&D. In addition, there were several products, including ASL3000 and Kalos2, that had been released to manufacturing, resulting in lower non recurring engineering (NRE) expenses associated with the development of those products. These savings were partially offset by the ongoing investment in new products and R&D expenses associated with the products obtained in the acquisition of NPTest. R&D expenses as a percentage of net sales were 18.3% and 40.3% in fiscal 2004 and fiscal 2003, respectively. The decrease in R&D expenses as a percentage of net sales was primarily attributable to the higher sales levels during 2004 as compared to fiscal 2003.

Selling, General and Administrative.    Selling, general and administrative, or SG&A, expenses were $121.2 million in fiscal 2004, compared to $91.1 million in the prior fiscal year, an increase of 33.0%. The increase was primarily due to the addition of NPTest, which resulted in an additional $17.6 million of SG&A expenses.

For the year ended October 31, 2004, there was an increase in variable compensation and commissions of $13.5 million related to our overall increase in net sales and profitability. In addition, we recorded approximately $3.1 million of expenses for costs associated with the integration of NPTest which primarily included acquisition consulting fees related to workforce and product line decisions. In the third quarter of fiscal 2003, we accelerated the remaining depreciation for leasehold improvements and property and equipment of $1.7 million related to buildings located in Fremont that we vacated when we moved to our new headquarters in Milpitas. These accelerated depreciation charges ended in the first quarter of fiscal 2004. As a percentage of net sales, SG&A expenses were 27.6% and 49.9% in fiscal 2004 and fiscal 2003, respectively. The decrease in SG&A expenses as a percentage of net sales was primarily attributable to the higher sales levels during 2004 as compared to fiscal 2003.

Amortization of Purchased Intangible Assets.    Amortization of purchased intangible assets and deferred compensation expenses were $17.4 million for fiscal 2004, compared to $9.5 million for the prior fiscal year, an increase of 83%. Amortization of purchased intangible assets was higher in fiscal 2004 due primarily to the acquisition of NPTest in May 2004.

In-process Research and Development.    In the third quarter of fiscal 2004, we recorded a charge of $7.9 million for the write-off of in-process research and development resulting from the acquisition of NPTest. In the first quarter of fiscal 2003, we recorded a charge of $1.5 million in for the write-off of in-process research and development resulting from the purchase of Optonics. The charges were recorded as an operating expense.

Restructuring Charges.    During fiscal year 2004, we recorded total restructuring charges of approximately $6.3 million. Of the $6.3 million, $3.7 million related to severance and related charges associated with the termination of 198 employees. In addition, we recorded $1.9 million related to the write-off of equipment and non-cancelable commitments incurred related to a decision to discontinue significant future investments in redundant product lines stemming from the acquisition of NPTest. As a result of the relocation of our corporate headquarters to our owned facilities in Milpitas, California and the vacating of our previously leased buildings in Fremont, California, we recorded $0.7 million to write-off the remaining lease payments for this lease, net of expected sublease income of the Austin, Texas facility. See Note—3 “Special Charges and Restructuring,” of the notes to the Consolidated Financial Statements for further discussion.

47

During the fiscal year 2003, we recorded restructuring charges of approximately $3.6 million as operating expenses related to headcount reductions. The reduction in force included the elimination of approximately 233 positions of the Company’s worldwide employee base.

Interest Income.    We generated interest income of $3.3 million and $5.8 million in fiscal 2004 and 2003, respectively. The decline in fiscal 2004 was primarily due to lower investment balances in fiscal 2004.

Interest Expense.    Interest expenses were $3.2 million and $2.0 million for the fiscal year 2004 and 2003, respectively, an increased of $1.2 million. The increase in interest expense in fiscal 2004 was primarily attributable to interest expense related to the convertible subordinated notes that we issued in June 2003.

Other Income and Expenses, net.    Other income and expenses were $19.3 million of income and $1.6 million of expenses for the fiscal year 2004 and 2003, respectively, an increase of $20.9 million. The increase in other income and expenses, net, in fiscal 2004 primarily was due to the mark down to fair value of an acquired liability owed to the former parent of NPTest. The decline in the liability during the year was $19.2 million as the liability declined from $29.5 million at the May 28, 2004 acquisition date to $10.3 million at October 31, 2004. The current value of the liability was based on our stock price as of October 31, 2004.

Income Taxes.    We recorded an income tax provision of $4.0 million and $1.0 million for fiscal years 2004 and 2003, respectively. The income tax expense in 2004 consisted of U.S. current income tax benefits of ($2.3) million and foreign tax on earnings and foreign withholding taxes of $6.3 million generated from our foreign operations, primarily Germany. The current U.S. income tax benefit consisted of ($0.5) million attributable to the settlement of an IRS audit, ($1.7) million related to domestic tax contingency reserves and net operating loss carryback for NPTest of $(0.1) million. Our effective tax rate was 6.6% for fiscal 2004 and 0.9% for fiscal 2003. For fiscal 2004 and 2003, the effective tax rate was greater than the expected federal statutory tax benefit rate of 35% primarily due to the establishment of a full valuation allowance against our net deferred tax assets.

At October 31, 2004, we had unused net operating loss and research tax credit carryforwards for federal income tax purposes of approximately $239.4 million and $8.0 million, respectively, which expire in 2005 through 2024.

Liquidity and Capital Resources

Net cash used in operating activities during fiscal 2005 was $5.3 million. The net cash flows used by operating activities for fiscal 2005 were primarily the net loss before depreciation, amortization and other non cash items of $9.5 million offset by cash generated from working capital of $4.2 million. Cash generated by working capital included $4.6 million from a reduction in accounts receivable and $14.8 million from a reduction in inventories. The accounts receivable reduction resulted primarily from improved collections as days sales in accounts receivable dropped from 103 days at the end of 2004 to 97 days at the end of 2005. The inventory reduction was attributable primarily to increase in sales of analog mixed signal and Sapphire products in the latter part of 2005.

Investing activities provided net cash of approximately $47.8 million in fiscal 2005 resulted primarily from net sales and maturities of available-for-sale securities of $61.8 million and from sales of property and equipment of $0.8 million, offset by $14.8 million used to acquire property and equipment.

Financing activities provided net cash flows of $7.1 million in fiscal 2005. The cash in fiscal 2005 was primarily provided by $8.1 million received from the issuance of common stock relating to our employee equity plans which were offset in part by payments of bank loans and notes payable related to leased products of $1.1 million.

48

As of October 31, 2005, we had working capital of approximately $207.1 million, including cash, cash equivalents and short-term investments of $150.0 million, and accounts receivable and inventories totaling $193.1 million. We believe that, because of the relatively long manufacturing cycles of many of our products and the new products we presently plan to introduce, investments in inventories will continue to represent a significant portion of our working capital. The semiconductor industry has historically been highly cyclical and has experienced downturns, which have had a material adverse effect on the semiconductor industry’s demand for automatic test equipment, including equipment manufactured and marketed by us. In addition, the ATE industry is highly competitive and subject to rapid technological change. It is possible that events related to these factors may occur in the near term which would cause a change to our estimate of the net realizable value of receivables, inventories or other assets, and the adequacy of accrued liabilities. See discussion of “Critical Accounting Policies and Estimates.”

As a result of the NPTest acquisition, we were required to make a payment to Schlumberger Limited at a date in the future pursuant to a provision in the acquisition agreement between NPTest and Schlumberger under which NPTest was acquired by Francisco Partners, L.P. from Schlumberger Limited. The payment amount was contingent upon the value of our common stock at the time of distribution. In May 2005, the parties reached a settlement, which required us to pay Schlumberger approximately $4.0 million in cash and 615,157 shares of our common stock which was valued at $5.0 million for a total settlement value of $9.0 million. According to this settlement, we fulfilled our obligations to Schlumberger and there were no outstanding liabilities in relation to this transaction at the end of fiscal 2005.

We lease some of our facilities and equipment under operating leases that expire through 2013 of which $17.2 million represents lease commitments that have been written-off to special operating charges during fiscal 2005 and fiscal 2004. Of the $17.2 million in lease commitments, the San Jose, California lease accounted for $15.8 million. The future minimum lease payments at October 31, 2005 are as follows (in thousands):

	Committed Gross Lease Payments		Leases Written Off in Restructuring Charges		Net Estimated Future Lease Expense
2006	$	7,424	$	4,917	$	2,507
2007		6,465		4,168		2,297
2008		5,474		4,048		1,426
2009		5,303		4,087		1,216
2010		840		—		840
Thereafter		1,732		—		1,732
	$	27,238	$	17,220	$	10,018

The leases written off in special charges of $11.5 million are accounted for in our accrued expenses and other liabilities balance on the consolidated balance sheets at October 31, 2005.

49

The following summarizes our minimum contractual cash obligations and other commitments at October 31, 2005, and the effect of such obligations in future periods (in thousands):

	Total		2006		2007		2008		2009		2010		Thereafter
Contractual Obligations:
Facilities and equipment operating leases (1)	$	27,238	$	7,424	$	6,465	$	5,474	$	5,303	$	840	$	1,732
Bank note (2)		5,000		5,000		—		—		—		—		—
Interest on liabilities related to bank note		30		30		—		—		—		—		—
Convertible subordinated notes (3)		180,000		—		—		180,000		—		—		—
Interest on convertible subordinated notes		8,100		2,700		2,700		2,700		—		—		—
Trade-in commitments (4)		1,600		1,600		—		—		—		—		—
Minimum payable for an employment agreement		1,000		1,000		—		—		—		—		—
Minimum payable for information technology outsourced services (4)		1,370		1,370		—		—		—		—		—
Minimum commitment under Technology Development Agreement		1,030		—		—		1,030		—		—		—
Open non-cancelable purchase order commitments		74,902		70,801		4,101		—		—		—		—
Total contractual cash and other obligations	$	300,270	$	89,925	$	13,266	$	189,204	$	5,303	$	840	$	1,732

(1) Approximately $11.5 million of this total has been accrued for as restructuring charge in the consolidated balance sheets as accrued expenses and other liabilities.

(2) This is recorded on the consolidated balance sheets as bank loans and notes payable—leased products.

(3) This is recorded on the consolidated balance sheets as convertible subordinated notes.

(4) This amount is recorded in the consolidated balance sheets as accrued expenses and other liabilities and deferred profit.

Some of the components that we purchase are unique to us and must be purchased in relatively high minimum quantities with long (four and five month) lead times. These business circumstances can lead to us holding relatively high inventory levels and associated risks. In addition, purchase commitments for unique components are relatively inflexible in terms of deferral or cancellation. At October 31, 2005, we had open and committed non-cancelable purchase orders totaling approximately $74.9 million. The contractual cash obligations and commitments table presented above contains our minimum obligations at October 31, 2005 under these arrangements and others. Actual expenditures will vary based on the volume of transactions and length of contractual service provided. In addition to minimum spending commitments, certain of these arrangements provide for potential cancellation charges.

As of October 31, 2005, our principal sources of liquidity consisted of approximately $142.2 million of cash and cash equivalents and short-term investments of $7.8 million.

We believe our current cash and investment positions will be sufficient to meet our anticipated business requirements for the next 12 months.

Off-Balance Sheet Arrangements.    As of October 31, 2005, we did not have any material off-balance-sheet arrangements, no material commitments for capital expenditures and did not have any special purpose entities.

50

Recent Accounting Pronouncements

In December 2004, the FASB issued Statement of Financial Accounting Standard No. 123R, “Share-Based Payment,” (SFAS 123R). SFAS 123R revised SFAS 123. In March 2005, the Securities and Exchange Commission (SEC) issued Staff Accounting Bulletin No. 107 (SAB 107) which provides the Staff’s views regarding interactions between SFAS No. 123(R) and certain SEC rules and regulations and provides interpretations of the valuation of share-based payments for public companies. SFAS No. 123(R) requires that the costs resulting from share-based payment transactions be recognized in the financial statements. The statement requires companies to use a fair-value-based payment measurement method in accounting for share-based payments with employees as well as for goods and services received from non-employees. SFAS 123R is effective for annual reporting periods that begin after June 15, 2005, with early adoption permitted. We expect to adopt SFAS 123R using the modified prospective method and the Black-Scholes-Merton pricing model effective November 1, 2005. We believe that the adoption of SFAS 123R will have a material effect on its results of operations; however, has not determined whether the adoption will result in amounts that are similar to the current pro forma disclosure under SFAS No. 123.

In December 2004, the FASB issued Statement of Financial Accounting Standard No. 153, “Exchanges of Non-monetary Assets,” (SFAS 153), an amendment of APB Opinion No. 29. SFAS 153 addresses the measurement of exchanges of non-monetary assets and redefines the scope of transactions that should be measured based on the fair value of the assets exchanged. SFAS 153 is effective for non-monetary asset exchanges beginning in our first quarter of fiscal 2006. We do not believe the adoption of SFAS 153 will have a material effect on our consolidated financial position or results of operations.

In December 2004, the FASB issued FASB Staff Position No. FAS 109-2, “Accounting and Disclosure Guidance for the Foreign Earnings Repatriation Provision within the American Jobs Creation Act of 2004” (FSP FAS 109-2). The American Jobs Creation Act introduces a special one-time dividends received deduction on the repatriation of certain foreign earnings to a U.S. taxpayer (repatriation provision), provided certain criteria are met. We may repatriate cash in the future; however, we have not determined whether the adoption of FSP FAS 109-2 will have any effect on its consolidated financial position or results of operations.

In March 2005, the FASB published FASB Interpretation No. 47, “Accounting for Conditional Asset Retirement Obligations,” which clarifies that the term, conditional asset retirement obligation, as used in Statement of Financial Accounting Standard No. 143, “Accounting for Asset Retirement Obligations,” (SFAS 143), refers to a legal obligation to perform an asset retirement activity in which the timing and (or) method of settlement are conditional on a future event that may or may not be within the control of the entity. The uncertainty about the timing and (or) method of settlement of a conditional asset retirement obligation should be factored into the measurement of the liability when sufficient information exists. The interpretation also clarifies when an entity would have sufficient information to reasonably estimate the fair value of an asset retirement obligation. We do not believe the adoption of SFAS 154 will have a material effect on our consolidated financial position or results of operations.

In May 2005, the FASB issued Statement of Financial Accounting Standard No. 154, “Accounting Changes and Error Corrections,” (SFAS 154) effective with fiscal years beginning after December 15, 2005. This statement replaces APB Opinion No. 20, “Accounting Changes,” and Statement of Financial Accounting Standard No. 3, “Reporting Accounting Changes in Interim Financial Statements,” and changes the requirements for the accounting for and reporting of a change in accounting principle. SFAS No. 154 applies to all voluntary changes in accounting principle and changes required by an accounting pronouncement in the unusual instance that the pronouncement does not include specific transition provisions. Under this pronouncement changes are required to be retrospectively applied to prior financial statements, unless it is impracticable to determine either the period-specific effects or the cumulative effect of the change. Retrospective application means the application of a different accounting principle to prior accounting periods as if that principle had always been used or as the adjustment of previously issued financial statements to reflect a change in the reporting entity. This statement requires that the retrospective application of a change in accounting principle be limited to the direct effects of

51

the change. This statement also requires that a change in depreciation, amortization, or depletion method for long-lived, non-financial assets be accounted for as a change in accounting estimate affected by a change in accounting principle. We do not believe the adoption of SFAS 154 will have a material effect on our consolidated financial position or results of operations.

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

Our exposure to market risk from changes in interest rates relates primarily to our cash equivalents and investment portfolio. We maintain a strict investment policy, which ensures the safety and preservation of our invested funds by limiting default risk, market risk, and reinvestment risk. Our investments consist primarily of commercial paper, medium term notes, asset backed securities, U.S. Treasury notes and obligations of U.S. Government agencies, bank certificates of deposit, auction rate preferred securities, corporate bonds and municipal bonds. The table below presents notional amounts and related weighted–average interest rates by year of maturity for our investment portfolio (in thousands, except percent amounts).

							Future maturities of investments held at October 31, 2005
	Balance October 31, 2004			Balance October 31, 2005			2006			2007	2008	2009	Thereafter
Cash equivalents
Amounts	$	94,052		$	142,180		$	142,180		—	—	—	—
Average rate		0.80	%		2.29	%		2.29	%	—	—	—	—
Short term investments
Amounts	$	69,182		$	7,425		$	7,425		—	—	—	—
Average rate		5.54	%		3.84	%		3.84	%	—	—	—	—
Total investment	$	163,234		$	149,605		$	149,605		—	—	—	—
Average rate		2.80	%		2.37	%		2.37	%	—	—	—	—
Equity instruments	$	772		$	391		$	391		—	—	—	—

We attempt to mitigate default risk by investing in high credit quality securities and by constantly positioning our portfolio to respond appropriately to a significant reduction in a credit rating of any investment issuer or guarantor. The portfolio includes only marketable securities with active secondary or resale markets to ensure portfolio liquidity and maintains a prudent amount of diversification.

The sensitivity analysis model used by us for interest rate exposure compares interest income on current investment interest rates versus current investment levels at current interest rates with a 10% increase. Based on this model, a 10% increase or decrease would result in an increase or a decrease in interest income of approximately $0.3 million. There can be no assurances that the above projected interest rate increase will materialize. Fluctuations of interest rates are beyond our control.

Foreign Exchange

We generate a significant portion of our sales from customers located outside the United States, principally in Asia and to a lesser extent Europe. International sales are made mostly to foreign distributors and some foreign subsidiaries and are typically denominated in U.S. dollars, but occasionally are denominated in the local currency for European and Japanese customers. The subsidiaries also incur most of their expenses in the local currency. Our Automotive product line is developed and manufactured in Germany and thus those expenses are Euro based. Accordingly, some of our foreign subsidiaries use the local currency as their functional currency. For the fiscal year ended October 31, 2005 and 2004, we recorded foreign currency gains of $1.6 million and foreign currency losses of $0.3 million, respectively.

Our international business is subject to risks typical of an international business including, but not limited to: differing economic conditions, changes in political climate, differing tax structures, other regulations and

52

restrictions, and foreign exchange rate volatility. Accordingly, our future results could be materially adversely impacted by changes in these or other factors. We do not currently use derivatives, but will continue to assess the need for these instruments in the future.

Interest Rate Risk

The Convertible Subordinated Notes bear interest at a fixed rate of 1.5%, and therefore changes in interest rates do not impact our interest expense on this debt. We from time to time have outstanding short-term borrowings with variable interest rates. The total average amount of these borrowings outstanding annually has been insignificant. Therefore, we expect that a 10% change in interest rate will not have any material effect on our interest expense.

53

Item 8. Financial Statements and Supplementary Data

For the years ended October 31, 2005, 2004 and 2003.

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

	Page
Report of Independent Registered Public Accounting Firm	55
Report of Independent Registered Public Accounting Firm on Internal Control Over Financial Reporting	56
Consolidated Balance Sheets—October 31, 2005 and 2004	57
Consolidated Statements of Operations—Years Ended October 31, 2005, 2004 and 2003	58
Consolidated Statements of Stockholders’ Equity—Years Ended October 31, 2005, 2004 and 2003	59
Consolidated Statements of Cash Flows—Years Ended October 31, 2005, 2004 and 2003	60
Notes to Consolidated Financial Statements	61

54

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Stockholders

Credence Systems Corporation

We have audited the accompanying consolidated balance sheets of Credence Systems Corporation as of October 31, 2005 and 2004, and the related consolidated statements of operations, stockholders’ equity, and cash flows for each of the three years in the period ended October 31, 2005. Our audits also included the financial statement schedule listed in the index at Item 15(a)(2). These financial statements and schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements and schedule based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of Credence Systems Corporation at October 31, 2005 and 2004, and the consolidated results of its operations and its cash flows for each of the three years in the period ended October 31, 2005, in conformity with U.S. generally accepted accounting principles. Also, in our opinion, the related financial statement schedule, when considered in relation to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the effectiveness of Credence Systems Corporation’s internal control over financial reporting as of October 31, 2005, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated January 11, 2006 expressed an unqualified opinion thereon.

/S/    ERNST & YOUNG LLP

San Jose, California

January 11, 2006

55

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ON INTERNAL CONTROL OVER FINANCIAL REPORTING

The Board of Directors and Stockholders

Credence Systems Corporation

We have audited management’s assessment, included in the accompanying Management’s Report on Internal Control over Financial Reporting, that Credence Systems Corporation maintained effective internal control over financial reporting as of October 31, 2005, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (the COSO criteria). Credence Systems Corporation’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting. Our responsibility is to express an opinion on management’s assessment and an opinion on the effectiveness of the company’s internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, evaluating management’s assessment, testing and evaluating the design and operating effectiveness of internal control, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the Company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, management’s assessment that Credence Systems Corporation maintained effective internal control over financial reporting as of October 31, 2005, is fairly stated, in all material respects, based on the COSO criteria. Also, in our opinion, Credence Systems Corporation maintained, in all material respects, effective internal control over financial reporting as of October 31, 2005, based on the COSO criteria.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Credence Systems Corporation as of October 31, 2005 and 2004, and the related consolidated statements of operations, stockholders’ equity, and cash flows for each of the three years in the period ended October 31, 2005 of Credence Systems Corporation and our report dated January 11, 2006 expressed an unqualified opinion thereon.

/S/    ERNST & YOUNG LLP

San Jose, California

January 11, 2006

56

CREDENCE SYSTEMS CORPORATION

CONSOLIDATED BALANCE SHEETS

(in thousands, except per share amounts)

	October 31,
	2005			2004
ASSETS
Current assets:
Cash and cash equivalents	$	142,180		$	94,052
Short-term investments		7,816			69,954
Accounts receivable, net of allowances of $4,325 and $1,607, respectively		114,042			124,393
Inventories		79,054			127,951
Income tax receivable		—			26
Deferred income taxes		9,473			20,544
Prepaid expenses and other current assets		18,506			20,962
Total current assets		371,071			457,882
Property and equipment, net		96,691			108,707
Goodwill		424,080			422,960
Other intangible assets, net of accumulated amortization of $70,934 and $50,491, respectively		96,439			116,882
Other assets		58,024			66,675
Total assets	$	1,046,305		$	1,173,106
LIABILITY AND STOCKHOLDERS’ EQUITY
Current liabilities:
Bank loans and notes payable—leased products	$	5,000		$	6,058
Accounts payable		45,846			51,742
Accrued expenses and other liabilities		39,756			51,651
Accrued payroll and related liabilities		18,336			17,755
Deferred revenue		17,716			14,654
Income tax payable		18,800			13,103
Accrued warranty		13,419			15,314
Deferred profit		5,112			9,718
Total current liabilities		163,985			179,995
Convertible subordinated notes (1.50%, due 2008, convertible into common stock at conversion price of $11.31 per share)		180,000			180,000
Long-term deferred income taxes		9,473			20,544
Long-term restructuring liabilities		7,261			—
Other liabilities		3,557			4,359
Commitments and contingencies (Note 5)
Stockholders’ equity:
Preferred Stock:
Authorized shares—41,304 ($0.001 par value); zero shares in 2005 and 12,328 shares in 2004		—			12
Common stock:
Authorized shares—150,000 ($0.001 par value); Issued shares—99,449 in 2005 and 85,413 in 2004; Outstanding shares—99,448 in 2005 and 85,284 in 2004		100			86
Additional paid-in capital		1,054,854			1,045,665
Treasury stock, at cost, zero shares in 2005 and 129 shares in 2004		—			(2,560	)
Deferred compensation		(4,183	)		(8,600	)
Accumulated other comprehensive income		509			2,924
Accumulated deficit		(369,251	)		(249,319	)
Total stockholders’ equity		682,029			788,208
Total liabilities and stockholders’ equity	$	1,046,305		$	1,173,106

See accompanying notes.

57

CREDENCE SYSTEMS CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

	Year Ended October 31,
	2005			2004			2003
Net sales:
Systems and upgrades	$	313,362		$	358,157		$	141,209
Service and spare parts		115,958			81,646			41,205
Total net sales		429,320			439,803			182,414
Cost of goods sold:
Systems and upgrades		179,404			183,768			89,923
Service and spare parts		70,581			52,935			25,643
Special charges		29,059			49,565			1,927
Gross margin		150,276			153,535			64,921
Operating expenses:
Research and development		92,538			80,535			73,520
Selling, general and administrative		126,823			121,226			91,124
Amortization of purchased intangible assets & deferred compensation (1)		23,470			17,353			9,456
In-process research and development		—			7,900			1,510
Restructuring charges		17,605			6,309			3,589
Total operating expenses		260,436			233,323			179,199
Operating loss		(110,160	)		(79,788	)		(114,278	)
Interest income		2,777			3,320			5,832
Interest expense		(3,226	)		(3,209	)		(2,038	)
Other income and expenses, net		2,066			19,262			(1,575	)
Loss before income tax provision		(108,543	)		(60,415	)		(112,059	)
Income taxes		11,389			3,989			1,006
Loss before minority interest		(119,932	)		(64,404	)		(113,065	)
Minority interest		—			74			47
Net loss	$	(119,932	)	$	(64,478	)	$	(113,112	)
Net loss per share
Basic	$	(1.28	)	$	(0.88	)	$	(1.80	)
Diluted	$	(1.28	)	$	(0.88	)	$	(1.80	)
Number of shares used in computing per share amounts
Basic		93,864			73,058			62,737
Diluted		93,864			73,058			62,737
(1)    Amortization of deferred compensation related to the following expense categories by period:
Cost of goods sold	$	379		$	250		$	69
Research and development		612			358			—
Selling, general and administrative		2,036			1,570			663
Total amortization of deferred compensation	$	3,027		$	2,178		$	732

See accompanying notes.

58

CREDENCE SYSTEMS CORPORATION

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in thousands)

	Preferred Stock					Common Stock			Additional Paid-in Capital			Treasury Stock					Deferred Compensation			Accumulated Other Comprehensive Income			Retained Earnings (Deficit)			Total Stockholders’ Equity
	Shares		Amount			Shares	Amount					Shares		Amount
Balance at October 31, 2002	—		$	—		61,901	$	62	$	608,845		(987	)	$	(21,186	)	$	(598	)	$	3,843		$	(71,729	)	$	519,237
Issuance of common stock for acquisition of Optonics	—			—		1,900		2		21,066		—			—			(1,819	)		—			—			19,249
Issuance of common stock under employee equity plans	—			—		573		—		(1,149	)	445			7,991			—			—			—			6,842
Amortization of deferred compensation	—			—		—		—		—		—			—			732			—			—			732
Net loss	—			—		—		—		—		—			—			—			—			(113,112	)		(113,112	)
Net unrealized loss on securities, net of tax	—			—		—		—		—		—			—			—			(2,254	)		—			(2,254	)
Plus: reclassification adjustment for losses included in earnings	—			—		—		—		—		—			—			—			939			—			939
Currency translation adjustment, net of tax	—			—		—		—		—		—			—			—			(1,006	)		—			(1,006	)
Total comprehensive loss	—			—		—		—		—		—			—			—			—			—			(115,433	)
Balance at October 31, 2003	—			—		64,374		64		628,762		(542	)		(13,195	)		(1,685	)		1,522			(184,841	)		430,627
Issuance of common stock for acquisition of NPTest	—			—		19,661		20		231,391		—			—			(9,967	)		—			—			221,444
Issuance of preferred stock for acquisition of NPTest	12,328			12		—		—		145,091		—			—			—			—			—			145,103
Issuance of common stock under employee equity plans	—			—		1,378		2		3,187		413			10,635			—			—			—			13,824
Issuance of stock options to non-employee	—			—		—		—		165		—			—			(165	)		—			—			—
Assumed NPTest stock options	—			—		—		—		38,108		—			—			—			—			—			38,108
Amortization of deferred compensation	—			—		—		—		—		—			—			2,178			—			—			2,178
Write-off of deferred compensation	—			—		—		—		(1,039	)	—			—			1,039			—			—			—
Net loss	—			—		—		—		—		—			—			—			—			(64,478	)		(64,478	)
Net unrealized loss on securities, net of tax	—			—		—		—		—		—			—			—			(314	)		—			(314	)
Plus: reclassification adjustment for losses included in earnings	—			—		—		—		—		—			—			—			93			—			93
Currency translation adjustment, net of tax	—			—		—		—		—		—			—			—			1,623			—			1,623
Total comprehensive loss	—			—		—		—		—		—			—			—			—			—			(63,076	)
Balance at October 31, 2004	12,328			12		85,413		86		1,045,665		(129	)		(2,560	)		(8,600	)		2,924			(249,319	)		788,208
Schlumberger Liability Settlement	—			—		615		1		4,999		—			—			—			—			—			5,000
Conversion of preferred stock to common stock	(12,328	)		(12	)	12,328		12		—		—			—			—			—			—			—
Issuance of common stock under employee equity plans	—			—		1,092		1		5,580		129			2,560			—			—			—			8,141
Amortization of deferred compensation	—			—		—		—		—		—			—			3,027			—			—			3,027
Write-off of deferred compensation	—			—		—		—		(1,390	)	—			—			1,390			—			—			—
Net loss	—			—		—		—		—		—			—			—			—			(119,932	)		(119,932	)
Net unrealized loss on securities, net of tax	—			—		—		—		—		—			—			—			(566	)		—			(566	)
Plus: reclassification adjustment for losses included in earnings	—			—		—		—		—		—			—			—			283			—			283
Currency translation adjustment, net of tax	—			—		—		—		—		—			—			—			(2,132	)		—			(2,132	)
Total comprehensive loss	—			—		—		—		—		—			—			—			—			—			(122,347	)
Balance at October 31, 2005	—		$	—		99,448	$	100	$	1,054,854		—		$	—		$	(4,183	)	$	509		$	(369,251	)	$	682,029

See accompanying notes.

59

CREDENCE SYSTEMS CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

Increase (decrease) in cash and cash equivalents

(in thousands)

	Year Ended October 31,
	2005			2004			2003
Cash flows from operating activities:
Net loss	$	(119,932	)	$	(64,478	)	$	(113,112	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		71,852			63,494			44,917
Non-cash charges related to restructuring and special charges		28,720			47,231			5,381
Provision for inventory write downs		6,761			10,201			6,351
In-process research and development		—			7,900			1,510
Provision for allowance for doubtful accounts		2,985			(1,460	)		192
Loss (gain) on disposal of property and equipment		111			(588	)		5,967
Realized net loss (gain) from investments		—			369			(449	)
Minority interest		—			55			22
Changes in operating assets and liabilities:
Accounts receivable, net		4,579			(19,044	)		(45,435	)
Inventories		14,817			(60,106	)		18,038
Income tax receivable and payable		6,466			2,136			24,463
Prepaid expenses and other assets		(13,097	)		(6,166	)		(15,758	)
Accounts payable		(5,670	)		7,959			8,433
Accrued expenses and other current liabilities		1,737			(9,750	)		(4,195	)
Deferred profit		(4,611	)		5,117			(2,588	)
Net cash used in operating activities		(5,282	)		(17,130	)		(66,263	)
Cash flows from investing activities:
Purchases of available-for-sale securities		(100,775	)		(247,526	)		(361,462	)
Sales and maturities of available-for-sale securities		162,552			503,319			242,806
Acquisition of property and equipment		(14,812	)		(24,400	)		(14,668	)
Acquisition of NPTest and SZ GmbH, net of cash and cash equivalents acquired		—			(159,913	)		—
Acquisition of other assets		—			(919	)		(4,548	)
Proceeds from sale of property and equipment and leased equipment		809			1,612			2,592
Net cash provided by (used in) investing activities		47,774			72,173			(135,280	)
Cash flows from financing activities:
Issuance of 1 1/2% convertible notes		—			—			174,246
Issuance of common & treasury stock		8,141			13,824			6,842
Payments of liabilities related to leased products		(1,058	)		(2,815	)		(1,563	)
Other		—			(213	)		(856	)
Net cash provided by financing activities		7,083			10,796			178,669
Effects of exchange rate on cash and cash equivalents		(1,447	)		895			—
Net increase (decrease) in cash and cash equivalents		48,128			66,734			(22,874	)
Cash and cash equivalents at beginning of the period		94,052			27,318			50,192
Cash and cash equivalents at end of the period	$	142,180		$	94,052		$	27,318
Supplemental disclosures of cash flow information:
Interest paid	$	3,007		$	2,632		$	2,036
Income taxes paid (received)	$	3,992		$	(74	)	$	(24,715	)
Noncash investing activities:
Net transfers of inventory to property and equipment	$	640		$	2,157		$	3,338
Acquisition of Optonics using Credence common stock	$	—		$	—		$	21,066
Acquisition of NPTest using Credence common stock and assumption of options	$	—		$	414,622		$	—
Schlumberger’s liability settlement using Credence common stock	$	5,000			—			—
Unrealized loss on securities	$	(283	)	$	(213	)	$	(1,315	)
Noncash financing activities:
Customer lease payments on liabilities guaranteed by Credence	$	—		$	(1,535	)	$	(5,041	)

See accompanying notes.

60

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 1—Organization and Summary of Significant Accounting Policies

Organization

Credence Systems Corporation (“Credence” or the “Company”) was incorporated under the laws of the State of California in March 1982 to succeed a sole proprietorship and was reincorporated in Delaware in October 1993. The principal business activity of the Company is the design, development, manufacture, sale and service of integrated test solutions throughout the design, validation and production processes for semiconductors.

In May 2004, the Company completed its acquisition of NPTest Holding Corporation (NPTest). NPTest designed, developed and manufactured advanced semiconductor test and diagnostic systems and provided related services for the semiconductor industry. The addition of NPTest expands the Company’s customer base and enables the Company to provide customers with a broader portfolio of solutions. In accordance with Statement of Financial Accounting Standard No. 141, “Business Combinations,” (SFAS 141) the acquisition was accounted for as a purchase transaction, and the Company has included in its results of operations, for the fiscal year ended October 31, 2004, the results of NPTest beginning on May 29, 2004.

As a result of the acquisition in fiscal 2003 of certain assets and liabilities of SZ Testsysteme AG and SZ Testsysteme GmbH, or SZ, the Company complemented its existing mixed-signal and wireless solutions with a division focused primarily on the automotive test market. The Automotive product line is included in the mobile products group of the Company. In January 2003, the Company acquired Optonics, Inc., which extended the Company’s product offerings in engineering validation test, design verification and diagnostics systems. The Optonics product line is included in the diagnostics and characterization group of the Company. In February 2003, the Company acquired certain assets and liabilities of Credence Capital Corporation, or CCC, which allows the Company to offer leasing and other financing solutions to customers seeking alternative options to acquire the Company’s equipment. CCC is operated as a wholly owned subsidiary.

The Company has subsidiaries in Singapore, Taiwan, China and Japan engaged in sales, marketing and service of the Company’s products and subsidiaries in Korea, Malaysia, and the Philippines engaged in service of the Company’s products. The Company also has European subsidiaries, which principally distribute, service, and support Credence products in Europe and the Middle East. The Company maintains research and development in the U.S., France, Germany, and the UK, and manufacturing in the U.S and Germany.

Basis of Presentation

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned and majority owned subsidiaries. All significant intercompany transactions and balances have been eliminated. Certain prior year amounts in the consolidated financial statements and related notes have been reclassified to conform to the current year’s presentation. During the fiscal year 2005, the Company reclassified its product consignment from inventory to other assets. The amount reclassified as of October 31, 2004 was $18.8 million. This reclassification had no effect on the financial position, results of operations, or cash flows for any of the periods presented.

Minority Interest—The Company liquidated Credence-Innotech Corporation, its joint venture with Innotech Corporation in Japan during the third quarter of fiscal 2004. The loss recognized upon liquidation was immaterial for fiscal year 2004.

Use of Estimates

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements.

61

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Actual results inevitably will differ from those estimates and such differences may be material to the financial statements. Estimates are used for, but not limited to, the accounting for the revenue recognition, accounts receivable factoring, allowance for doubtful accounts, inventory valuation, depreciation and amortization, share-based compensation valuation, residual values of leased assets, product maturity and receivable collectibility for purposes of revenue recognition, warranty costs, restructuring costs, deferred taxes and contingencies.

The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability or unwillingness of its customers to make required payments. The Company records its bad debt expenses as selling, general and administrative expenses. When the Company becomes aware that a specific customer is unable to meet its financial obligations to the Company, generally because of bankruptcy or deteriorations in the customer’s operating results or financial position, the Company records a specific allowance to reflect the level of credit risk in the customer’s outstanding receivable balance. In addition, the Company records additional allowances based on certain percentages of its aged receivable balances. These percentages are determined by a variety of factors including, but not limited to, current economic trends, historical payment and bad debt write-off experience.

Due to the cyclical nature of the semiconductor equipment industry, the Company monitors its inventory levels in light of changes in the marketplace. In fiscal 2005, the Company recorded special charges to cost of goods sold totaling approximately $29.1 million. Of the $29.1 million, $27.8 million related to inventory write-downs. In fiscal 2004, the Company recorded special charges to cost of goods sold totaling approximately $49.6 million, which consisted primarily of the write-down of excess and obsolete inventory and other charges related to the Company’s decision to discontinue significant future investment in its redundant product lines stemming from the acquisition of NPTest. Of the $49.6 million, $45.0 million was directly related to inventory write-downs resulting from duplicate product lines caused by the acquisition of NPTest. The Company evaluated the redundant product lines using internal and external marketing data, the development roadmap for each product line, existing and potential customers and demand for the product. As a result of the evaluation, the Company identified production inventory, finished goods, consignment and demonstration inventory in excess of estimated future customer demand of approximately $ 35.2 million; write-downs to estimated current market value of approximately $9.8 million; non-cancelable purchase commitments of approximately $1.0 million; field service spares of approximately $0.9 million, and other assets and expenses of approximately $2.7 million. The Company recorded a charge in the third quarter of fiscal 2003 of $1.3 million due to a legal settlement with an inventory vendor relating to cancelled purchase contracts and $0.6 million due to spare parts write-offs.

Residual values assigned to the Company’s products that are leased to customers are based on their remaining useful economic life at the end of the lease terms. The amounts assigned to the residual values are evaluated periodically against technological change and the forecasted business cycle.

Revenue Recognition

Under Securities and Exchange Commission’s Staff Accounting Bulletin No. 104, “Revenue Recognition,” (SAB 104), the Company recognizes revenue on the sale of semiconductor manufacturing equipment when title and risk of loss have passed to the customer, there is persuasive evidence of an arrangement, delivery has occurred or services have been rendered, the sales price is fixed or determinable, collectibility is reasonably assured and customer acceptance criteria have been successfully demonstrated. Revenue recognition policies are applied consistently among the Company’s semiconductor manufacturing equipment product lines. Product revenue is recognized upon shipment only when achieving the customer acceptance criteria can be demonstrated prior to shipment, which generally occurs with mature product. Revenue related to the fair value of the installation obligation is recognized upon completion of the installation. Service revenues are generally

62

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

recognized upon performance of the activities requested by the customers. Products are classified as mature after several different customers have accepted similar systems. When the customer acceptance criteria cannot be demonstrated prior to shipment, revenue and the related cost of goods sold are deferred until customer acceptance. For some customers in certain countries where collections may be an issue, the Company may require a letter of credit to be established or cash receipt in advance before revenue can be recognized. Lease revenue is recorded in accordance with Statement of Financial Accounting Standard No. 13, “Accounting for Leases,” (SFAS No. 13), which requires that a lessor accounts for each lease by either the direct financing, sales-type or operating method. Revenue from sales-type leases is recognized at the net present value of future lease payments. Revenue from operating leases is recognized over the lease period.

During fiscal 2005, 2004 and 2003, the Company introduced several new enhancements, systems and products. Certain revenues from sales of these new systems and products during these years were deferred until the revenue recognition requirements of the Company’s revenue recognition policy are satisfied. This practice will continue in the future. In the past, the Company experienced significant delays in the introduction and acceptance of new testers as well as certain enhancements to the Company’s existing testers. Delays in introducing a product or delays in the Company’s ability to obtain customer acceptance, if they occur in the future, will delay the recognition of revenue and gross profit by the Company.

With respect to arrangements with multiple deliverables, the Company follows the guidance in EITF 00-21, “Revenue Arrangements with Multiple Deliverables,” to determine whether there is more than one unit of accounting. To the extent that the deliverables are separable into multiple units of accounting, the Company then allocates the total fee on such arrangements to the individual units of accounting using the residual method. The Company then recognizes revenue for each unit of accounting depending on the nature of the deliverable(s) comprising the unit of accounting (principally following SAB 104).

Sales in the United States are principally made through the Company’s direct sales organization consisting of direct sales employees and representatives. Sales outside the United States utilize both direct sales employees and distributors. There are no significant differences in revenue recognition policies based on the sales channel, due to the business practices that have been adopted with the Company’s distributor relationships. Because of these business circumstances, the Company does not use “price protection,” “stock rotation” or similar programs with its distributors. It does not typically sell inventory into its distributors for eventual sale to end-users, but rather the Company sells product to the distributors on the basis of a purchase order received from an end-user. The Company evaluates any revenue recognition issues based on the characterization of the end customer in light of its revenue recognition policy.

The Company has embedded software in its semiconductor manufacturing equipment. The Company believes this embedded software is incidental to its products and therefore it is excluded from the scope of SOP 97-2 since the embedded software in the Company’s products is not sold separately, cannot be used on another vendor’s products, and the Company cannot fundamentally enhance or expand the capability of the equipment with new or revised embedded software. In addition, the equipment’s principal performance characteristics are governed by digital speed and pin count, which are primarily a function of the hardware.

Deferred revenue includes deferred revenue related to maintenance contracts (and other undelivered services) and to extended warranties where products were sold with more than the standard one-year warranty. Deferred profit is related to equipment that was shipped to certain customers, but the revenue and cost of goods sold were not recognized because the customer-specified acceptance criteria has not been met as of the fiscal period end or because the customer is deemed to be a high credit risk and payment has not been received as of the fiscal period end.

63

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The Company warrants its products to its customers generally for one year from the date of shipment. In addition to the provision of standard warranties, the Company may offer customer paid extended warranty services with a fixed fee. The fixed fees are recognized as revenue on a straight-line basis over the applicable term of the contract. Costs related to extended warranty services are recorded as incurred.

For certain customers, typically those with whom the Company has long-term relationships, the Company may grant extended payment terms. Certain of the Company’s receivables have due dates in excess of 90 days and the Company has a history of successfully collecting these extended payment term accounts receivable.

Advertising

Advertising costs are expensed as incurred and included in selling, general and administrative expenses in the consolidated statements of operations. Advertising expense were approximately $201,000, $346,000 and $47,000 in fiscal years 2005, 2004 and 2003, respectively.

Derivative Instruments and Hedging Activities

In the first quarter of fiscal 2001, the Company adopted Statement of Financial Accounting Standards No. 133 “Accounting for Derivative Instruments and Hedging Activities,” (SFAS 133), as amended by SFAS 137 and SFAS 138, which establishes accounting and reporting standards for derivative instruments and for hedging activities. SFAS 133 requires that an entity recognize derivatives as either assets or liabilities on the balance sheet and measure those instruments at fair value. The accounting for changes in the fair value of a derivative depends on the intended use of the derivative and the resulting designation. The Company does not currently use derivatives, but will continue to assess the need for these instruments in the future.

Foreign Currency Translation

The Company’s international subsidiaries operate primarily using local functional currencies. Accordingly, all assets and liabilities of these subsidiaries are translated using exchange rates in effect at the end of the period, and revenues and costs are translated using average rates for the period. The resulting cumulative translation adjustments are presented as a separate component of stockholders’ equity. Realized and unrealized exchange gains or losses from transaction adjustments are reflected in operations and have not been material.

Guarantees

The Company accounts for guarantees in accordance with FASB Interpretation No. 45, “Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees to Others, an interpretation of FASB Statements No. 5, 57 and 107 and a rescission of FASB Interpretation No. 34” (FIN 45). Accordingly, the Company evaluates its guarantees to determine whether (a) the guarantee is specifically excluded from the scope of FIN 45, (b) the guarantee is subject to FIN 45 disclosure requirements only, but not subject to the initial recognition and measurement provisions, or (c) the guarantee is required to be recorded in the financial statements at fair value. The Company has evaluated its guarantees and has concluded that they are either not within the scope of FIN 45 or do not require recognition in the financial statements.

Our corporate by-laws require that the Company indemnify its officers and directors, as well as those who act as directors and officers of other entities at the Company’s request, against expenses, judgments, fines, settlements and other amounts actually and reasonably incurred in connection with any proceedings arising out of their services to the Company. In addition, the Company has entered into separate indemnification agreements

64

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

with each director and each executive officer of the Company that provide for indemnification of these directors and officers under similar circumstances and under additional circumstances. The indemnification obligations are more fully described in the by-laws and the indemnification agreements. The Company purchases standard directors and officers insurance to cover claims or a portion of the claims made against its directors and officers. Since a maximum obligation is not explicitly stated in the Company’s by-laws or in the indemnification agreements and will depend on the facts and circumstances that arise out of any future claims, the overall maximum amount of the obligations cannot be reasonably estimated. Historically, the Company has not been required to make payments related to these obligations, and the fair value for these obligations is zero on the consolidated balance sheet as of October 31, 2005.

As part of the amended employment contract entered into between the Company and one of its board of directors, which was previously between NPTest and its director, the Company will have an obligation to pay compensation up to approximately $1.0 million to this director if at the end of the term of the employment contract in July 2006, the total value received from the exercising of his options is below the amount as stated in the contract.

As is customary in the Company’s industry and as provided for under local law in the U.S. and other jurisdictions, many of the Company’s standard contracts provide remedies to customers and others with whom the Company does business, such as defense, settlement, or payment of judgment for intellectual property claims related to the use of the Company’s products. From time to time, the Company indemnifies customers, as well as the Company’s suppliers, contractors, lessors under operating lease agreements for environmental matters, lessees, companies that purchase the Company’s businesses or assets and others with whom the Company enters into contracts, against combinations of loss, expense, or liability arising from various triggering events related to the sale and the use of the Company’s products and services such as warranty, the use of their goods and services, the use of facilities and state of the Company’s owned facilities, the state of the assets and businesses that the Company sells and other matters covered by such contracts, usually up to a specified maximum amount. Based on past experience, claims made under such indemnifications are rare and the associated estimated fair value of the liability is not material.

The Company occasionally grants trade-in rights to its customers. As of October 31, 2005, the Company had approximately $1.6 million, the estimated fair value of these obligations, included in the consolidated balance sheet under current liabilities.

Cash, Cash Equivalents, and Short-Term Investments

For purposes of cash flow reporting, the Company considers all highly liquid investments with minimum yield risks and original maturity dates of three months or less to be cash equivalents. Short-term investments consist primarily of commercial paper, medium term notes, asset-backed securities, U.S. Treasury notes and obligations of U.S. Government agencies, equity securities, corporate bonds and municipal bonds carried at amortized costs adjusted to fair market value.

At October 31, 2005 and 2004, the Company classified all investments as available-for-sale and reported their fair market value. Unrealized gains or losses on available-for-sale securities, if material, are included, net of tax, in equity until disposition.

Realized gains, losses and declines in value judged to be other-than-temporary on available-for-sale securities are included in interest income. The cost of securities sold is based on the specific identification method.

65

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Gross unrealized gains and losses were not significant in fiscal 2005 and fiscal 2004. The realized profits (losses) and interest of $0, ($0.4) million and $0.4 million are included in interest income in the consolidated statements of operations for fiscal years 2005, 2004 and 2003, respectively. Unrealized gains and losses are reflected as a separate component of comprehensive income and are included in the consolidated statements of stockholders’ equity.

The fair market value of cash equivalents, short-term and long-term debt investments represents the quoted market prices at the balance sheet dates. Cash and cash equivalents are categorized as follows (in thousands):

	October 31,
	2005		2004
Money market	$	91,769	$	39,381
Cash		50,411		54,671
Cash and cash equivalents	$	142,180	$	94,052

Short-term investments mature in less than one year. At October 31, 2005 and 2004, these investments are classified as available-for-sale and consist of the following (in thousands):

	Amortized Cost		Unrealized Gains in Accumulated Other Comprehensive Income		Unrealized Losses in Accumulated Other Comprehensive Income			Aggregate Fair Value
	(In thousands)
October 31, 2005
Auction rate preferred	$	7,425	$	—	$	—		$	7,425
Equity securities		200		191		—			391
Short and long term investments	$	7,625	$	191	$	—		$	7,816
October 31, 2004
Auction rate preferred	$	44,400	$	—	$	—		$	44,400
Treasury notes and obligations of U.S. government agencies		17,040		—		(129	)		16,911
Auction rate securities		1,500		—		—			1,500
Equity securities		200		572		—			772
Government bonds		1		—		—			1
Municipal bonds		6,340		30		—			6,370
Short and long term investments	$	69,481	$	602	$	(129	)	$	69,954

The estimated fair value of cash, cash equivalents and short-term investments classified by the maturity date listed on the security is as follows (in thousands):

	October 31,
	2005		2004
Due within 1 year	$	149,996	$	164,006
Cash, cash equivalents and short-term investments	$	149,996	$	164,006

66

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Accounts Receivable Factoring without Recourse

The Company had an agreement with a commercial bank to sell certain of its trade receivables in non-recourse transactions. Under the terms of the agreement, the Company could sell up to $30.0 million of its trade receivables at any one time. The Company was retained by the bank to service the collection aspect of the trade receivables sold. The trade receivables were sold at a discount plus administrative and other fees. The discount amount, administrative and other fees for the fiscal year 2005 of approximately $0.1 million were accounted for in other income and expense, net in the consolidated statements of operations. Sales of trade receivables were reflected as a reduction of accounts receivable in the accompanying consolidated balance sheets. The proceeds received were included as cash in the accompanying consolidated balance sheets and as operating activities in the consolidated statements of cash flows. During the first three months of fiscal 2005, the Company recorded approximately $7.2 million in gross cash proceeds from the sale of trade receivables. This facility was terminated in the third quarter of fiscal 2005 and no sales of trade receivables occurred after the first quarter of fiscal 2005.

Inventories

Inventories are stated at the lower of standard cost (which approximates first-in, first-out cost) or market. Shipping and handling expenses for purchased inventory items are expensed to cost of goods sold. Inventories consist of the following (in thousands):

	October 31,
	2005		2004
Raw materials	$	43,790	$	80,922
Work-in-process		21,121		29,388
Finished goods		14,143		17,641
	$	79,054	$	127,951

The Company makes inventory commitments and purchase decisions based upon sales forecasts. Each year the Company forecasts an annual operating plan and a three-year strategic plan as part of its strategic planning process. The Company also has a 12-month rolling forecast that estimates business levels for the next four quarters. These forecasts require the Company to estimate its ability to sell current and future products in the next cyclical period of the industry and compare those estimates with its current inventory levels. It is difficult to predict the timing of the next recovery or recession as well as the strength of that recovery or recession. The Company sells capital equipment with relatively longer technological lives than many of the components that are included in the manufacture of its products. Some of the components that the Company purchases are unique to the Company and must be purchased in relatively high minimum quantities with long (approximately four and five month) lead times. These business circumstances can lead to the Company holding relatively high inventory levels with the associated risks. In addition, purchase commitments for unique components are relatively inflexible in terms of deferral or cancellation. This results in the Company entering into a variety of purchase commitments in order to mitigate component supply constraints, capture purchasing efficiencies and obtain supplies of components that are nearing end of life.

The Company reviews excess and obsolete inventory on an annual basis in light of its three year strategic planning process and then again on a quarterly basis for significant events that might have an impact on inventories. In evaluating the need for inventory write-offs, the Company considers a number of factors including anticipated product life cycles, new product introductions, and expected future use of all raw materials, work-in-process, and finished goods on hand as well as purchase order commitments to purchase inventory. If

67

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

the forecasts or estimates change, or product roadmaps change, then the Company would need to adjust its assessment of the inventory valuations. The Company reviews inventory on a cyclical basis rather than a seasonal or annual basis because of the nature of its industry, the relatively long lives of its products and the volatility of the business from quarter to quarter. Once the Company has identified excess or obsolete inventory materials, including purchase commitments, it considers alternative future uses for the items in question. In cases where no alternative future uses have been identified, and if the Company concludes that it is probable that the costs associated with the excess or obsolete materials will not be recovered, then an appropriate write-off is recorded. The Company then writes off 100% of the cost of inventory that it specifically identifies. The Company does not as a matter of course scrap all inventory that is identified as excess or obsolete. The Company’s products are capital goods with potentially long economic lives and historically the opportunity to sell these products has arisen or fallen unexpectedly. The Company has occasionally encountered unexpected demand for old products. The Company closely monitors the inventories that have been written off or written down but not scrapped, so that if any sales of these items occur and affect our reported gross margins, the effect, if material is disclosed.

The Company consigns a portion of its finished goods inventory to both external and internal customers on a short-term basis primarily for the purpose of customer demonstration. This inventory is categorized as other assets on the consolidated balance sheet. The Company depreciates all consigned inventories during the period that they are held on consignment over 18 to 36 months. The depreciation expense for consigned inventory is charged to selling, general and administrative expense.

Property and Equipment, Net and Other Assets

Machinery and equipment, software and furniture and fixtures are stated at cost and are depreciated using the straight-line method over three years. Personal computer equipment that meets the Company’s capitalization threshold is depreciated over two years. Leasehold improvements are depreciated using the straight-line method over the shorter of seven years or the applicable lease term. Tenant improvements in owned facilities are generally depreciated over seven years. Buildings are depreciated using the straight-line method over the assets’ estimated useful lives of thirty years. Assets under capitalized leases are amortized using the straight-line method over the shorter of the estimated useful life of the asset or the lease term.

Property and equipment, net consists of the following (in thousands):

	October 31,
	2005			2004
Land	$	26,835		$	26,908
Buildings		35,746			36,823
Machinery and equipment		104,626			102,783
Software		30,705			28,980
Leasehold improvements		39,106			39,511
Furniture and fixtures		10,456			10,792
		247,474			245,797
Less accumulated depreciation		(150,783	)		(137,090	)
Net property and equipment	$	96,691		$	108,707

Depreciation expense was approximately $24.6 million, $27.9 million, and $24.2 million for the years ended October 31, 2005, 2004 and 2003, respectively.

68

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

In addition, the Company capitalizes a small number of finished systems into the manufacturing function for use in de-bug, quality control, and software development as well as the sales function for use in demonstrations and application development.

Other intangible assets, excluding goodwill, consist of the following (in thousands):

October 31, 2005	Cost		Accumulated Amortization			Net
Purchased technology	$	125,206	$	(48,446	)	$	76,760
Customer relations		19,802		(10,013	)		9,789
Maintenance contracts		13,800		(3,910	)		9,890
Product backlog		4,900		(4,900	)		—
Trademarks		2,053		(2,053	)		—
Patents		862		(862	)		—
Non-compete agreements		750		(750	)		—
Total	$	167,373	$	(70,934	)	$	96,439
October 31, 2004	Cost		Accumulated Amortization			Net
Purchased technology	$	125,206	$	(36,328	)	$	88,878
Customer relations		19,802		(7,735	)		12,067
Maintenance contracts		13,800		(1,150	)		12,650
Product backlog		4,900		(2,042	)		2,858
Trademarks		2,053		(1,848	)		205
Patents		862		(732	)		130
Non-compete agreements		750		(656	)		94
Total	$	167,373	$	(50,491	)	$	116,882

Amortization expenses for the other intangible assets were $20.4 million, $15.5 million and $9.5 million for fiscal 2005, 2004 and 2003, respectively.

The estimated future amortization expense of purchased intangible assets with definite lives for the next five years is as follows (in thousands):

Year Ending October 31,	Amount
2006	$	16,604
2007		16,466
2008		14,518
2009		12,718
2010		9,934
Thereafter		26,199
Total	$	96,439

As of November 1, 2002 the Company adopted Statements of Financial Accounting Standards No. 142 “Goodwill and Other Intangible Assets,” (SFAS 142). Under SFAS 142, goodwill and indefinite lived intangible assets are no longer amortized, but are reviewed annually (or more frequently if impairment indicators arise) for impairment. For purposes of SFAS 142, the Company determined to have only a single reporting unit since fiscal

69

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

year 2003. To perform the goodwill impairment test, the Company determines the carrying value of its reporting unit by assigning the assets and liabilities, including existing goodwill and intangible assets, to it. The Company then compares the carrying value with the fair value of the reporting unit. To the extent the Company’s reporting unit’s carrying amount exceeds its fair value, the Company must perform the second step of the impairment test. In the second step, the Company must compare the implied fair value of the reporting unit’s goodwill to its carrying amount. If no impairment exists under step one, the second step is not required. No impairment loss was recognized in any of the periods presented.

The determination as to whether a write down of goodwill is necessary involves significant judgment based on the short-term and long-term projections of the future performance of the Company. The assumptions supporting the estimated future cash flows of the reporting unit, including the discount rate used and estimated terminal value reflect the Company’s best estimates.

As of November 1, 2002, the Company adopted Statements of Financial Accounting Standards No. 144 “Accounting for the Impairment or Disposal of Long-Lived Assets,” (SFAS 144). In the quarter ended July 31, 2003, in accordance with SFAS No. 144, the Company accelerated the depreciation for leasehold improvements related to buildings located in Fremont, California that the Company vacated in the first quarter of fiscal 2004 when the Company moved to its new headquarters in Milpitas, California. The amount of the accelerated depreciation related to these leasehold improvements was approximately $1.7 million and was recognized over nine months ended January 31, 2004. In the first quarter of fiscal 2005, the Company began to accelerate the depreciation for leasehold improvements related to the San Jose and Simi Valley, California buildings as part of the facilities consolidations. The amount of the accelerated depreciation related to these leasehold improvements was approximately $1.4 million and was recognized through May 2005. Accelerated depreciation related to the leasehold improvements was recorded in operating expenses.

Equity Investment

At October 31, 2005, the Company had one equity method investment in a privately held company that is intended to provide strategic technologies and relationships to the Company’s businesses. This privately held company is currently in the development stage. Based on this status, the Company has determined that this equity investment does not require consolidation, as it is not a variable interest entity. The Company’s maximum exposure to loss for this investment at October 31, 2005 is limited to its carrying amount of $1.8 million and a minimum product purchase commitment of approximately $1.0 million by December 31, 2008.

Post-Employment Benefits

Post-employment benefits accrued for workforce reductions related to restructuring activities initiated in and after October 2004 are accounted for under Statement of Financial Accounting Standards No.112, “Employer’s Accounting for Post-employment Benefits,” (SFAS 112). A liability for post-employment benefits is recorded when payment is probable, the amount is reasonably estimable, and the obligation relates to rights that have vested or accumulated.

Bank Loans and Note Payable—Leased Products

In February 2003, the Company acquired certain assets and liabilities of Credence Capital Corporation, or CCC, a non-related leasing company. The net assets of CCC consisted primarily of a portfolio of leases of Credence equipment and its liabilities included indebtedness associated with the lease portfolio. The associated liabilities at October 31, 2005 include a bank note.

70

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The bank note had an annual interest rate of prime (approximately 6.75% at October 31, 2005). The note had a covenant requiring the Company to maintain a minimum aggregated balance of cash, cash equivalents, and short and long-term investments of $100.0 million. As of October 31, 2005, the Company was in compliance with the covenant and this bank note had a balance of $5.0 million. See the maturity schedule for this obligation in Note 5—“Commitments and Contingencies.” The note expired and paid in full in November 2005 and was not renewed.

Other Balance Sheet Components

Prepaid expenses and other current assets consist of the following (in thousands):

	October 31,
	2005		2004
Short-term lease receivables	$	1,227	$	1,692
Receivable from contract equipment manufacturers		4,383		3,851
Other prepaid expenses		12,896		15,419
Total	$	18,506	$	20,962

Other assets consist of the following (in thousands):

	October 31,
	2005		2004
Long-term lease receivables	$	3,489	$	6,553
Equipment on lease		415		3,089
Field service spares		30,001		29,488
Product consignment		16,439		18,790
Other assets		7,680		8,755
Total	$	58,024	$	66,675

Product spare parts that are used in the Company’s service business are classified as other assets and are depreciated using the straight-line method over five years. When spare parts are sold to third parties the transaction is recorded as net sales. Amortization expense was approximately $9.3 million, $4.4 and $4.8 million for fiscal years 2005, 2004 and 2003, respectively.

Product consignments to internal and external customers are classified as other assets and are depreciated using the straight-line method over 18 to 36 months. Amortization expense was approximately $13.5 million, $7.2 and $4.9 million for fiscal years 2005, 2004 and 2003, respectively.

Other accrued expenses and liabilities consist of the following (in thousands):

	October 31,
	2005		2004
Accrued distributor commissions		2,010		3,412
Accrued bonuses		5,073		10,083
Accrued restructuring expenses		10,178		6,522
Accrued State Taxes		7,784		5,426
Accrued value added taxes		2,062		2,650
Contingent payable to Schlumberger		—		10,266
Accrued interest expense		1,238		1,252
Other accrued liabilities		11,411		12,040
	$	39,756	$	51,651

71

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Stock-Based Compensation

The Company accounts for its employee stock option and employee stock purchase plans under the intrinsic value recognition and measurement principles of Accounting Principles Board Opinion (“APB”) No. 25, “Accounting for Stock Issued to Employees,” and related Interpretations, and has adopted the disclosure-only provisions of Statement of Financial Accounting Standard No. 123, “Accounting for Stock-Based Compensation,” (SFAS 123), as amended by Statement of Financial Accounting Standard No. 148, “Accounting for Stock-Based Compensation—Transition and Disclosures,” (SFAS 148). As the exercise price of the Company’s employee stock options equals the market price of the underlying stock on the date of the grant, no compensation expense is recognized in the Company’s financial statements.

In calculating pro forma compensation, the fair value of each option grant is estimated on the date of grant using the Black-Scholes-Merton options pricing model. The Black-Scholes-Merton option pricing model was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. In addition, the Black-Scholes-Merton model requires the input of highly subjective assumptions including the expected stock price volatility. As the Company’s stock-based awards to employees have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in management’s opinion, the existing models do not necessarily provide a reliable single measure of its stock-based awards to its employees. Stock-based employee compensation expense already included in the reported net loss is a result of amortization of deferred compensation related to acquisitions.

The fair value for the stock options was estimated at the grant date using a Black-Scholes-Merton option pricing model assuming no expected dividends with the following weighted average assumptions for the years ended October 31, 2005, 2004, and 2003.

	2005		2004		2003
Expected life of options (years)	5.16		4.94		6.34
Expected stock volatility	0.73		0.74		0.77
Risk-free interest rate	3.55	%	3.33	%	3.45	%

The weighted average fair value of options granted was $5.63, $7.64 and $5.95 in fiscal year 2005, 2004 and 2003, respectively.

The fair value of issuances under the Employee Stock Purchase Plan is estimated on the issuance date using the Black-Scholes-Merton options pricing model assuming no expected dividends and the following weighted average assumptions for issuances made in 2005, 2004 and 2003:

	2005		2004		2003
Expected life of options (years)	0.50		0.50		0.50
Expected stock volatility	0.57		0.53		0.93
Risk-free interest rate	2.71	%	1.52	%	1.42	%

The weighted-average fair value of purchase rights granted was $1.91, $2.44 and $3.86 in fiscal year 2005, 2004 and 2003, respectively.

72

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Had the Company determined stock-based compensation costs based on the estimated fair value at the grant date for its stock options and the estimated fair value at the issuance date for its Employee Stock Purchase Plan, the Company’s net loss and net loss per share for the years ended October 31, 2005, 2004 and 2003 would have been as follows (in thousands, except per share data):

	2005			2004			2003
Net loss as reported	$	(119,932	)	$	(64,478	)	$	(113,112	)
Add: Stock-based employee compensation expense included in reported net loss		3,027			2,178			732
Less: Stock-based employee compensation expense determined under fair value based methods for all awards		(34,685	)		(26,156	)		(24,057	)
Pro forma net loss	$	(151,590	)	$	(88,456	)	$	(136,437	)
Basic net loss per share as reported	$	(1.28	)	$	(0.88	)	$	(1.80	)
Basic net loss per share pro forma	$	(1.61	)	$	(1.21	)	$	(2.17	)
Diluted net loss per share as reported	$	(1.28	)	$	(0.88	)	$	(1.80	)
Diluted net loss per share pro forma	$	(1.61	)	$	(1.21	)	$	(2.17	)

The basic and diluted pro forma net loss per share for the fiscal years 2004 and 2003 have been revised from the previously disclosed amounts in the Company’s annual report on Form 10-K for the fiscal years ended 2004 and 2003.

Net Loss Per Share

Basic and diluted net loss per share is based upon the weighted average number of common shares outstanding during the period. Diluted net income per share is based upon the weighted average number of common shares and dilutive-potential common shares outstanding during the period.

The following table sets forth the computation of basic and diluted loss per share for the fiscal years ended October 31, (in thousands, except per share amounts):

	2005			2004			2003
Numerator:
Net loss	$	(119,932	)	$	(64,478	)	$	(113,112	)
Denominator:
Weighted-average shares outstanding		93,864			73,058			62,737
Basic net loss per share	$	(1.28	)	$	(0.88	)	$	(1.80	)
Diluted net loss per share	$	(1.28	)	$	(0.88	)	$	(1.80	)

During fiscal 2005, the Company excluded options to purchase 18,158,000 shares of common stock and 15,915,119 shares issuable under the terms of the convertible subordinated notes from the diluted loss per share calculation, as their effect was anti-dilutive. During fiscal 2004, the Company excluded options to purchase 18,745,141 shares of common stock, 12,328,200 shares of convertible preferred stock and 15,915,119 shares issuable under the terms of the convertible subordinated notes from the diluted loss per share calculation because they were anti-dilutive. During fiscal 2003, the Company excluded options to purchase 13,195,611 shares of common stock and 15,915,119 shares issuable under the terms of the convertible subordinated notes from the diluted net loss per share calculation because they were anti-dilutive.

73

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Recent Accounting Pronouncements

In December 2004, the FASB issued Statement of Financial Accounting Standard No. 123R, “Share-Based Payment,” (SFAS 123R). SFAS 123R revised SFAS 123. In March 2005, the Securities and Exchange Commission (SEC) issued Staff Accounting Bulletin No. 107 (SAB 107) which provides the Staff’s views regarding interactions between SFAS No. 123(R) and certain SEC rules and regulations and provides interpretations of the valuation of share-based payments for public companies. SFAS No. 123(R) requires that the costs resulting from share-based payment transactions be recognized in the financial statements. The statement requires companies to use a fair-value-based payment measurement method in accounting for share-based payments with employees as well as for goods and services received from non-employees. SFAS 123R is effective for annual reporting periods that begin after June 15, 2005, with early adoption permitted. The Company expects to adopt SFAS 123R using the modified prospective method and the Black-Scholes-Merton pricing model effective November 1, 2005. The Company believes that the adoption of SFAS 123R will have a material effect on its results of operations; however, has not determined whether the adoption will result in amounts that are similar to the current pro forma disclosure under FAS No. 123.

In December 2004, the FASB issued Statement of Financial Accounting Standard No. 153, “Exchanges of Non-monetary Assets,” (SFAS 153), an amendment of APB Opinion No. 29. SFAS 153 addresses the measurement of exchanges of non-monetary assets and redefines the scope of transactions that should be measured based on the fair value of the assets exchanged. SFAS 153 is effective for non-monetary asset exchanges beginning in the first quarter of fiscal 2006. The Company does not believe the adoption of SFAS 153 will have a material effect on its consolidated financial position or results of operations.

In December 2004, the FASB issued FASB Staff Position No. FAS 109-2, “Accounting and Disclosure Guidance for the Foreign Earnings Repatriation Provision within the American Jobs Creation Act of 2004” (“FSP FAS 109-2”). The American Jobs Creation Act introduces a special one-time dividends received deduction on the repatriation of certain foreign earnings to a U.S. taxpayer (repatriation provision), provided certain criteria are met. The Company may repatriate cash in the future; however, it has not determined whether the adoption of FSP FAS 109-2 will have any effect on its consolidated financial position or results of operations.

In March 2005, the FASB published FASB Interpretation No. 47, “Accounting for Conditional Asset Retirement Obligations,” which clarifies that the term, conditional asset retirement obligation, as used in Statement of Financial Accounting Standard No. 143, “Accounting for Asset Retirement Obligations,” (SFAS 47), refers to a legal obligation to perform an asset retirement activity in which the timing and (or) method of settlement are conditional on a future event that may or may not be within the control of the entity. The uncertainty about the timing and (or) method of settlement of a conditional asset retirement obligation should be factored into the measurement of the liability when sufficient information exists. The interpretation also clarifies when an entity would have sufficient information to reasonably estimate the fair value of an asset retirement obligation. The Company does not believe the adoption of SFAS 154 will have a material effect on its consolidated financial position or results of operations.

In May 2005, the FASB issued Statement of Financial Accounting Standard No. 154, “Accounting Changes and Error Corrections,” (SFAS 154) effective with fiscal years beginning after December 15, 2005. This statement replaces APB Opinion No. 20, “Accounting Changes,” and Statement of Financial Accounting Standard No. 3, “Reporting Accounting Changes in Interim Financial Statements”, and changes the requirements for the accounting for and reporting of a change in accounting principle. Under this pronouncement changes are required to be retrospectively applied to prior financial statements, unless it is impracticable to determine either the period-specific effects or the cumulative effect of the change. Retrospective application means the application of a different accounting principle to prior accounting periods as if that principle had always been used or as the

74

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

adjustment of previously issued financial statements to reflect a change in the reporting entity. This statement addresses restatement of previously issued financial statements to reflect the correction of an error. This statement requires that the retrospective application of a change in accounting principle be limited to the direct effects of the change. This statement also requires that a change in depreciation, amortization, or depletion method for long-lived, non-financial assets be accounted for as a change in accounting estimate affected by a change in accounting principle. The Company does not believe the adoption of SFAS 154 will have a material effect on its consolidated financial position or results of operations.

Note 2—Acquisitions

NPTest Holding Corporation:

In May 2004, the Company acquired 100% of the outstanding common stock of NPTest Holding Corporation (NPTest), a company that designed, developed and manufactured advanced semiconductor test and diagnostic systems and provided related services for the semiconductor industry. The addition of NPTest expands the Company’s customer base and enables the Company to provide customers with a broader portfolio of solutions. The acquisition resulted in a total cash payment to shareholders of NPTest of approximately $230 million and the right to receive approximately 32 million shares of the Company’s common stock, including the assumed conversion of 203,036 shares of the Company’s preferred stock at a conversion ratio of 100 to 1, with an aggregate fair value at the acquisition date of approximately $376.5 million. As of fiscal 2005, all of the 32 million shares were issued and outstanding as common stock. In fiscal year 2004, the former majority shareholder of NPTest converted 79,754 shares of the Company’s non-voting convertible preferred stock into 7,975,400 shares of the Company’s common stock. During fiscal 2005, the remaining 123,282 shares of the preferred stock were converted into approximately 12,328,200 shares of common stock. The common stock issued in the acquisition was valued using the average closing price of the Company’s common stock over a five-day trading period beginning two days before and ending two days after the date the transaction was announced. The Company also assumed all of the outstanding NPTest stock options with a fair value of approximately $38.1 million. The options were valued using the Black-Scholes-Merton options pricing model with the following assumptions: dividend of $0, volatility of 0.77, expected life of 6.35 years, risk-free interest rate of 3.45% and a market value of the Company’s common stock of $11.77 per share, which was determined as described above. The Company also incurred direct costs associated with the acquisition of approximately $5.9 million. Below is a summary of the total purchase price (in thousands):

Cash	$	229,950
Common and preferred stock		376,514
Outstanding stock options		38,108
Direct acquisition costs		5,910
Total purchase price	$	650,482

The majority owner of NPTest, who owned approximately 63% of NPTest’s common stock, received 203,036 shares of non-voting convertible preferred stock of the Company as a result of the acquisition. Each share of NPTest common stock held by this majority owner was exchanged for 0.008 of a share of the Company’s non-voting convertible stock. Each share of the non-voting convertible stock was convertible into 100 shares of the Company’s common stock. The non-voting convertible stock was identical in all respects to the Company’s common stock except that, prior to conversion, it had no voting rights, but had a liquidation preference of $0.001 per share. The non-voting convertible stock is classified as preferred stock. During fiscal 2005, the majority owner converted all of the 203,036 shares of the Company’s non-voting convertible preferred stock into 20,303,600 shares of the Company’s common stock.

75

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

In accordance with Statement of Financial Accounting Standard No. 141, “Business Combination,” (SFAS 141), the purchase was accounted for as a purchase transaction and the Company has included in its results of operations, for the fiscal year ended October 31, 2004, the result of NPTest beginning on May 29, 2004. The Company allocated the purchase price to the tangible and intangible assets acquired, including in-process research and development, and liabilities assumed based on their estimated fair values, and to deferred stock compensation. The excess purchase price over those fair values was recorded as goodwill. The fair value assigned to tangible and intangible assets acquired and liabilities assumed were based on estimates and assumptions provided by management, and other information compiled by management, including valuations that utilize established valuation techniques appropriate for the high technology industry. Goodwill recorded as a result of these acquisitions is not expected to be deductible for tax purposes. In accordance with Statement of Financial Accounting Standard No. 142, “Goodwill and Other Intangible Assets,” (SFAS 142), goodwill and purchased intangible assets with indefinite lives are not amortized but reviewed at least annually for impairment. Purchased intangible assets with finite lives will be amortized on a straight-line basis over their respective estimated useful lives. The total purchase price has been allocated as follows (in thousands, except years):

	Amount			Annual Amortization		Useful Lives (Years)
Purchase Price Allocation:
Cash and cash equivalents	$	76,103		$	—	—
Short-term investments		19,481			—	—
Accounts receivable		37,704			—	—
Inventories		60,027			—	—
Prepaid expenses and other current assets		34,923			—	—
Property and equipment		18,238			—	—
Other assets		22,996			—	—
Accounts payable		(19,916	)		—	—
Other accrued expenses and liabilities		(44,546	)		—	—
Contingent payable to Schlumberger		(29,450	)		—	—
Other long-term liabilities		(695	)		—	—
Net tangible assets assumed		174,865			—	—
Intangible assets acquired:
Developed technology		70,300			7,030	10
Maintenance agreements		13,800			2,760	5
Customer relationships		12,100			1,729	7
Product backlog		4,900			4,900	1
Total amortizable intangible assets		101,100			16,419	—
In-process research and development		7,900			—	—
Deferred compensation on unvested stock options		9,967			3,067	3.25
Deferred tax		(29,362	)		—	—
Goodwill		386,012			—	—
Total purchase price	$	650,482		$	19,486

The purchase price allocation changed by $1.1 million during the fiscal year 2005, primarily due to additional accrued expenses and liabilities recognized. The write up of additional accrued liabilities of $1.1 million during the fiscal year 2005 consisted of $1.7 million that pertained to severance and related charges, $1.0 million for the Simi Valley facility clean-up costs, and relocation and other charges of approximately $0.5 million for the Simi Valley facility, offset by $2.1 million write-down of accrued liabilities related to

76

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

pre-acquisition costs and other liabilities. These amounts were charged or credited to goodwill in accordance with EITF Issue No. 95-3, “Recognition of Liabilities in Connection with Purchase Business Combinations” (EITF Issue No. 95-3).

The purchase price allocation changed during the fourth quarter of fiscal 2004 to account for the write down of other assets of $1.4 million, the write up of additional accounts payable of $0.1 million, the write up of additional other accrued expenses and liabilities of $2.0 million and additional transaction fees of $47,000.

Net Tangible Assets

NPTest’s assets and liabilities as of May 28, 2004 were reviewed and adjusted, if necessary, to their fair value. Reserves and allowances were reviewed for appropriateness and approved by management. Management also reviewed the liabilities to ensure that the proper value was recorded based on estimates at that date.

In November 2004, the Board of Directors approved moving forward with a major component of management’s original integration plan, which involved closing the Simi Valley, California facility and moving all manufacturing activities at this site to Hillsboro, Oregon. As a part of the approved plan, during the fiscal year 2005, the Company accrued charges related to the approved plan of $3.8 million. Of the total charges, severance and related charges for 100 employees accounted for $2.1 million, facilities leasehold restoration costs of $1.1 million and relocation expenses of $0.6 million. The Company recognized these costs in accordance with EITF 95-3. The related facility lease charges will be paid through the end of the lease terms, which extend through June 2008, of which the majority of the payment related to the Simi Valley facility, which ends in January 2007. As of October 31, 2005, $2.8 million remained to be paid for these charges. The following table illustrates the charges and the estimated timing of future payouts at October 31, 2005 (in thousands):

	Balance at October 31, 2004			Charges			Utilized		Adjustments		Balance at October 31, 2005
Severance	$	(409	)	$	(2,072	)	$	2,220	$	30	$	(231	)
Facilities		(1,969	)		(1,119	)		680		60		(2,348	)
Relocation		(113	)		(595	)		294		232		(182	)
Total	$	(2,491	)	$	(3,786	)	$	3,194	$	322	$	(2,761	)
Estimated timing of future payouts:
Fiscal 2006												2,451
Fiscal 2007												260
Fiscal 2008												50
Total											$	2,761

As a result of the NPTest acquisition, the Company was required to make a payment to Schlumberger Limited (Schlumberger), the former parent of NPTest, at a date in the future pursuant to a provision in the acquisition agreement between NPTest and Schlumberger under which NPTest was acquired by Francisco Partners, L.P. from Schlumberger. The future payment date could have been triggered by various events, including certain distributions by NPTest Holding, LLC (an entity controlled by Francisco Partners, L.P.) to its members, or, at Schlumberger’s option, it could have been triggered on May 28, 2005. The payment amount was contingent upon the value of the Company’s common stock at the time of distribution. If payment was triggered at Schlumberger’s option, the Company could have generally settled this payment in cash or stock. If payment was triggered by a distribution by NPTest Holding, LLC to its members, the payment to Schlumberger was required to be in the same form and could have been made in cash, stock or both. This contingent liability was required to be marked to market at the end of each fiscal period until settled using the Company’s closing stock

77

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

price on the last day of the fiscal period, and the changes in carrying value flow through other income and expense, net in the condensed consolidated statements of operations. In May 2005, the Company and Schlumberger reached a settlement, which required the Company to pay Schlumberger $4.0 million in cash and 615,157 shares of the Company’s common stock valued at $5.0 million. According to this settlement, the Company had fulfilled its obligation to Schlumberger and there were no outstanding liabilities related to this transaction at the end of fiscal 2005.

Amortizable Intangible Assets

Developed technology consists of products that have reached technological feasibility. Developed technology was valued using the discounting forecasted cash flow (DCF) method. This method calculates the value of the intangible asset as being the net present value of the after tax cash flows potentially attributable to it. The Company amortizes the fair value of the developed technology on a straight-line basis over the remaining estimated useful life of ten years.

Maintenance agreements represent the revenue generated by contracts with customers who pay for annual maintenance and support. The DCF method was used to value the maintenance contracts, which includes estimating the beginning balance of customer service agreements, expected contract renewal rates, specific cost of sales estimates, and estimated general and administrative costs. The Company amortizes the fair value of the maintenance agreements on a straight-line basis over the remaining estimated useful life of five years.

Customer relationships represent the value of the installed base of NPTest’s products and the relationships developed over time with those customers. The customer relationships were valued using an income approach, which takes into account the loss of revenue if the existing customer relationships were not in place, and also the cost required to identify, pursue, and secure the existing customer relationships. The Company amortizes the fair value of the customer relationships on a straight-line basis over the remaining estimated useful life of seven years.

Product backlog represents the value of the standing orders for products. The product backlog was valued using the DCF method, which accounts for the expected profit related to the existing firm purchase orders in place at the time of acquisition. The Company amortizes the fair value of the product backlog on a straight-line basis over the remaining estimated useful life of one year.

In-process Research and Development

In-process research and development (IPR&D) represents projects that have not reached technological feasibility and which have no alternative future use. Technological feasibility is determined when a product reaches the beta-phase, and there is no remaining risk relating to the development. At the time of acquisition, NPTest had multiple IPR&D efforts under way for current product lines. These efforts included developing the next generation of the Sapphire product and OptiFIB product. The Company utilized the DCF method to value the IPR&D, using discount rates ranging from 19% to 21%, depending on the estimated useful life of the technology. To determine the value of the technology in the development stage, the Company considered, among other factors, the stage of development of each project, the time and resources needed to complete each project, expected income and associated risks. Associated risks included the inherent difficulties and uncertainties in completing the project and thereby achieving technological feasibility, and the risks related to the viability of and potential changes to future target markets. In applying the DCF method, the analysis resulted in $7.9 million of the purchase price being charged to acquired IPR&D. The next generation Sapphire and OptiFIB product were launched in 2005.

78

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Deferred Compensation

Unvested stock options valued at approximately $10.0 million at the time of the NPTest acquisition have been allocated to deferred compensation in the purchase price allocation and are being amortized to expense using the straight-line vesting method. The portion of the purchase price allocated to deferred compensation cost was based on the portion of the intrinsic value at the consummation date related to the future vesting period. Options assumed in conjunction with the acquisition had exercise prices ranging from $5.86 to $13.56 per share, with a weighted-average exercise price of $6.71 per share and a weighted average remaining contractual life of approximately 9.25 years. The Company is amortizing the fair value of the deferred compensation on a straight-line basis over the remaining vesting period of approximately 3.25 years. The Company assumed approximately 4.1 million stock options.

Deferred Income Taxes

The acquisition of NPTest during the fiscal year 2004 resulted in the addition of $9.5 million in net deferred tax assets, but such deferred tax assets have been subject to a full valuation allowance similar to the Company’s other deferred tax assets. Should these $9.5 million in net deferred tax assets be recognized in the future, the benefit will result in a reduction in goodwill otherwise recorded as part of the purchase accounting. The deferred tax assets primarily represent the benefits of future tax deductions for inventory reserves, while the deferred tax liabilities primarily represent book-tax basis differences in the non-goodwill intangible assets acquired in the acquisition.

Pro Forma Results

The following pro forma financial information presents the combined results of operations of the Company and NPTest as if the acquisition had occurred as of the beginning of the periods presented. Certain adjustments to reflect charges to cost of goods sold for inventory and property and equipment write-up, charges to operating expense for the amortization of the intangible assets, IPR&D, deferred compensation, restructuring charges, elimination of amortization associated with intangible assets previously acquired by NPTest, reduction of the investment income due to lower cash and investment balances due to the cash used to pay for the acquisition, reduction of NPTest income tax benefits and inclusion of the gain on the Schlumberger’s liability adjustment of $20.4 million and $85.0 million have been made to the combined results of operations for the fiscal year ended October 31, 2004 and 2003, respectively. The unaudited pro forma financial information is not intended to represent or be indicative of the consolidated results of operations or financial condition of the Company that would have been reported had the acquisition been completed as of the dates presented, and should not be taken as representative of the future consolidated results of operations or financial condition of the Company.

	Fiscal Year Ended October 31,
(in thousands, except per share amounts)	2004			2003
Net revenue	$	553,454		$	413,477
Net loss		(85,034	)		(205,467	)
Basic net loss per share	$	(0.95	)	$	(2.49	)
Diluted net loss per share	$	(0.95	)	$	(2.49	)

79

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The pro forma financial information above includes the following material, non-recurring charges for all periods presented (in thousands):

Cost of goods sold from inventory write-up	$	14,567
Amortization of the product backlog intangible asset	$	4,900
In-process research and development	$	7,900
Special cost of goods sold charges – discontinued product lines	$	49,565
Restructuring charges	$	6,309
Integration costs	$	1,849

The pro forma information above for the fiscal year ended October 31, 2004 and 2003 excluded the impact of material, non-recurring charges related to the acquisition of NPTest Inc. from Schlumberger by NPTest Holding Corporation, which was incorporated by Francisco Partners, and the initial public offering effect on NPTest. Those charges include, among others, 1) the amortization of intangible assets, 2) amortization of tangible assets written up to fair value, 3) indirect costs associated with its initial public offering such as preferred stock dividends, annual advisory fees to Francisco Partners and interest expense on the senior debt, and 4) the tax effect associated with excluding these charges which net to a gain of $69.9 million and $67.2 million, respectively.

Credence—SZ GmbH:

In February 2004, the Company acquired all of the outstanding stock of Credence-SZ GmbH (SZ GmbH) for approximately $649,000 in cash, and thereafter merged SZ GmbH with and into Credence-SZ System GmbH, a wholly-owned subsidiary of the Company. Of the $649,000 paid, approximately $537,000 was accounted for as goodwill and included in the Company’s consolidated balance sheet at October 31, 2004. SZ GmbH was the employer of the employees that were contracted to Credence-SZ System GmbH. Credence-SZ System GmbH is based in Amerang, Germany, with approximately 135 employees and is managed within the Company’s Mobile Products Group. The acquisition was accounted for as a purchase transaction in accordance with SFAS 141, and accordingly, the assets acquired and liabilities assumed were recorded at their estimated fair value at the date of the acquisition. Pro forma results of operations have not been presented because the effect of the acquisition was not material.

SZ Testsysteme Japan Limited:

In August 2003, the Company completed the acquisition of certain assets of SZ Testsysteme Japan Limited, a distributor of automotive test equipment, for approximately $1.0 million in cash including acquisition costs. The acquisition was intended to provide a distribution channel to Japanese customers for the Company’s products focused primarily on the Japanese automotive test market. The purchase price was allocated in the fourth quarter of 2003 to assets and liabilities, primarily cash, inventory, property and equipment, and accrued liabilities. The Company’s consolidated statement of operations includes the operations of SZ Testsysteme Japan Limited from the date of the Company’s purchase of their net assets in August 2003. Thereafter, SZ Testsysteme Japan Limited was merged with and into Credence Systems KK, the Company’s Japanese subsidiary.

Credence Capital Corporation:

In February 2003, the Company acquired certain assets and liabilities of Credence Capital Corporation, or CCC, a non-related leasing company. The acquisition allows the Company to directly offer leasing and other financing solutions to customers seeking alternative options to acquire the Company’s equipment. The Company paid $5.5 million and contemporaneous with the transaction, CCC’s sole shareholder repaid indebtedness to CCC

80

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

in the approximate amount of $5.2 million resulting in a net cash outflow of $0.3 million. The net assets of CCC consisted primarily of a $15.3 million portfolio of leases of Credence equipment and its liabilities included indebtedness of approximately $15.3 million associated with the lease portfolio. The Company operates CCC as a wholly-owned subsidiary to provide leasing and other financing solutions to Credence customers. The Company’s consolidated statement of operations includes the results of operations of CCC from the date of acquisition in February 2003.

Prior to the acquisition, the Company’s business arrangement with CCC included selling products to CCC when there was an end-user customer purchase order in place. In cases where third party financing was to be obtained, Garrett Capital Group, which then owned, controlled, and managed CCC, obtained committed funding for the transaction. CCC was compensated by the Company for its distribution activities with a commission rate similar to other distributors.

SZ Testsyteme AG:

In fiscal 2003, the Company completed the acquisition of certain assets of SZ Testsysteme AG and SZ Testsysteme GmbH, or SZ. The assets of these companies were purchased out of bankruptcy and the Company subcontracted approximately 135 former employees to re-launch the business. The acquisition was designed to complement the Company’s existing mixed-signal and wireless solutions with a focused primarily on the automotive test market. The Credence-SZ group operates from a facility located in Amerang, Germany and focuses on the advanced analog, power automotive and communications markets. The SZ product line is included in the Company’s analog mixed signal products group. The purchase price for the assets was approximately $4.6 million in cash and the purchase price was allocated to tangible assets, primarily inventory and property and equipment. The Company’s consolidated statement of operations includes the results of operations of SZ from the date of the Company’s purchase of their net assets in January 2003.

Optonics:

In January 2003, the Company acquired Optonics, Inc., a company that designed and manufactured integrated systems for emission-based optical diagnostics and failure analysis. The addition of Optonics was designed to extend the Company’s product offerings in engineering validation test, design verification and diagnostics systems. The Optonics product line is included in the Company’s diagnostics and characterization group. The total purchase price of approximately $21.0 million included consideration of approximately 1.9 million common shares of Credence valued at $20.1 million and $0.9M in assumed Optonics stock options that were converted to options to purchase approximately 100,000 shares of Credence common stock. The net tangible asset deficit assumed was approximately $0.5 million. The Company’s statement of operations includes the results of operations of Optonics from the date of acquisition in January 2003.

The total purchase cost of Optonics was as follows (in thousands):

Credence common stock	$	20,152
Assumption of Optonics’ stock options		894
Total purchase cost	$	21,046

81

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The purchase price allocation was as follows (in thousands, except years):

	Amount			Annual Amortization		Amortization Period (Years)
Purchase Price Allocation:
Tangible net assets (deficit)	$	(463	)	$	—	—
Deferred compensation		1,819			606	3
Intangible assets acquired:
Developed technology		12,990			2,598	5
In-process research and development		1,510			—	—
Non-compete agreements		750			375	2
Customer relationships		1,650			550	3
Goodwill		2,790			—	—
Total purchase price allocation	$	21,046		$	4,129

A valuation of the purchased assets was undertaken by a third party valuator to assist the Company in determining the fair value of each identifiable intangible asset and in allocating the purchase price among acquired assets, including the portion of the purchase price attributed to in-process research and development projects. Standard valuation procedures and techniques were utilized in determining the fair value of the acquired in-process research and development. To determine the value of the technology in the development stage, the Company considered, among other factors, the stage of development of each project, the time and resources needed to complete each project, and expected income and associated risks. Associated risks included the inherent difficulties and uncertainties in completing the project and thereby achieving technological feasibility, and the risks related to the viability of and potential changes to future target markets. The analysis resulted in $1.5 million of the purchase price being charged to acquired in-process research and development using a discount rate of 35%. The IPR&D acquired from Optonics consists of features and projects related to the Emiscope II, which is the next generation Emiscope with added functionality including solid immersion lens and spray cooling system. The Company estimated that these projects varied in terms of completion from 15% to 50% completed based on research and development complexity, costs, and time expended to date relative to the expected remaining costs and time to reach technological feasibility. The Emiscope II has been completed and is currently in production. The intangible assets, consisting primarily of developed technology, customer relationships, non-compete agreements and goodwill, were assigned a value of $18.2 million and are being amortized, except for goodwill, over their estimated useful lives, ranging from two to five years. In addition, $1.8 million of the purchase price was allocated to deferred compensation, calculated using the Black-Scholes-Merton stock option valuation model, and represents the value of unvested options and unvested restricted shares assumed by the Company in the transaction. The deferred compensation is amortized as compensation cost over the weighted average remaining future vesting period of the unvested options (three years). The balance of the deferred compensation is reflected as a contra-equity in the Consolidated Statements of Shareholders’ Equity.

Note 3—Special Charges and Restructuring

Special charges—cost of goods sold

The Company reviews excess and obsolete inventory annually based on information available from the strategic planning process and also on a quarterly basis identifying and addressing significant events that might have an impact on inventories and related reserves. See Note 1—“Inventories,” for further discussion of the Company’s reserve methodology.

82

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The following table summarizes special charges recorded in cost of goods sold by fiscal year for the three-year period ended October 31, 2005 (in thousands):

Fiscal 2005	$	29,059
Fiscal 2004	$	49,565
Fiscal 2003	$	1,927

In fiscal 2005, the Company recorded special charges to cost of goods sold of $29.1 million which consisted of $23.0 million write-downs of excess and obsolete Kalos II, Octet, Vanguard II and Duo inventory, $5.4 million for certain components being phased out of the bill of materials of the Sapphire product that was not economical to rework, $1.6 million of inventory liabilities, and $0.6 million related to the write-off of Octet and Vanguard II property and equipment.

In fiscal 2004, the Company recorded special charges to cost of goods sold of $49.6 million. Of this $49.6 million, $45.0 million was directly related to inventory write-downs. These write-downs were related to the acquisition of NPTest which resulted in duplicate product lines in the combined company. The Company evaluated the redundant product lines using internal and external marketing data, the development roadmap for each product line, existing and potential customers and demand for the product. As a result of the evaluation, the Company identified production inventory, finished goods and consignment and demonstration inventory in excess of estimated future customer demand of approximately $35.2 million; write-downs to estimated current market value of approximately $9.8 million; purchase commitments of approximately $1.0 million; field service spares of approximately $0.9 million and other assets and expenses of approximately $2.7 million.

In fiscal 2003, the Company recorded cost of goods sold—special charges of $1.3 million due to a settlement reached with an inventory supplier relating to cancelled purchase orders and $0.6 million for write-offs of spare parts relating to the Valstar product line.

The schedule below shows the detail usage of the special charges and the remaining $32.4 million as of October 31, 2005:

10/31/02 Balance	$	39,997
FY03 Scrapping		(10,672	)
10/31/03 Balance		29,325
FY04 Additional special charges		44,979
FY04 Scrapping		(14,079	)
FY04 Sale of fully reserved inventory		(2,341	)
FY04 Kalos lower of cost or market adjustment on fully reserved inventory		(7,215	)
FY04 Octet-Quartet lower of cost or market adjustment on fully reserved inventory		(21,123	)
10/31/04 Balance		29,546
FY05 Additional special charges		27,774
FY05 Scrapping		(16,717	)
FY05 Sale of fully reserved inventory		(1,633	)
FY05 Octet lower of cost or market adjustment on fully reserved inventory		(6,523	)
10/31/05 Balance	$	32,447

83

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Restructuring Charges

Over the past years, the Company has recorded restructuring charges as it rationalized operations in light of customer demand declines and the economic downturn. The measures, which included reducing the workforce, consolidating facilities and changing the strategic focus of a number of sites, was largely intended to align the Company’s capacity and infrastructure to anticipated customer demand and transition its operations for higher utilization of facility space. The restructuring charges include employee severance and benefit costs, and costs related to leased facilities vacated and subleased. Severance and benefit costs and other costs associated with restructuring activities were normally recorded in compliance with Statement of Financial Accounting Standard No. 146, “Accounting for Costs Associated with Exit or Disposal Activities,” (SFAS 146). During October 2004, the Company also adopted Statement of Financial Accounting Standard No. 112, “Employer’s Accounting for Postemployment Benefits,” (SFAS 112), for severance and benefit costs, the Company concluded that it had a substantive severance plan. This accounting for restructuring costs requires us to record provisions and charges when the Company has a formal and committed restructuring plan.

The following tables illustrate the restructuring cost activity for the year ended October 31, 2005 and the estimated timing of future payouts for the major restructuring categories (in thousands):

	Balance at October 31, 2004			Charges			Utilized			Adjustments			Balance at October 31, 2005
Severance	$	(3,019	)	$	(4,958	)	$	4,467		$	618		$	(2,892	)
Operating leases		(1,043	)		(11,474	)		2,146			(44	)		(10,415	)
Deferred rent write-off		—			709			(709	)		—			—
Property and equipment		—			(1,089	)		1,089			—			—
Other liabilities		(32	)		(1,399	)		30			32			(1,369	)
Total	$	(4,094	)	$	(18,211	)	$	7,023		$	606		$	(14,676	)
Estimated timing of future payouts:
Fiscal 2006														7,725
Fiscal 2007														2,379
Fiscal 2008														2,213
Fiscal 2009														2,359
Total													$	14,676

During the fiscal year 2005, the Company recorded the following activity related to restructuring charges:

• The severance and other related charges amounted to $5.0 million, which accounted for headcount reduction of 110 employees. Of the $5.0 million, the amount recorded under FAS 112 at October 31, 2005 was $1.5 million. The affected employees were primarily in research and development and selling general and administrative functions throughout the world.

• The property and equipment write off, amounting to $1.1 million, resulted from the Company’s decision to halt additional research and development investment in one of its products that was rendered redundant by the acquisition of NPTest.

• The operating lease charges of $11.5 million, which are net of expected sublease rentals, resulted from vacating the former NPTest headquarters facilities in San Jose. The lease on these facilities expires in October 2009.

• Other liabilities of $1.4 million which represents cancellation fees of early termination of certain outsourcing contracts.

84

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The following tables illustrate the restructuring cost activity for the year ended October 31, 2004 for the major restructuring categories (in thousands):

	Balance at October 31, 2003			Charges			Utilized		Balance at October 31, 2004
Severance	$	(233	)	$	(3,880	)	$	1,094	$	(3,019	)
Operating leases		(2,368	)		(652	)		1,977		(1,043	)
Other liabilities		—			(1,966	)		1,934		(32	)
Total	$	(2,601	)	$	(6,498	)	$	5,005	$	(4,094	)

During the fiscal year 2004, the Company recorded the following activity related to restructuring charges:

• $3.9 million charge taken for severance and other related charges. These charges were incurred in connection with the NPTest acquisition and were for 198 employees. The affected employees were from manufacturing, research and development and selling, general and administrative functions.

• $2.0 million charge taken related to the write-off of equipment and liabilities incurred related to the decision to discontinue significant future investments in redundant product lines stemming from the acquisition of NPTest.

• $0.7 million related to write-off the remaining lease payments for this lease, net of expected sublease income. This resulted from the Company relocated its corporate headquarters to its owned facilities in Milpitas, California and vacated its previously leased buildings in Fremont, California. The lease for three of the buildings expired at the end of December 2003. The lease on the final building, consisting of 27,000 square feet, expired in June 2005.

Note 4—Industry Segments and Concentration of Risks

Credit Risk, Product Line and Segment/Geographic Data

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of investments in cash equivalents, short-term and trade receivables. Credit risk evaluations, including Dun & Bradstreet ratings, are performed on all new customers, and subsequent to credit application approval, the Company monitors its customers’ financial statements and payment performance. The Company is exposed to credit risks in the event of default by the financial institutions or customers to the extent of the amounts recorded on the consolidated balance sheets. In general, the Company does not require collateral on sales except in certain circumstances where a letter of credit is required to be established prior to shipping product.

Operating segments are business units that have separate financial information and are separately reviewed by the Company’s chief decision makers. The Company’s chief decision makers are the Chief Executive Officer and Chief Financial Officer. The Company and its subsidiaries currently operate in a single industry segment: the design, development, manufacture, sale and service of advanced semiconductor test and diagnostic systems used in the production of semiconductors. The Company has a single reporting unit for purposes of Statement of Financial Accounting Standard No. 131, “Disclosure About Segments of an Enterprise and Related Information,” (SFAS 131), advanced semiconductor test and diagnostic systems, primarily because all of the components of the Company’s advanced semiconductor test and diagnostic systems segment are subject to similar economic characteristics, have similar production processes, have common customers, and are distributed using the same channels.

85

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Starting in the second quarter of fiscal 2005, the Company’s chief decision makers reviewed the breakdown of revenues using different product line grouping, therefore, the Company’s net sales by product line consisted of:

	Year Ended October 31,
	2005		2004		2003
SoC	37	%	22	%	27	%
Analog Mixed Signal	22		32		28
Memory	3		23		16
Design Characterization Group	11		4		4
Service and other	27		19		25
Total net sales	100	%	100	%	100	%

The Company sells its products primarily to distributors and semiconductor manufacturers located in the United States, Asia Pacific and Europe. The Company performs ongoing credit evaluations of its customers and generally does not require collateral. The Company maintains reserves for potential credit losses and such losses historically have been within management’s expectations.

Most of the Company’s products are manufactured in the U.S. Export sales from the U.S. are primarily denominated in U.S. dollars but occasionally denominated in Japanese Yen or in the Euro. The Automotive product line is manufactured in Germany and these sales are denominated in U.S. dollars, Japanese Yen and the Euro. All of the Company’s products are shipped to the Company’s customers throughout North America, Asia Pacific, Europe, and the Middle East. Sales by the Company to customers in different geographic areas, expressed as a percentage of revenue, for the periods ended were:

	Year Ended October 31,
	2005		2004		2003
North America	31	%	28	%	36	%
Taiwan	12		20		15
China	5		7		3
Southeast Asia	20		20		10
Rest of Asia Pacific	10		5		10
Europe & Middle East	22		20		26
Total net sales	100	%	100	%	100	%

A distributor in Taiwan, Spirox Corporation, accounted for 14%, 23% and 19% of the Company’s net sales in fiscal 2005, 2004 and 2003, respectively. Spirox Corporation accounted for 19% and 20% of gross accounts receivable at October 31, 2005 and 2004, respectively. In fiscal 2005, two end-user customers headquartered in the U.S. accounted for 25% and 14% of the Company’s net sales, respectively, and 22% and 20% of the Company’s gross receivables, respectively. One end-user customer headquartered in Europe accounted for 15%, and 10% of the Company’s net sales in fiscal 2004, and 2003, respectively. That customer accounted for 18%, and 24% of the Company’s 2004, and 2003 fiscal year-end gross accounts receivable, respectively.

This concentration subjects a significant portion of the Company’s receivables and future revenues to the risks associated with doing business in foreign countries, including political and economic instability, currency exchange rate fluctuations and regulatory changes. Disruption of business in Asia caused by the previously mentioned factors could have a material impact on the Company’s business, financial condition or results of operations.

As of October 31, 2005, 2004 and 2003, the majority of the Company’s long-lived assets were attributable to its U.S. operations.

86

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Note 5—Commitments and Contingencies

The Company leases some of its facilities and equipment under operating leases that expire periodically through 2013 of which approximately $11.5 million, $0.7 million, and $0.2 million have been written off to special operating charges during fiscal 2005 and fiscal 2004, respectively.

The future minimum lease payments at October 31, 2005 are as follows (in thousands):

	Committed Gross Lease Payments		Leases Written Off in Restructuring Charges		Net Estimated Future Lease Expense
2006	$	7,424	$	4,917	$	2,507
2007		6,465		4,168		2,297
2008		5,474		4,048		1,426
2009		5,303		4,087		1,216
2010		840		—		840
Thereafter		1,732		—		1,732
	$	27,238	$	17,220	$	10,018

Some of the components that the Company purchases are unique to the Company and must be purchased in relatively high minimum quantities with long (four and five month) lead times. These business circumstances can lead to the Company holding relatively high inventory levels and associated risks. In addition, purchase commitments for unique components are relatively inflexible in terms of deferral or cancellation. At October 31, 2005, the Company has open and committed non-cancelable purchase orders totaling approximately $74.9 million.

The following summarizes our minimum contractual cash obligations and other commitments at October 31, 2005, and the effect of such obligations in future periods (in thousands):

	Total		2006		2007		2008		2009		2010		Thereafter
Contractual Obligations:
Facilities and equipment operating leases (1)	$	27,238	$	7,424	$	6,465	$	5,474	$	5,303	$	840	$	1,732
Bank note (2)		5,000		5,000		—		—		—		—		—
Interest on liabilities related to bank note		30		30		—		—		—		—		—
Convertible subordinated notes (3)		180,000		—		—		180,000		—		—		—
Interest on convertible subordinated notes		8,100		2,700		2,700		2,700		—		—		—
Trade-in commitments (4)		1,600		1,600		—		—		—		—		—
Minimum payable for an employment agreement		1,000		1,000		—		—		—		—		—
Minimum payable for information technology outsourced services (4)		1,370		1,370		—		—		—		—		—
Minimum commitment under Technology Development Agreement		1,030		—		—		1,030		—		—		—
Open non-cancelable purchase order commitments		74,902		70,801		4,101		—		—		—		—
Total contractual cash and other obligations	$	300,270	$	89,925	$	13,266	$	189,204	$	5,303	$	840	$	1,732

(1) Approximately $11.5 million of this total has been accrued for as restructuring charges in the consolidated balance sheets as accrued expenses and other liabilities.

(2) This amount is recorded in the consolidated balance sheets as bank loans and notes payable—leased products.

(3) This amount is recorded in the consolidated balance sheets as convertible subordinated notes.

(4) This amount is recorded in the consolidated balance sheets as accrued expenses and other liabilities and deferred profit.

87

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Rent expense was approximately $6.2 million, $4.6 million, and $3.7 million for the years ended October 31, 2005, 2004, and 2003, respectively.

The contractual cash obligations and commitments table presented above contains our minimum obligations at October 31, 2005 under these arrangements and others. Actual expenditures will vary based on the volume of transactions and length of contractual service provided. In addition to minimum spending commitments, certain of these arrangements provide for potential cancellation charges.

There were no material commitments for capital expenditures at October 31, 2005.

The Company warrants its products to its customers generally for one year from the date of shipment. The Company provides reserves for the estimated costs of product warranties at the time revenue is recognized. The Company estimates the costs of warranty obligations based on historical experience of known product failure rates, use of materials to repair or replace defective products and service delivery costs incurred in correcting product failures.

The following table represents the activity in the warranty accrual for the twelve months ended October 31, 2005 (in thousands):

	For the year ended October 31,
	2005			2004
Beginning balance	$	15,314		$	5,501
Add: Accruals for warranties issued during the period		16,910			17,177
Acquired pre-existing warranty obligations		—			7,110
Less: Adjustments of accrual estimates		(411	)		457
Warranty spending		(18,394	)		(14,931	)
Ending balance	$	13,419		$	15,314

Note 6—Convertible Subordinated Notes

In June 2003, the Company issued $180 million of 1 ¹/2% convertible subordinated notes (the “Notes”) due May 2008 in a private placement. The Notes are unsecured obligations of the Company and are subordinated to all present and future senior indebtedness of the Company. Interest is payable semiannually on May 15 and November 15, commencing November 15, 2003. The Notes are convertible into common stock of the Company at an initial conversion price of $11.31 per share, subject to adjustment in certain dilution events. The Notes do not include a beneficial conversion feature or financial covenants. Expenses of $5.8 million associated with the offering were capitalized upon issuance and are included in other current assets and in other long-term assets. Such expenses are being amortized to interest expenses over the term of the Notes. The Company continues to use the net proceeds of the offering for general corporate purposes, including working capital and potential acquisitions.

Note 7—Stockholders’ Equity

Deferred Compensation

Deferred compensation generally results when the Company, during an acquisition, assumes the obligation of stock option grants made by the acquired company. Deferred compensation is amortized as compensation cost over the weighted average remaining future vesting period of unvested options related to the options assumed. The balance for the deferred compensation is reflected as a contra-equity in the consolidated statements of shareholders’ equity.

88

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The Company allocated approximately $10.0 million of the purchase price of NPTest to deferred compensation. The portion of the purchase price allocated to deferred compensation cost was based on the portion of the intrinsic value at the consummation date related to the future vesting period of NPTest options assumed by the Company. Options assumed in conjunction with the acquisition had exercise prices ranging from $5.86 to $13.56 per share, with a weighted-average exercise price of $6.71 per share and a weighted average remaining contractual life of approximately 9.25 years. The Company is amortizing the fair value of the deferred compensation on a straight-line basis over the remaining vesting period of approximately 3.25 years. The Company assumed approximately 4.1 million stock options.

The Company allocated $1.8 million of the purchase price of Optonics to deferred compensation in January 2003, calculated using the intrinsic value method, and representing the value of unvested options and unvested restricted shares assumed by the Company in the purchase of Optonics. The amount is being amortized using the straight-line method over an expected vesting period of three years.

The Company recorded $1.0 million of deferred compensation and additional paid-in capital in fiscal 2001 upon the issuance of certain stock options issued to IMS employees by IMS, prior to the Company acquiring IMS, at less than fair market value at the date of grant. On the date of grant, deferred compensation was recorded for the difference between the fair market value and the actual option exercise price. This amount is being amortized using the straight-line method over an expected vesting period of four years.

During the periods ended October 31, 2005, 2004, and 2003, the Company recognized expense related to the deferred compensation of $3.0 million, $2.2 million, and $0.7 million, respectively.

Stock Option Plans

The stock option plans program is a broad-based, long-term retention program that is intended to attract and retain qualified management and employees, and align stockholder and employee interest. The stock option plans program consists of two plans: one under which non-employee directors may be granted options to purchase shares of the Company’s stock, and another in which non-employee directors, employees and consultants may be granted options to purchase shares of our stock, restricted stock units and other types of equity awards. Under this program, stock options generally have a vesting period of four years, are exercisable for a period not to exceed ten years from the date of issuance and are generally granted at prices not less than the fair market value of our common stock at the grant date. Restricted stock units may be granted with varying criteria such as time based or performance based vesting. In addition, the Board of Directors has the discretion to use a different vesting schedule and has done so from time to time.

In fiscal 2005, the Company’s Board of Director and shareholders approved the 2005 Stock Incentive Plan (the “2005 Plan”) which provides for the grant of options to purchase shares of the Company’s common stock, stock appreciation rights and restricted stock to employees, members of the Board of Directors and consultants. The maximum number of shares available for grant under the 2005 Plan is 5.9 million shares.

During fiscal 2005, the 1993 Stock Option Plan (the “1993 Plan”), under which the Company previously granted options to employees and members of the Board of Directors, expired. However, outstanding options granted under the 1993 Plan remains exercisable in accordance with the terms of the original grant agreements.

In August 2005, the Company’s Board of Directors approved the accelerated vesting of certain unvested and “out-of-the-money” non-qualified stock options previously awarded to employees and officers with option exercise prices equal to or greater than $9.15. Options held by non-employee directors are excluded from the vesting acceleration. In addition, in order to prevent executive officers from unintended personal benefits, the

89

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Company’s executive officers have agreed to the imposition of restrictions on any shares received through the exercise of accelerated options. Those restrictions will prevent the sale of any shares received from the exercise of an accelerated option until the earlier of the original vesting date of the option or the executive officer’s termination of employment. The $9.15 price was selected because it was higher than the closing price of the Company’s common stock of $8.84 on August 29, 2005, the date of this acceleration. The accelerated options represent approximately 15 percent or approximately 2.8 million shares of the total of all outstanding Credence options. Under SFAS 123R, the Company will be required to recognize the expense associated with its outstanding unvested stock options beginning in the first quarter of fiscal year 2006. The acceleration will result in the reduction of the stock option expense the Company otherwise would be required to record in the future.

A summary of the activity under all plans, as defined below (in thousands, except per share amounts) is as follows:

	Options Available for Grant (Authorized)		Number of Options Outstanding		Price Per Share		Weighted Average Exercise Price
Balance at October 31, 2002	658		13,518		$	1.07-67.99	$	17.56
Increase in authorized shares	2,132		—			—		—
Assumed Optonics options	85		31		$	0.57-5.03	$	4.17
Options granted	(2,704	)	2,704		$	0.57-15.85	$	8.49
Options canceled	2,469		(2,469	)	$	0.58-67.99	$	18.67
Options exercised	—		(589	)	$	0.57-16.19	$	8.55
Options expired	(286	)	—			—		—
Balance at October 31, 2003	2,354		13,195		$	0.58-67.99	$	15.85
Increase in authorized shares	2,234		—			—		—
Assumed NPTest options	—		4,143		$	5.86-13.56	$	7.04
Options granted	(4,665	)	4,665		$	6.88-16.78	$	12.61
Options canceled	1,881		(1,881	)	$	0.58-67.99	$	17.45
Options exercised	—		(1,377	)	$	0.58-16.19	$	7.34
Options expired	(434	)	—			—		—
Balance at October 31, 2004	1,370		18,745		$	0.58-67.99	$	13.56
Increase in authorized shares	8,885		—			—		—
Options granted	(2,603	)	2,603		$	7.34-9.60	$	8.91
Options canceled	2,153		(2,153	)	$	4.98-67.99	$	15.38
Options exercised	—		(546	)	$	0.00-10.21	$	7.27
Options expired	(3,714	)	(491	)		—		—
Balance at October 31, 2005	6,091		18,158		$	0.00-67.99	$	12.87

The Company has reserved for issuance approximately 24,249,000 shares of common stock in connection with the stock option plans.

90

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The following table summarizes information about options outstanding and exercisable at October 31, 2005 (in thousands except per share amounts):

Options Outstanding		Weighted Average Remaining Contractual Life (years)	Weighted Average Exercise Price	Options Exercisable
Range of Exercise Prices	Options Outstanding at Oct. 31, 2005			Options Currently Exercisable Oct. 31, 2005	Weighted Average Exercise Price
$  0.00 - $  5.87	2,142	7.68	$  5.82	1,537	$  5.80
6.38 -     8.84	4,127	6.05	7.59	2,203	7.65
8.94 -   13.22	4,574	7.14	10.97	4,104	11.11
13.31 -   19.75	5,588	5.88	16.60	5,269	16.62
19.86 -   25.56	1,294	4.66	21.30	1,230	21.33
34.69 -   38.31	230	4.76	38.27	230	38.27
40.25 -   67.99	203	4.43	51.80	203	51.80
$  0.00 -$67.99	18,158	6.33	$12.87	14,776	$13.84

These options will expire, if not exercised, at specific dates from March 2006 to October 2014.

Stock Purchase Plan

In 1994, the Company adopted the 1994 Employee Stock Purchase Plan (the “1994 Plan”), which provides direct employees, employed with the Company for at least thirty consecutive days as of the entry date into any offering period, with the opportunity to acquire shares of the Company’s common stock. Employees may contribute up to 10% of their base wages to the plan. The purchase price is 85% of the fair market value per share of common stock on the date on which the purchase period begins or on the date on which the purchase period ends, whichever is lower. The plan restricts the maximum number of shares that an employee can purchase to 1,500 shares each semi-annual period and to $25,000 worth of common stock each year. Approximately 129,332, 413,105, and 444,472 shares were issued pursuant to the plan in 2005, 2004 and 2003, respectively. At October 31, 2005, approximately 1,161,645 shares were reserved for issuance under the 1994 Plan.

Note 8—Employee Benefit Plans

The Company maintains a 401(k) retirement savings plan for its full-time domestic employees, which allows them to contribute up to 20% of their pre-tax wages subject to IRS limits. The Company did not make any contributions to this plan during the fiscal years ended October 31, 2004 and 2003, but during the fiscal year ended October 31, 2005, the Company’s contribution to this plan was approximately $1.8 million.

The Company assumed NPTest’s North America 401(k) plan as part of the acquisition occurred in May 2004. The plan matches dollar-for-dollar, up to 4%, of an employee’s contribution per pay period. For the fiscal year 2004, the Company contributed approximately $0.6 million to the plan. During fiscal 2005, the Company contributed approximately $ 0.3 million to the plan for the two months ended December 31, 2004. The NPTest plan was merged into the Company’s plan effective January 1, 2005.

Outside of the U.S., the Company also assumed several defined benefit and defined contribution plans that cover substantially all employees. Where applicable, employees are covered by statutory plans. For defined benefit plans, charges to expense are based upon costs computed by independent actuaries. These plans are substantially fully funded with trustees in respect to past and current service. At October 31, 2005, the pension liability was $0.6 million. The expenses associated with these plans were not material during fiscal year 2005.

91

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The Company has a deferred compensation for certain employees (a “Rabbi Trust” or “trust”). The assets in the Rabbi Trust, consisting of cash equivalents and debt and equity securities, are recorded at current market prices. The trust assets are available to satisfy claims of the Company’s general creditors in the event of its bankruptcy. The trust’s assets, included in other assets, and the corresponding deferred compensation liability, included in other liabilities were approximately $2.4 million and $3.0 million at October 31, 2005 and 2004, respectively.

Note 9—Income Taxes

The tax provision consisted of the following (in thousands):

	Year Ended October 31,
	2005			2004			2003
Federal:
Current	$	(180	)	$	(602	)	$	—
Deferred		—			—			—
		(180	)		(602	)
State:
Current		315			(1,684	)		—
Deferred		—			—			—
		315			(1,684	)		—
Foreign:
Current		11,254			6,275			1,006
Deferred		—			—			—
Income tax provision	$	11,389		$	3,989		$	1,006

Pre-tax income from foreign operations was approximately $44.0 million, $14.3 million and $4.7 million in 2005, 2004 and 2003, respectively.

Reconciliation between the Company’s effective tax rate of 10.5% in 2005, 6.6% in 2004, and 0.9% in 2003 and the U.S. statutory rate of 35% is as follows (in thousands):

	Year Ended October 31,
	2005			2004			2003
Tax computed at statutory rate	$	(37,990	)	$	(21,145	)	$	(39,221	)
State income tax		315			(1,684	)		—
U.S. losses not benefited		53,380			23,369			40,346
Non-deductible in-process research and development		—			2,765			529
Foreign rate differential		(4,136	)		1,286			(648	)
Other items		(180	)		(602	)		—
Income tax provision	$	11,389		$	3,989		$	1,006

The income tax provision in 2005 consists primarily of foreign tax on earnings and foreign withholding taxes generated from our foreign operations.

92

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Significant components of the Company’s deferred tax assets are as follows (in thousands):

	October 31,
	2005			2004
Deferred tax assets:
Accounting for inventories	$	44,353		$	46,151
Allowance for doubtful accounts		721			687
Accruals not currently deductible		24,730			31,967
Net operating loss and credit carryforwards		165,895			112,706
Book over tax depreciation		4,392			3,836
Deferred revenue/profit/commissions		3,717			5,642
Total deferred tax assets		243,808			200,989
Valuation allowance for deferred tax assets		(210,137	)		(153,073	)
		33,671			47,916
Deferred tax liability:
Intangibles		(33,671	)		(47,916	)
Net deferred tax assets	$	—		$	—

At October 31, 2005, the Company has unused net operating loss and research tax credit carryforwards for federal income tax purposes of approximately $396.2 million and $8.8 million, respectively, which if not utilized will expire in 2012 through 2025. Utilization of the Company’s net operating loss and tax credit carryforwards will be subject to annual limitations due to the ownership change limitations provided by the Internal Revenue Code of 1986, as amended, and similar state provisions. The annual limitations may result in expiration of net operating loss and tax credit carryforwards before full utilization.

Realization of the net deferred tax assets is dependent on the Company generating sufficient taxable income in future years in appropriate tax jurisdictions to obtain reversals of temporary differences, net operating loss and tax credit carryforwards. Due to uncertainties in the timing and amount of such realization of its deferred tax assets, the Company has provided a valuation allowance equal to its net deferred tax assets at October 31, 2005 and October 31, 2004. The Company had a net increase of $57.1 million in the valuation allowance in fiscal 2005 due to current year change of non-deductible accruals, reserves and increase of net operating loss, a net increase of $48.3 million in the valuation allowance in fiscal 2004 due to build of non deductible accruals, reserves and the NPTest acquisition, and a net increase of $36.6 million in the valuation allowance in fiscal 2003. Approximately $5.6 million of the valuation allowance for deferred tax assets is attributable to stock option deductions, the benefit of which will be credited to equity when realized. Approximately $10.0 million in the valuation allowance for deferred tax assets is related to the acquisition of NPTest during fiscal year 2004, the benefit will be credited to goodwill when realized.

Note 10—Legal Matters

In March 2005, Roy Schmidt, a former employee, filed a complaint in the Superior Court of Santa Clara County, California against the Company, alleging fraud and various other contractual and tort claims in connection with the termination of his employment by the Company. Mr. Schmidt alleges damages in excess of $3.0 million and seeks in addition punitive damages. Formal discovery is in early stages in this litigation. The Company intends to vigorously defend these claims and believes it possesses meritorious defenses to the claims.

The Company is involved in various claims arising in the ordinary course of business. The Company currently believes that the ultimate amount of liability, if any, for any pending claims of any type (either alone or

93

CREDENCE SYSTEMS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

combined) will not materially affect its financial position, results of operations or liquidity. However, the ultimate outcome of any litigation is uncertain, and either unfavorable or favorable outcomes could have a material negative impact. Regardless of outcome, litigation can have an adverse impact on the Company because of defense costs, diversion of management resources and other factors.

Note 11—Accumulated Other Comprehensive Income

The Company’s accumulated other comprehensive income consists of the accumulated net unrealized gains or losses on available-for-sale investments and foreign currency translation adjustments. At October 31, 2005 and 2004, the Company had a balance of net unrealized gains of $0.2 million and $0.5 million, respectively, on available-for-sale investments. Additionally, at October 31, 2005 and 2004, the Company had a balance of $0.3 million and $2.4 million, respectively, of net foreign currency translation gains.

Accumulated other comprehensive income and changes thereto consist of (in thousands):

	Year Ended October 31,
	2005			2004			2003
Beginning balance, net of tax	$	2,924		$	1,522		$	3,843
Unrealized loss on available-for-sale securities, net of tax		(283	)		(221	)		(1,315	)
Currency translation adjustment, net of tax		(2,132	)		1,623			(1,006	)
Ending balance, net of tax	$	509		$	2,924		$	1,522

Note 12—Related Party Transactions

Dr. William G. Howard Jr., a director of the Company, is a director of Xilinx, Inc. (Xilinx). For the years ended October 31, 2005, 2004, and 2003, the Company sold approximately $0.6 million, $1.7 million, and $0.8 million, respectively, of products and services to Xilinx. For the years ended October 31, 2005, 2004, and 2003, the Company purchased goods and services of approximately $0, $1,000, and $11,000, respectively, from Xilinx. The Company had no amounts owed from Xilinx at October 31, 2005, 2004 and 2003, respectively.

Dipanjan Deb, a director of the Company since May 2004, is a Director of AMI Semiconductor (AMIS Holdings, Inc.). For the years ended October 31, 2005 and 2004, the Company sold approximately $3.5 million and $4.0 million of product and services to AMI Semiconductor, respectively. The amounts receivable from AMI Semiconductor were approximately $449,000 and $127,000 at October 31, 2005 and 2004, respectively. Mr. Deb is also a director of Conexant Systems. For the years ended October 31, 2005 and 2004, the Company sold approximately $0 and $110,000 of product and services to Conexant Systems, respectively. The Company had no amounts owed from Conexant Systems at October 31, 2005 and 2004. Prior to our acquisition of NPTest, pursuant to an amended advisory agreement with Francisco Partner, L.P., NPTest made certain payments to Francisco Partners, L.P., for services provided to NPTest.

Richard Beyer, a director of the Company since September 2003, is President, Chief Executive Officer and a Director of Intersil. For the years ended October 31, 2005 and 2004, the Company sold approximately $4,065 and $15,000 of products and services to Intersil, respectively. The amounts receivable from Intersil were approximately $0 and $10,000 at October 31, 2005 and 2004, respectively.

Thomas Franz, a director of the Company until October 22, 2004, is a Corporate Vice President of Intel Corporation. For the years ended October 31, 2004 and 2003, the Company sold approximately $47.8 million and $15.1 million, respectively, of products and services to Intel. The amounts receivable from Intel were approximately $13.1 million and $3.5 million at October 31, 2004 and 2003, respectively.

94

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

Not applicable.

Item 9A. Controls and Procedures

Attached as exhibits to this Form 10-K are certifications of Credence’s Chief Executive Officer (CEO) and Chief Financial Officer (CFO), which are required in accordance with Rule 13a-14 of the Securities Exchange Act of 1934, as amended (the Exchange Act). This “Controls and Procedures” section includes information concerning the controls and controls evaluation referred to in the certifications. Part II, Item 8 of this Form 10-K sets forth the report of Ernst & Young LLP, our independent registered public accounting firm, regarding its audit of Credence’s internal control over financial reporting and of management’s assessment of internal control over financial reporting set forth below in this section. This section should be read in conjunction with the certifications and the Ernst & Young report for a more complete understanding of the topics presented.

Evaluation of Disclosure Controls and Procedures.    We conducted an evaluation of the effectiveness of the design and operation of our “disclosure controls and procedures” (Disclosure Controls) as of the end of the period covered by this Form 10-K. The controls evaluation was conducted under the supervision and with the participation of management, including our CEO and CFO. Disclosure Controls are controls and procedures designed to reasonably assure that information required to be disclosed in our reports filed under the Exchange Act, such as this Form 10-K, is recorded, processed, summarized and reported within the time periods specified in the U.S. Securities and Exchange Commission’s (SEC’s) rules and forms. Disclosure Controls are also designed to reasonably assure that such information is accumulated and communicated to our management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosure. Our quarterly evaluation of Disclosure Controls includes an evaluation of some components of our internal control over financial reporting, and internal control over financial reporting is also separately evaluated on an annual basis for purposes of providing the management report which is set forth below.

The evaluation of our Disclosure Controls included a review of the controls’ objectives and design, the Company’s implementation of the controls and the effect of the controls on the information generated for use in this Form 10-K. In the course of the controls evaluation, we reviewed identified data errors or control problems and sought to confirm that appropriate corrective actions, including process improvements, were being undertaken. This type of evaluation is performed on a quarterly basis so that the conclusions of management, including the CEO and CFO, concerning the effectiveness of the Disclosure Controls can be reported in our periodic reports on Form 10-Q and Form 10-K. Many of the components of our Disclosure Controls are also evaluated on an ongoing basis by us. The overall goals of these various evaluation activities are to monitor our Disclosure Controls, and to modify them as necessary. Our intent is to maintain the Disclosure Controls as dynamic systems that change as conditions warrant.

Based upon the controls evaluation, our CEO and CFO have concluded that, subject to the limitations noted in this Part II, Item 9A, as of the end of the period covered by this Form 10-K, our Disclosure Controls were effective to provide reasonable assurance that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified by the SEC, and that material information relating to Credence and its consolidated subsidiaries is made known to management, including the CEO and CFO, particularly during the period when our periodic reports are being prepared.

Management’s Report on Internal Control over Financial Reporting.    Our management is responsible for establishing and maintaining adequate internal control over financial reporting to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in

95

accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.

Management assessed our internal control over financial reporting as of October 31, 2005, the end of our fiscal year. Management based its assessment on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Management’s assessment included evaluation of such elements as the design and operating effectiveness of key financial reporting controls, process documentation, accounting policies, and our overall control environment.

Based on our assessment, management has concluded that our internal control over financial reporting was effective as of the end of the fiscal year to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principles. We reviewed the results of management’s assessment with the Audit Committee of our Board of Directors.

Our independent registered public accounting firm, Ernst & Young LLP, audited management’s assessment and independently assessed the effectiveness of the Company’s internal control over financial reporting. Ernst & Young has issued an attestation report concurring with management’s assessment, which is included in Part II, Item 8 of this Form 10-K.

Changes in Internal Control over Financial Reporting.    As of October 31, 2004, we disclosed material weaknesses in the operation of our internal control over financial reporting. We disclosed these material weaknesses in each of the first three quarters of fiscal 2005 and took steps to remediate those material weaknesses through the fourth quarter of fiscal 2005. During the fourth quarter of fiscal 2005, we completed our testing of the design and operating effectiveness of the remediated controls and concluded that the previously reported material weaknesses were remediated.

Prior to the end of the fourth quarter of fiscal 2005, we strengthened our internal control over financial reporting and our control environment, taking many actions including:

• Improved controls over our financial statement close process including increased management review of account reconciliations and subsidiary trial balances;

• Evaluated and addressed staffing requirements, including the hiring of a complement with appropriate qualifications that we believe is sufficient to address various previously-disclosed weaknesses;

• Enhanced revenue recognition management process;

• Enhanced our documentation, review and remediation efforts around all of our business and IT processes as part of our implementation of Section 404 of the Sarbanes-Oxley Act of 2002;

• Required support certification regarding accounting and controls from operational management and others with particular knowledge or span of control; and

• Increased initiatives to educate all our employees regarding our Code of Conduct and Business Ethics and the existence of and availability of our whistle-blower hotline provided by an external agency.

Inherent Limitations on Effectiveness of Controls.    The Company’s management, including the CEO and CFO, does not expect that our Disclosure Controls or our internal control over financial reporting will prevent or detect all error and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered

96

relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

Item 9B. Other Information

2005 Incentive Plan Cash Bonuses

During the first quarter of the Company’s 2005 fiscal year, upon the recommendation of the Compensation Committee, the Board of Directors approved the 2005 Incentive Plan which provided for the payment of cash bonuses upon the achievement of specific performance criteria for the 2005 fiscal year. Substantially all of the Company’s non-sales employees were eligible to participate in the 2005 Incentive Plan, including the Company’s executive officers. The payment of bonuses under the 2005 Incentive Plan was dependent upon the achievement of Company financial goals, divisional financial goals and corporate or personal goals. Not all of the goals were applicable to each Plan participant and the personal goals varied depending on the employee’s position within the Company. Bonuses under the 2005 Incentive Plan could range from 5% to 100% of an employee’s salary, with such percentage varying among the employees. To the extent the Company had a year end cash balance below a certain minimum amount, earned bonuses would be scaled down. To the extent certain Company financial goals were exceeded, earned bonuses would be scaled up. Executive officers of the Company were eligible to earn bonuses based solely on the achievement of Company financial goals and specific personal goals which were the same for each executive officer.

In November 2005, the Compensation Committee approved cash bonus payments under the 2005 Incentive Plan for the executive officers as set forth below. These payments reflect the failure to achieve any of the Company financial goals and only partial achievement of the specific corporate goals.

Name	Position	Cash Bonus
David A. Ranhoff	President and Chief Executive Officer	$	82,931
John C. Batty	Senior Vice President, Chief Financial Officer and Secretary	$	30,683
Brett Hooper	Senior Vice President, Human Resources	$	20,961
Byron Milstead	Senior Vice President and General Counsel	$	23,497
Graham J. Siddall	Executive Chairman	$	218,000

97

2006 Incentive Plan Cash Bonuses

During the first quarter of the Company’s 2006 fiscal year, upon the recommendation of the Compensation Committee, the Company’s Board of Directors approved the 2006 Incentive Plan which provides for the payment of cash bonuses upon the achievement of specific performance criteria for the 2006 fiscal year. Substantially all of the Company’s non-sales employees are eligible to participate in the 2006 Incentive Plan, including the Company’s executive officers. The payment of bonuses under the 2006 Incentive Plan is dependent upon the Company achieving a minimum operating income for the 2006 fiscal year, with the amount available for payment of bonuses scaling up as operating income exceeds the minimum amount. The specific amount of bonuses payable out of the amount available for bonus award is determined based upon the achievement of objective goals relating to new customer orders, quality and revenue. Up to twenty-five percent (25%) of the bonuses payable relate to new customer order goals, up to twenty-five percent (25%) of the bonuses payable relate to quality goals and up to fifty percent (50%) of the bonuses payable relate to revenue goals. Bonuses under the 2006 Incentive Plan may be from 5% to 100% of an employee’s salary, with such percentage varying among the employees. Each of Messrs. Ranhoff, Batty, Hooper and Milstead may receive bonuses of up to 100%, 60%, 50% and 50%, respectively, of their annual salaries, subject to increases if operating income increases over the minimum amount discussed above.

98

PART III

Item 10. Directors and Executive Officers of the Registrant

The information required by this item relating to the Company’s directors and nominees and disclosure relating to compliance with Section 16(a) of the Securities Exchange Act of 1934 is included under the captions “Election of Directors” and “Compliance with Section 16(a) of the Securities Exchange Act of 1934” in the Company’s Proxy Statement for the 2006 Annual Meeting of Stockholders and is incorporated herein by reference. The information required by this item relating to the Company’s executive officers and key employees will be included under the caption “Executive Officers and Key Employees” in Part I of this Form 10-K Annual Report.

The Company has adopted a Code of Ethics that applies to its principal executive officer, principal financial officer and controller and a Code of Business Conduct and Ethics within the meaning of Section 406 of the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder that applies to all Company employees. A copy of the Code of Ethics or the Code of Business Conduct and Ethics is available at the Company’s website: www.credence.com, and without charge upon written request to: Mr. John C. Batty, the Company’s Senior Vice President, Chief Financial Officer and Secretary at the Company’s headquarters at 1421 California Circle, Milpitas, California 95035. To the extent required by law, amendments to, and waivers from, any provision of our code of ethics will promptly be disclosed to the public. To the extent permitted by such legal requirements, the Company intends to make such public disclosure by posting such information on the Company’s website in accordance with SEC rules.

Item 11. Executive Compensation

The information required by this item will be included under the caption “Executive Compensation and Related Information” in the Company’s Proxy Statement for the 2006 Annual Meeting of Stockholders and is incorporated herein by reference.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The information required by this item is included under the caption “Ownership of Securities” in the Company’s Proxy Statement for the 2006 Annual Meeting of Stockholders and is incorporated herein by reference.

99

Equity Compensation Plan Information

The following table provides information as of October 31, 2005 with respect to the shares of the Company’s Common Stock that may be issued under the Company’s existing equity compensation plans. The table does not include information with respect to shares subject to outstanding options granted under equity compensation plans assumed by the Company in connection with mergers and acquisitions of the companies that originally granted those options. Footnote (5) to the table sets forth the total number of shares of the Company’s Common Stock issuable upon the exercise of those assumed options as of October 31, 2005, and the weighted average exercise price of those options. No additional options may be granted under those assumed plans.

	A	B		C
Plan Category	Number of Securities to be Issued Upon Exercise of Outstanding Options	Weighted Average Exercise Price of Outstanding Options		Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column A) (4)
Equity Compensation Plans Approved by Stockholders (1)(3)	13,962,993	$	14.06	5,570,545
Equity Compensation Plans Not Approved by Stockholders (2)	899,865	$	13.50	520,635
Total	14,862,858	$	13.98	6,091,180

(1) Consists of the 1993 Stock Option Plan (the “1993 Plan”) and the 2005 Stock Option Plan (the “2005 Plan”).

(2) Consists solely of the Supplemental Stock Option Plan. Options under this Plan are not held by any directors or executive officers of the Company.

(3) Excludes employee stock purchase rights accruing under the 1994 Employee Stock Purchase Plan. Under the 1994 Plan, each eligible employee may purchase up to 1,500 shares of Common Stock at semi-annual intervals on February 14th and August 14th each year at a purchase price per share equal to 85% of the lower of (i) the closing selling price per share of Common Stock on the employee’s entry date into the offering period in which that semi-annual purchase date occurs or (ii) the closing selling price per share on the semi-annual purchase date.

(4) Consists of shares available for future issuance under the Plans. As of October 31, 2005, an aggregate of 1,161,645 shares of Common Stock were available for issuance under the 1994 Plan and 5,570,545 shares of Common Stock were available for issuance under the 1993 Plan and the 2005 Plan. However, pursuant to the automatic share increase provisions of the 1994 Plan, the number of shares reserved for each such plan will automatically increase on the first trading day of each fiscal year over the term of the relevant plan by a number of shares equal to one half of one percent (0.5%) of the total number of shares of Common Stock outstanding on the last trading day of the immediately preceding fiscal year. In no event, however, may any such annual increase to the share reserve of the 1994 Plan exceed 500,000 shares, as adjusted from time to time to reflect any subsequent stock dividends or stock splits.

(5) The table does not include information for equity compensation plans assumed by the Company in connection with mergers and acquisitions of the companies that originally established those plans. As of October 31, 2005, a total of 3,294,700 shares of the Company’s Common Stock were issuable upon exercise of outstanding options under those assumed plans. The weighted average exercise price of those outstanding options is $7.86 per share. No additional options may be granted under those assumed plans.

A Supplemental Stock Option Plan (the “Supplemental Plan”) was implemented by the Board on August 9, 2000. The Supplemental Plan is a non-shareholder approved plan under which options may be granted to employees of the Company (or any parent or subsidiary corporation) who are neither officers nor Board members at the time of grant. 1,500,000 shares of Common Stock have been authorized by the Board for issuance under the Supplemental Plan. All option grants will have an exercise price per share equal to the fair market value per share of Common Stock on the grant date. Each option will vest in installments over the optionee’s period of

100

service with the Company. The options will vest on an accelerated basis in the event the Company is acquired and those options are not assumed or replaced by the acquiring entity. Each option will have a maximum term (not to exceed 10 years) set by the plan administrator (either the Board or a Board committee) at the time of grant, subject to earlier termination following the optionee’s cessation of employment. All options are non-statutory options under the Federal tax law.

Share issuances under the 2005 Plan will not reduce or otherwise affect the number of shares of Common Stock available for issuance under the Supplemental Plan, and share issuances under Supplemental Plan will not reduce or otherwise affect the number of shares of Common Stock available for issuance under the 2005 Plan.

Item 13.    Certain Relationships and Related Transactions

The information required by this item will be included under the caption “Certain Relationships and Related Transactions” in the Company’s Proxy Statement for the 2006 Annual Meeting of Stockholders and is incorporated herein by reference.

Item 14.    Principal Independent Registered Public Accounting Firm Fees and Services

The information required by this item will be included under the caption “Principal Independent Registered Public Accounting Firm Fees and Services” in the Company’s Proxy Statement for the 2006 Annual Meeting of Stockholders and is incorporated herein by reference.

101

PART IV

Item 15. Exhibits and Financial Statement Schedules

(a)  The following documents are filed as part of the Annual Report on Form 10-K:

1.  Financial Statements.    The following Consolidated Financial Statements of Credence Systems Corporation are included in Item 8 of this Annual Report on Form 10-K:

	Page
Report of Independent Registered Public Accounting Firm	55
Report of Independent Registered Public Accounting Firm on Internal Control Over Financial Reporting	56
Consolidated Balance Sheets—October 31, 2005 and 2004	57
Consolidated Statements of Operations—Years Ended October 31, 2005, 2004 and 2003	58
Consolidated Statements of Stockholders’ Equity—Years Ended October 31, 2005, 2004 and 2003	59
Consolidated Statements of Cash Flows—Years Ended October 31, 2005, 2004 and 2003	60
Notes to Consolidated Financial Statements	61

2.  Financial Statement Schedule.    The following financial statement schedule of Credence Systems Corporation, for the years ended October 31, 2005, 2004 and 2003, is filed as part of this Annual Report on Form 10-K and should be read in conjunction with the Consolidated Financial Statements of Credence Systems Corporation:

	Page
Schedule II—Valuation and Qualifying Accounts	105

Schedules other than the one listed above have been omitted since they are either not required, are not applicable or the required information is shown in the consolidated financial statements or related notes.

3.  Exhibits.    See Exhibit Index on page 106.

102

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, as of January 17, 2006.

CREDENCE SYSTEMS CORPORATION (Registrant)
By:	/S/    DAVID A. RANHOFF
	David A. Ranhoff
	President and Chief Executive Officer

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints David A. Ranhoff and Byron W. Milstead, and each of them, as his true and lawful attorneys-in-fact and agents, with full power of substitution and re-substitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments to this Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming that said attorneys-in-fact and agents, or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

Signature	Title	Date
/S/    DAVID A. RANHOFF         David A. Ranhoff	President, Chief Executive Officer and Director (Principal Executive Officer)	January 17, 2006
/S/    JOHN C. BATTY         John C. Batty	Senior Vice President, Chief Financial Officer and Secretary (Principal Financial and Accounting Officer)	January 17, 2006
David House	Executive Chairman and Director	January     , 2006
/S/    RICHARD M. BEYER         Richard M. Beyer	Director	January 17, 2006
/S/    DIPANJAN DEB         Dipanjan Deb	Director	January 17, 2006
/S/    HENK J. EVENHUIS         Henk J. Evenhuis	Director	January 17, 2006

103

Signature	Title	Date
/S/    LORI HOLLAND         Lori Holland	Director	January 17, 2006
/S/    WILLIAM G. HOWARD, JR.         William G. Howard, Jr.	Director	January 17, 2006
/S/    JON D. TOMPKINS         Jon D. Tompkins	Director	January 17, 2006
/S/    BRUCE R. WRIGHT         Bruce R. Wright	Director	January 17, 2006

104

Item 15(a)(2).

Schedule II

CREDENCE SYSTEMS CORPORATION

VALUATION AND QUALIFYING ACCOUNTS

(In thousands)

	Balance at Beginning of Year		Additions			Write-offs		Balance at End of Year
Year ended October 31, 2005
Allowance for doubtful accounts	$	1,607	$	2,985		$	267	$	4,325
Year ended October 31, 2004
Allowance for doubtful accounts	$	2,444	$	(118	)*	$	719	$	1,607
Year ended October 31, 2003
Allowance for doubtful accounts	$	5,388	$	192		$	3,136	$	2,444

* This amount consisted of an additional allowance of approximately $74,000, reversal of the beginning allowance amount of approximately $1,534,000 and assumption of the allowance for former NPTest’s accounts receivable of approximately $1,342,000.

105

EXHIBIT INDEX

Exhibit     Number
3.1(3)	Amended and Restated Certificate of Incorporation of the Company, as currently in effect.
3.2(5)	Amended and Restated Bylaws of the Company, as currently in effect.
4.1(9)	Certificate of Designation for the Non-Voting Convertible Stock of the Registrant.
4.2(2)	Indenture, dated as of June 2, 2003 between Credence Systems Corporation and The Bank of New York, as Trustee.
4.3(2)	Form of Global Note (included in Exhibit 4.3).
10.1(14)	Form of Indemnification Agreement Between the Company and each of its officers and directors.
10.2(6)	1993 Stock Option Plan, as Amended and Restated through March 19, 2003.
10.3(1)	Form of Notice of Grant to be generally used in connection with the 1993 Stock Option Plan.
10.4(1)	Form of Stock Option Agreement to be generally used in connection with the 1993 Stock Option Plan.
10.5(1)	Addendum to the Stock Option Agreement (Special Tax Elections).
10.6(1)	Addendum to the Stock Option Agreement (Limited Stock Appreciation Rights).
10.7(1)	Addendum to the Stock Option Agreement (Change in Control).
10.8(1)	Addendum to the Stock Option Agreement (Financial Assistance).
10.9(1)	Form of Notice of Grant of Stock Option (Non-Employee Director) to be generally used in connection with the automatic option grant program of the 1993 Stock Option Plan.
10.10(1)	Form of Stock Option Agreement (Non-Employee Director) to be generally used in connection with the automatic option grant program of the 1993 Stock Option Plan.
10.11	Employee Stock Purchase Plan, as Amended and Restated through May 17, 2000.
10.12(1)	Form of Stock Purchase Agreement.
10.13(1)	Form of Enrollment/Change Form.
10.14(4)	Supplemental Stock Option Plan, as amended and restated through November 27, 2000.
10.15(7)	Registration Rights Agreement, dated as of June 2, 2003, by and between Credence Systems Corporation and Citigroup Global Markets, Inc.
10.16(11)	Executive Employment Agreement, dated as of September 9, 2004, and effective May 28, 2004, by and between the Company and Byron Milstead.
10.17(12)	Executive Succession Agreement, dated as of November 5, 2004, and effective January 1, 2005, by and between the Company and Graham J. Siddall.
10.18(12)	Amended Executive Employment Agreement, dated as of November 5, 2004, and effective January 1, 2005, by and between the Company and David A. Ranhoff.
10.20(8)	Amended and Restated Executive Employment Agreement, dated as of December 6, 2004, and effective May 28, 2004, by and between the Company and Ashok Belani.
10.21(13)	Executive Employment Agreement, dated as of December 31, 2004, by and between the Company and John Batty.

106

Exhibit     Number
10.22(10)	Settlement Agreement dated May 26, 2005, by and among Schlumberger Technology Corporation, Schlumberger Technologies, Inc., Schlumberger B.V., NPTest Holding Corporation, NPTest Acquisition Corporation and the Company.
10.23(10)	2005 Stock Incentive Plan, as amended.
10.24(15)	Resale Restriction Agreement with respect to certain stock option award agreements issued under the Company’s 1993 Stock Option Plan.
10.25(16)	Executive Employment Agreement, dated as of December 9, 2005, by and between the Company and David House.
10.26	Fiscal Year 2006 Incentive Plan.
12.1	Statement of Computation of Ratio of Earnings to Fixed Charges.
21.1	Subsidiaries of the Company.
23.1	Consent of Independent Registered Public Accounting Firm.
24.1	Power of Attorney (reference is made to the signature page of this report).
31.1	Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.
31.2	Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.
32.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

(1) Exhibits 10.3 through 10.10 and Exhibits 10.12 and 10.13 are incorporated herein by reference to Exhibits 99.2, 99.3, 99.4, 99.5, 99.6, 99.7, 99.8, 99.9, 99.11 and 99.12, respectively, to the Company’s Registration Statement on Form S-8 (File No. 333-27499) declared effective with the Securities and Exchange Commission on May 20, 1997.

(2) Incorporated by reference to Exhibit 4.3 to the Company’s Registration Statement on Form S-3 (File No. 333-108069) as filed with the Commission on August 19, 2003.

(3) Incorporated by reference to Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q (Filed No. 000-22366) for the quarterly period ended April 30, 2000.

(4) Incorporated by reference to Exhibit 99.1 to the Company’s Registration Statement on Form S-8 (File No. 333-58100), as filed with the Commission on April 2, 2001.

(5) Incorporated by reference to Exhibit 3.01 to the Company’s Current Report on Form 8-K (File No. 000-22366) filed on August 29, 2005.

(6) Incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q (Filed No. 000-22366) for the quarterly period ended April 30, 2003.

(7) Incorporated herein by reference to Exhibit 4.5 to the Company’s Registration Statement on Form S-3 (File No. 333-108069) declared effective with the Securities and Exchange Commission on November 26, 2003.

(8) Incorporated by reference to Exhibit 10.1 to the Company’s Report on Form 8-K (File No. 000-22366) filed on December 8, 2004.

(9) Incorporated by reference to Exhibit 4.7 to the Company’s Registration Statement on Form S-4 (File No. 333-113990) filed on March 29, 2004.

(10) Exhibits 10.22 and 10.23 are incorporated herein by reference to Exhibits 10.1 and 10.2, respectively, to the Company’s Quarterly Report on Form 10-Q (File No. 000-22366) for the quarterly period ended April 30, 2005.

107

(11) Exhibits 10.12 is incorporated herein by reference to Exhibit 10.4, to the Company’s Report on Form 8-K (File No. 000-22366) filed on September 14, 2004.

(12) Exhibits 10.17 and 10.18 are incorporated herein by reference to Exhibits 10.1 and 10.2, respectively, to the Company’s Report on Form 8-K (File No. 000-22366) filed on November 8, 2004.

(13) Incorporated by reference to Exhibits 10.1 to the Company’s Report on Form 8-K (File No. 000-22366) filed on January 3, 2005.

(14) Exhibit 10.1 is incorporated herein by reference to Exhibit 10.1 to the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2003.

(15) Exhibit 10.24 is incorporated herein by reference to Exhibit 1.01 to the Company’s Current Report on Form 8-K (File No. 000-22366) filed on September 1, 2005.

(16) Exhibit 10.24 is incorporated herein by reference to Exhibit 1.01 to the Company’s Current Report on Form 8-K (File No. 000-22366) filed on December 13, 2005.

108

EX-10.11

Exhibit 10.11

CREDENCE SYSTEMS CORPORATION

EMPLOYEE STOCK PURCHASE PLAN

(As Amended and Restated Through May 17, 2000)

1. PURPOSE OF THE PLAN

The Credence Systems Corporation 1994 Employee Stock Purchase Plan (the “Plan”) is intended to provide a suitable mans by which eligible employees of the Credence Systems Corporation (the “Company”) may accumulate, through voluntary, systematic payroll deductions, amounts regularly credited to their account to be applied to the purchase of shares of the Company’s common stock, par value $0.001 (the “Common Stock”), pursuant to the exercise of options granted from time to time hereunder. The Plan provides employees with the opportunities to acquire proprietary interests in the Company, and will also provide them with additional incentives to continue their employment and promote the best interests of the Company. Options granted under the Plan are intended to qualify under Section 423 of the Internal Revenue Code of 1986, as amended (the “Code”).

2. SHARES OF STOCK SUBJECT TO THE PLAN

Subject to the provisions of Section 12, the number of shares of Common Stock which may be issued on the exercise of options granted under the Plan will initially be limited to 1,600,000 shares of the Company’s Common Stock. Such share reserve includes (i) the initial share reserve of 600,000 shares;¹ (ii) an additional 400,000 share increase authorized by the Board on February 12, 1997 and approved by the stockholders at the 1997 Annual Meeting; and (iii) an additional 600,000 share increase authorized by the Board on January 22, 1999 and approved by the stockholders at the 1999 Annual Meeting.

The number of shares of Common Stock available for issuance under the Plan shall automatically increase on the first trading day of each fiscal year over the remaining term of the Plan, beginning with the fiscal year commencing November 1, 2000, by an amount equal to one-half of one percent (0.50%) of the total number of shares of Common Stock outstanding on the last trading day in the immediately preceding fiscal year, but in no event shall any such annual increase exceed 500,000 shares.

Any shares subject to an option under the Plan, which option for any reason expires or is terminated unexercised as to such shares, shall again be available for issuance on the exercise of other options granted under the Plan. Shares delivered on the exercise of options may, at the election of the Board of Directors of the Company, be authorized but previously unissued Common Stock or Common Stock reacquired by the Company, or both.

¹ Reflects the 2-for-1 split of the Corporation’s outstanding Common Stock on May 17, 2000 and the 3-for-2 split of the Corporation’s outstanding Common Stock effected June 5, 1995.

3. ADMINISTRATION

The Plan shall be administered by the Compensation Committee (the “Committee”) of the Company’s Board of Directors, which shall be composed of not less than two non-employee members of the Board of Directors of the Company, all of whom shall be ineligible to participate in this Plan and shall otherwise qualify as disinterested persons under Rule 16b-3(b)(3)(i) promulgated by the Securities and Exchange Commission. Subject to the provisions of the Plan, the Committee shall have full discretion and authority (i) to determine the terms and conditions under which the shares shall be offered and corresponding options shall be granted under the Plan for each Offering Period (as defined in Section 4) consistent with the provisions of the Plan, and (ii) to resolve all questions relating to the administration of the Plan.

The interpretation and application by the Committee of any provision of the Plan shall be final and conclusive on all employees and others persons having, or claiming to have, an interest under the Plan. The Committee may, in its discretion, establish such rules and guidelines relating to the Plan as it may deem desirable.

The Committee may employ such legal counsel, consultants and agents as it may deem desirable for the administration of the Plan and may rely upon any opinion received from any such counsel or consultant and any computation received from any such counsel or consultant or agent. The Committee shall keep minutes of its actions under the Plan.

No member of the Board of Directors or the Committee shall be liable for any action or determination made in good faith with respect to the Plan or any options granted hereunder.

4. OFFERING PERIODS

Shares of Common Stock shall be offered for purchase under the Plan through a series of successive Offering Periods until such time as (i) the maximum number of shares of Common Stock available for issuance under the Plan shall have been purchased or (ii) the Plan shall have been sooner terminated.

Each Offering Period shall be of such duration (not to exceed twelve (12) months) as determined by the Committee prior to the start date of such Offering Period. However, the initial Offering Period under the December 1999 Restatement shall commence on August 15, 2000 and terminate on August 14, 2001. The next Offering Period shall commence on August 15, 2001, and subsequent Offering Periods shall commence as designated by the Committee. Prior to August 15, 2000, there shall be an interim Offering Period from January 1, 2000 to August 14, 2000, with a Purchase Date occurring on the August 14, 2000 ending date of that period.

2.

Each Offering Period shall consist of a series of one or more successive Purchase Intervals. Purchase Intervals shall run from February 15 to August 14 each year and from August 15 each year to February 14 of the following year. Shares of Common Stock shall be purchased on the following semi-annual Purchase Dates each year: February 14 and August 14.

Should the Fair Market Value per share of Common Stock on any Purchase Date within an Offering Period be less than the Fair Market Value per share of Common Stock on the start date of that Offering Period, then that Offering Period shall automatically terminate immediately after the purchase of shares of Common Stock on such Purchase Date, and a new Offering Period shall commence on the next business day following such Purchase Date. The new Offering Period shall have a duration of twelve (12) months, unless a shorter duration is established by the Committee within five (5) business days following the start date of that Offering Period.

5. ELIGIBILITY TO PARTICIPATE

The persons eligible to participate in this Plan shall be all employees (including officers) of the Company, or any participating affiliate, who have been actively employed by the Company, or such affiliate, for at least thirty (30) consecutive days as of their entry date into any Offering Period, but excluding employees whose customary employment is for not more than five (5) months in any calendar year or is for twenty (20) hours or less per week. An employee who is eligible to participate in this Plan pursuant to the foregoing requirements is hereinafter referred to as an Employee. A participating affiliate, for purposes of the Plan, shall include any now existing or hereafter established parent or subsidiary corporation of the Company, as determined in accordance with Code Sections 424(e) and 424(f), which elects, with the consent of the Company’s Board of Directors, to extend the benefits of the Plan to its eligible employees.

Nothing contained in the Plan shall confer upon any Employee any right to continue in the employ of the Company or any of its affiliates, or interfere in any way with the right of the Company or any of its affiliates to terminate his or her employment at any time.

6. PARTICIPATION IN THE PLAN

An Employee may join a particular Offering Period either as of the start date of that Offering Period or on any Semi-Annual Entry Date within that Offering Period on which he or she remains an Employee. Semi-Annual Entry Dates shall occur on the 15th day of February and August each calendar year within the Offering Period. The date on which the Employee joins the Offering Period shall be designated his or her Entry Date. A copy of the Plan will be furnished to each Employee prior to his or her Entry Date for the first Offering Period during which he or she participates in the Plan.

To participate in the Plan, an Employee must deliver (or cause to be delivered) to the Company, within seven (7) days prior to his or her Entry Date into the first Offering Period during which participation in the Plan is desired, a contingent subscription for Common Stock and authorization for payroll deductions to effect the purchase of Common Stock (hereinafter called a “Participation Election”). In the Participation Election an Employee must:

(i) authorize payroll deductions within the limits prescribed in Sections 9 and 10 and specify the percentage to be deducted regularly from his or her Compensation (as defined in Section 9);

3.

(ii) elect and authorize the purchase on each Purchase Date within the Offering Period of a specific number of shares of Common Stock, provided that such specific number of shares shall not exceed a total of 1,500 shares on any one Purchase Date;

(iii) furnish the exact name or names and address or addresses in which the stock certificates for Common Stock purchased by him or her under the Plan are to be issued; and

(iv) agree to notify the Company if he or she should dispose of the shares of Common Stock purchased through the Plan within two (2) years after his or her Entry Date into the Offering Period in which those shares were purchased or within one (1) after the Purchase Date of those shares.

The Committee may increase or decrease the per-Employee share limitation of clause (ii) above as of the start date of any future Offering Period.

Stock certificates for shares of Common Stock purchased under the Plan may be issued in the Employee’s name or, if so designated by the Employee, in his or her name and the name of another person who is a member of his or her family, with right of survivorship; for this purpose the “family” of an Employee shall include only his or her spouse, ancestors and lineal descendants and brothers and sisters.

An Employee need not, and may not, make a down payment in order to participate in the Plan.

Participation in the Plan is entirely voluntary, and a participating Employee may withdraw from participation, as provided in Section 16, during any Purchase Interval at any time prior to the scheduled Purchase Date for that Purchase Interval.

7. GRANT OF OPTIONS

During each Offering Period, participating Employees shall accumulate credits to a bookkeeping account maintained by the Company (hereinafter referred to as a “Stock Purchase Account”) through payroll deductions to be made at the close of each pay period for the purchase of shares of Common Stock on each semi-annual Purchase Date within that Offering Period. Accordingly, each participating Employee shall be granted a separate purchase option for each Offering Period in which he or she participates. The purchase option shall be granted on the Employee’s Entry Date into the Offering Period and shall provide the Employee with the right to purchase shares of Common Stock, in a series of successive installments over the remainder of that Offering Period, subject to the provisions of sections 2, 6, 12 and 13. The purchases shall be

4.

effected by applying the amounts credited to such Employee’s Stock Purchase Account to the acquisition of shares of Common Stock on each Purchase Date within the Offering Period on which such Employee remains a participant (such number of shares to be subject to reduction in the event of a pro rata apportionment provided for in Section 18).

8. PURCHASE PRICE

The purchase price per share at which Common Stock will be purchased on the Employee’s behalf on each semi-annual Purchase Date within the Offering Period shall be equal to eighty-five percent (85%) of the lower of (i) the Fair Market Value per share of Common Stock on the Employee’s Entry Date into that Offering Period or (ii) the Fair Market Value per share of Common Stock on that Purchase Date.

For purposes of the Plan, the Fair Market Value of a share of Common Stock on any relevant date shall be the mean between the high and low selling prices of such Common Stock reported for such date or, if such date is not a business day, then the immediately preceding business day, on the Nasdaq National Market and published in The Wall Street Journal.

9. PAYROLL DEDUCTIONS - AUTHORIZATION AND AMOUNT

Employees shall authorize in their Participation Elections from 1% to 10% (in whole percentage increments) of their Compensation to which such election relates (subject to the limitations of Section 10). For purposes of the Plan, the “Compensation” of an Employee for any Purchase Interval shall mean the gross amount of his or her base pay on the basis of his or her regular, straight-time hourly, weekly or monthly rate for the number of hours normally worked, exclusive of overtime, sales commissions, bonuses, shift premiums and other forms of compensation.

A participating Employee may, at any time during a Purchase Interval, reduce the amount of Compensation to be deducted from his or her Compensation pursuant to his or her Participant Election.

By delivering to the Company within seven (7) days prior to the commencement of the next Purchase Interval a revised Participation Election, a participating Employee may either increase or decrease the amount to be deducted from his or her Compensation during the remaining Purchase Intervals in the Offering Period, subject to the limitations of this Section 9 and Section 10.

A participating Employee’s authorization for payroll deductions will remain in effect for the duration of the Plan, subject to the provisions of Sections 12 and 15, unless his or her election to purchase Common Stock shall have been terminated pursuant to the provisions of Section 14, the amount of the deduction is changed, as provided in this Section 9, or the Employee withdraws or is considered to have withdrawn from the Plan under Section 16 or 17.

5.

Prior to the split of the Common Stock effected June 5, 1995, the maximum number of shares of Common Stock purchasable per participating Employee on any one Purchase Date under the Purchase Plan was limited to 500 shares. To reflect such stock split, the limit was increased to 750 shares per participating Employee for each Purchase Date after May 6, 1995. As a result of the split of the Common Stock effected on May 17, 2000, the maximum number of shares of Common Stock purchasable per participating Employee on any one Purchase Date was increased to 1,500 shares per participating Employee for each Purchase Date, on or after May 17, 2000.

All amounts credited to the Stock Purchase Accounts of participating Employees shall be held in the general funds of the Company but shall be used from time to time in accordance with the provisions of the Plan.

10. LIMITATIONS ON THE GRANTING OF OPTIONS

Anything in the Plan to the contrary notwithstanding, no participating Employee may be granted an option which permits his or her rights to purchase Common Stock under all employee stock purchase plans of the Company and its parent and subsidiary companies (if any) to accrue at a rate which exceeds $25,000 of the Fair Market Value of such Common Stock (determined at the time such option is granted) for each calendar year in which such option is outstanding at any time. For purposes of this Section 10:

(i) The right to acquire Common Stock under each outstanding purchase option shall accrue in a series of installments on each successive Purchase Date during the Offering Period on which such option remains outstanding.

(ii) No right to acquire Common Stock under any outstanding purchase option shall accrue to the extent the Employee has already accrued in the same calendar year the right to acquire Common Stock under one or more other purchase options at a rate equal to Twenty-Five Thousand Dollars ($25,000.00) worth of Common Stock (determined on the basis of the Fair Market Value per share on the date or dates of grant) for each calendar year such options were at any time outstanding.

(iii) If by reason of such accrual limitations, any purchase option of an Employee does not accrue for a particular Purchase Interval, then the payroll deductions that the Employee made during that Purchase Interval with respect to such purchase option shall be promptly refunded.

No participating Employee may be granted an option hereunder if such Employee, immediately after the option is granted, owns (within the meaning of Section 423 (b) (3) of the Code) stock possessing five (5) percent or more of the total combined voting power or value of all classes of stock of the Company or of its parent or subsidiary corporation. For purposes of the Plan, the terms “parent corporation” and “subsidiary corporation” shall have the respective meanings set forth in section 424 of the Code.

6.

11. STOCK PURCHASE AMOUNTS

The amount deducted from the Compensation of each participating Employee shall be credited to his or her individual Stock Purchase Account. Employees participating in the Plan may not make direct cash payments to their Stock Purchase Accounts.

Following each Purchase Date, the Company will furnish to each participating Employee a statement of that Employee’s individual Stock Purchase Account. This statement shall show (i) the total amount of payroll deductions for the Purchase Interval ending with such Purchase Date, (ii) the number of full shares (and the purchase price per share) of Common Stock purchased, pursuant to the provisions of Section 12, by the participating Employee on that Purchase Date, and (iii) any remaining balance of payroll deductions which are to be refunded to the Employee following the close of the Purchase Interval (or carried forward to the next Purchase Interval in the case of amounts representing fractional shares).

12. ISSUANCE AND PURCHASE OF COMMON STOCK

Shares of Common Stock may be purchased by a participating Employee only on a semi-annual Purchase Date within the Offering Period; and the options which the Company grants to participating Employees for the purchase of Common Stock for a particular Offering Period may be exercised only on the Purchase Dates within that Offering Period on which such Employee remains a participant. No fractional shares of Common Stock may be purchased hereunder. The purchase price per share for each participating Employee shall be determined as set forth in Section 8.

A participating Employee shall, pursuant to the exercise of the options granted to him or her under the Plan, purchase as many full shares as shall be stated in the Participation Election that the Employee has completed, subject to the limitations set forth in Sections 6, 9, 10, 13 and 18; provided that in no even may shares be purchased other than by application of the balance in the Stock Purchase Account on the Purchase Date and that in no event may a participating Employee purchase a greater number of shares than would be purchasable at the purchase price determined for such Employee in accordance with Section 8 through the application of the balance in his or her Stock Purchase Account on such Purchase Date. Any balance remaining in such a participating Employee’s Stock Purchase Account following a Purchase Date shall be refunded to the Employee as soon as practicable thereafter; provided, however, that any such balance representing a fractional share shall be carried over to the next succeeding Purchase Interval.

Certificates for Common Stock so purchased shall be delivered to the participating Employee as soon as practicable.

7.

All rights as an owner of shares of the Common Stock purchased under the Plan shall accrue to the participating Employee who purchased the shares effective as of the Purchase Date on which the amounts credited to his or her Stock Purchase Account were applied to the purchase of those shares; and such Employee shall not have any rights as a shareholder prior to such Purchase Date by reason of his or her having elected to purchase such shares.

13. CORPORATE TRANSACTIONS AND OTHER CHANGES IN CAPITALIZATION

If the Company is a party to any merger or consolidation, or undergoes any separation, reorganization (other than a reincorporation in another state) or liquidation (collectively, a “Corporate Transaction”), then the options outstanding under the Plan shall be exercised immediately prior to the effective date of such Corporate Transaction, and such date shall accordingly qualify as a Purchase Date for the Offering Period in which such Corporate Transaction occurs. The purchase price payable per share of Common Stock on such Purchase Date shall be equal to eighty-five percent (85%) of the lower of (i) the Fair Market Value per share of Common Stock on the Employee’s Entry Date into the Offering Period in which such Corporate Transaction occurs or (ii) the Fair Market Value per share of Common Stock immediately prior to the effective date of such Corporate Transaction. However, the applicable limitation on the number of shares of Common Stock purchasable per participating Employee shall continue to apply to such purchase.

In the event of a reclassification, stock split, combination of shares, separation (including a spin-off), dividend on shares of the Common Stock payable in stock, or other similar change in capitalization or in the corporate structure of the shares of the Common Stock of the Company, the Committee shall conclusively determine the appropriate adjustment in (i) the purchase price and other terms of purchase for shares subject to outstanding Participation Elections for the Offering Period in effect at such time, (ii) the number and kind of shares or other securities which may by purchased on each Purchase Date within that Offering Period, (iii) the maximum number and kind of shares or other securities which may be purchased under the Plan, (iv) the maximum number and kind of shares or other securities which may be purchased per Employee on any Purchase Date within that Offering Period and (v) the maximum number and kind of shares or other securities by which the share reserve under the Plan is to increase at the start of each fiscal year pursuant to the automatic share increase provisions of Section 2. Any such adjustment in the shares or other securities subject to the outstanding options granted to such Employee (including any adjustments in the option price) shall be made in such manner as not to constitute a modification as defined by Section 424(h)(3) of the Code and only to the extent permitted by Sections 423 and 424 of the Code.

14. NO ASSIGNMENT OF PLAN RIGHTS OR OF PURCHASED STOCK

A participating Employee’s privilege to purchase Common Stock under the Plan can be exercised only by him or her; and he or she cannot purchase Common Stock for someone else, although he or she may designate (in accordance with the provisions of Section 6) that stock certificates of Common Stock purchased by the Employee be issued in the joint names of the Employee and a family member.

8.

An Employee participating in the Plan may not sell, transfer, pledge, or assign to any other person any interest, privilege or right under the Plan or in any amounts credited to his or her Stock Purchase Account; and if this provision shall be violated, his or her election to purchase Common Stock shall terminate, and the only right remaining thereunder will be to have paid to the person entitled thereto the amount then credited to the Employee’s Stock Purchase Account.

15. SUSPENSION OF DEDUCTIONS

A participating Employee’s payroll deductions under the Plan shall be suspended if on account of a leave of absence, layoff or other reason a participating Employee does not have sufficient Compensation in any payroll period to permit payroll deductions authorized under the Plan to be made in full. The suspension will last until the participating Employee again has sufficient Compensation to permit such payroll deductions to be made in full; but if the suspension shall not have been removed by the end of the Purchase Interval in which it began, shares will be purchased on the Purchase Date for that Purchase Interval, to the extent that the Employee contributed funds prior to the suspension of deductions. In the event of voluntary withdrawal or termination of employment, funds will be returned to the Employee as provided in Section 16.

16. WITHDRAWAL FROM, AND REPARTICIPATION IN THE PLAN

During any Purchase Interval, a participating Employee may withdraw from the Plan at any time prior to the Purchase Date for that Purchase Interval; and, subject to, and in accordance with the provisions of Sections 6 and 9, he or she may again participate in the Plan at the beginning of any new Purchase Interval subsequent to the Purchase Interval in which he or she withdrew, and that date shall be the Employee’s new Entry Date for the remaining Purchase Intervals within the Offering Period and for purposes of determining the purchase price to be in effect for the Employee under Section 8 on each subsequent Purchase Date within that Offering Period. Withdrawal of a participating Employee shall be effected by written notification prior to such Purchase Date to the Company on a form which the Company shall provide for this purpose (“Notice of Withdrawal”). In the event a participating Employee shall withdraw from the Plan, all amounts then credited to his or her Stock Purchase Account shall be returned as soon as practicable after his or her Notice of Withdrawal shall have been received.

If an Employee’s payroll deductions shall be interrupted by any legal process, a Notice of Withdrawal will be considered as having been received on the day the interruption shall occur.

17. TERMINATION OF PARTICIPATION

A participating Employee’s right to continue participation in the Plan will terminate upon the earliest to occur of (i) the Company’s termination of the Plan, (ii) the Employee’s transfer to ineligible employment status, or (iii) retirement, disability, death or other termination of employment with the Company. Upon the termination of an Employee’s right to continue participation in the Plan on account of the occurrence of any of the foregoing events, all

9.

amounts then credited to the individual’s Stock Purchase Account not already used for the purchase of Common Stock will be repaid as soon as practicable. Such repayments shall be made to the participating Employee unless the termination of participation occurred by reason of such Employee’s death, in which event such repayment shall be made to such Employee’s beneficiary. For this purpose, an Employee’s beneficiary shall be the person, persons or entity designated by the Employee on a form prescribed by and delivered to the Company or, in the absence of an effective beneficiary designation, the Employee’s estate; provided, however, that the determination of the Employee’s beneficiary hereunder shall be subject to any applicable community property or other laws.

18. APPORTIONMENT OF STOCK

If at any time shares of Common Stock authorized for purposes of the Plan shall not be available in sufficient number to meet the purchase requirements under all outstanding Participation Elections, the Committee shall apportion the remaining available shares among the participating Employees on a pro rata basis. In no case shall any apportionment of shares be made with respect to a participating Employee’s election to purchase unless such election is then in effect (subject only to any suspension provided for in the Plan). The Committee shall give notice of such apportionment and of the method of apportionment used to each participating Employee to whom shares shall have been apportioned.

19. GOVERNMENT REGULATIONS

The Plan, and the obligation of the Company to issue, sell and deliver Common Stock under the Plan are subject to all applicable laws and to all applicable rules, regulations and approvals of government agencies.

20. AMENDMENT OR TERMINATION

The Board of Directors of the Company may at any time amend, suspend or terminate the Plan; provided, however, that no amendment (other than an amendment authorized by Section 13) may be made increasing the maximum number of shares of Common Stock which may be issued pursuant to the Plan, reducing the minimum purchase price at which shares may be purchased hereunder or changing the class of employees eligible to participate hereunder; without the approval of the holders of a majority of the outstanding voting shares of the Company.

21. EFFECTIVE DATE

The Plan became effective upon adoption by the Board on January 20, 1994 and was approved by the Company’s stockholders at the 1994 Annual Meeting. The Plan was subsequently amended by the Board on February 12, 1997 to (i) increase the maximum number of shares of Common Stock authorized for issuance over the term of the Plan from 300,000 to 500,000 shares and (ii) extend the termination date of the Plan from December 31, 1998 to December 31, 2003. The February 1997 Amendment was approved by the stockholders at the 1997 Annual Meeting. The Plan was again amended by the Board on January 22, 1999 to

10.

increase the maximum number of shares of Common Stock authorized for issuance over the term of the Plan from 500,000 shares, to 800,000, and such increase was approved by the stockholders at the 1999 Annual Meeting. No purchase rights were granted, and no shares of Common Stock were issued, on the basis of such 300,000 share increase until such stockholder approval had been obtained. The Plan was again amended by the Board on December 8, 1999 (the “December 1999 Amendment”) to (i) implement an automatic share increase feature whereby the number of shares reserved for issuance under the Plan will automatically increase on the first trading day of each fiscal year, beginning November 1, 2000, by an amount equal to one-half of one percent (0.5%) of the total number of shares of the Company’s Common Stock outstanding on the last day of the immediately preceding fiscal year, but no such annual increase is to exceed 250,000 shares, (ii) revise the Offering Periods in effect under the Plan so that each such period may have a maximum duration of twelve (12) months, with purchases to occur at six (6)-month intervals during the Offering Period on the 14th day of February and August each year, and (iii) extend the termination date of the Purchase Plan to August 14, 2010. The December 1999 Amendment is subject to stockholder approval at the 2000 Annual Meeting, and no purchase options will be granted, and no shares of Common Stock will be issued, on the basis of such December 1999 Amendment until and until such stockholder approval is obtained.

22. TERMINATION

The Plan shall terminate on August 14, 2010. Any unexpired Offering Period that commenced prior to such termination date shall forthwith expire on such termination date, which shall be deemed the final Purchase Date under the Plan.

11.

EX-10.26

Exhibit 10.26

CREDENCE SYSTEMS CORPORATION FISCAL YEAR 2006 INCENTIVE PLAN

The goal of the Fiscal Year 2006 Incentive Plan (the “Plan”) is to compensate participants for achievement of the Company’s financial and strategic objectives. The Plan rewards financial performance above and beyond the 2006 financial plan. Awards paid under the Plan will be measured in part based on the Company’s ability to attain certain financial targets and in part based on the achievement of pre-determined Company objectives for the fiscal year 2006.

Goals

• Create a clear and transparent incentive program that aligns employee compensation with the Company’s priorities.

• Focus all levels of the Company’s human capital on financial performance and a common set of strategic objectives.

• Compensate achievement while driving for and rewarding exceptional performance.

Eligibility; Bonus Payment Per Participant

Plan participants include substantially all of the Company’s non-sales employees, including executive officers. Standard bonuses range from 5% to 100% of any Plan participant’s salary, with such percentage varying among Plan participants. Bonuses scale as operating income levels increase or decrease over certain established levels. Participant’s bonus can accelerate above their standard bonus range when operating income exceeds the Company’s 2006 financial target.

Thresholds for Payments Under the Plan

The payment of bonuses under the Plan is dependent upon the Company achieving a minimum operating income for the 2006 fiscal year, with the amount available for payment of bonuses scaling up as operating income exceeds the minimum amount. The specific amount of bonuses payable out of the amount available for bonus award is determined based upon the achievement of Company objectives relating to new customer orders, quality and revenue.

Plan Funding: Minimum Operating Income

The Plan will only be funded upon the achievement by the Company of a minimum threshold of operating income, at which time the Plan will be considered 33% funded. As the Company attains increased levels of operating income, the level of funding for the 2006 Plan will increase up to a maximum of 200%.

Company Objectives

The following table identifies the specific Company objectives outlined under the Plan and the percentage make-up of each objective as it relates to the total percentage for all Company’s objectives:

	% of Total Company Objectives	Company Objectives
	25%	Obtain multiple systems orders with designated customers, with each multiple order obtained accounting for 5% toward this objective.
	25%	Increase the level of quality in designated product lines (with particular quarterly objectives set out for applicable product line).
	50%	Achieve profitable growth for (i) specific product lines and (ii) the Company in general. The level of growth for specific product lines will be measured against individually determined product line growth targets. The level of growth for the Company in general will be measured against a pre-determined Company growth target range.
Total	100%

Payment as a Function of Plan Funding and Company Objectives

Plan awards are a direct function of the level of funding of the Plan (as it relates to the total operating income of the Company) multiplied by the percentage total of the objectives that have been met. For example, if the Plan is 100% funded and 80% of the objectives have been met, then a Plan participant will receive 80% of his/her target incentive bonus. In the event the Company generates a level of operating income for fiscal year 2006 causing the Plan to be 150% funded, and 80% of the Plan objectives have been met, then a Plan participant will receive 120% of his/her target incentive bonus. The reverse is also true in the event the Plan is funded for a percentage less than 100%. For example, if the Plan is only 33% funded, and 80% of the Plan objectives have been met, then a Plan participant will only receive 26.4% of his/her target incentive bonus.

EX-12.1

EXHIBIT 12.1

RATIO OF EARNINGS TO FIXED CHARGES

(in thousands)

	2005		2004		2003		2002		2001
Earnings:
Pretax income (loss) from continuing operations	(108,543	)	(60,415	)	(112,059	)	(163,632	)	(155,587	)
Add fixed charges	4,913		4,560		3,068		1,583		2,422
Earnings (as defined)	(103,630	)	(55,855	)	(108,991	)	(162,049	)	(153,165	)
Fixed Charges:
Interest expense	3,226		3,209		2,038		112		577
Estimate of interest within rental expense	1,687		1,351		1,030		1,471		1,845
Total fixed charges	4,913		4,560		3,068		1,583		2,422
Ratio of earnings to fixed charges	(21.09	)	(12.25	)	(35.53	)	(102.37	)	(63.24	)
Deficiency	(108,543	)	(60,415	)	(112,059	)	(163,632	)	(155,587	)

EX-21.1

Exhibit 21.1

CREDENCE SYSTEMS CORPORATION

SUBSIDIARIES OF THE COMPANY

The following are certain wholly-owned or majority-owned direct or indirect subsidiaries of Credence Systems Corporation as of December 31, 2005:

Credence Capital Corporation, a California corporation;

Credence Europa Limited, a private limited company in the United Kingdom;

Credence Systems (UK) Limited, a privately limited company in the United Kingdom;

Credence International Limited, Inc., a Delaware corporation;

Credence Systems KK, a Japanese company;

Credence Korea Ltd., a South Korea company;

Credence Systems GmbH, a German corporation;

NPTest International Ltd., a British Virgin Islands limited company;

Credence Systems (Philippines) Inc., a Philippines corporation;

NPTest (Philippines) Inc., a Philippines corporation;

Credence Systems Pte Ltd., a Singapore limited company;

Credence Systems(Malaysia) Sdn BhD, a Malaysian limited company;

NPTest UK Ltd., a United Kingdom limited company;

Credence Italia SRL, an Italian company; and

Credence France SAS, a French company.

EX-23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the following Registration Statements:

(1) Registration Statement (Form S-8 No. 333-126094) pertaining to Credence Systems Corporation Amended and Restated 1993 Stock Option Plan, Amended and Restated Employee Stock Purchase Plan and Amended and Restated 2005 Stock Incentive Plan,

(2) Registration Statement (Form S-8 No. 333-116047) pertaining to the NPTest Holdings Corporation 2003 Stock Incentive Plan (assumed by Credence Systems Corporation),

(3) Registration Statement (Form S-8 No. 114768) pertaining to Credence Systems Corporation Amended and Restated 1993 Stock Option Plan and Amended and Restated Employee Stock Purchase Plan,

(4) Registration Statement (Form S-8 Nos. 333-27499) pertaining to Credence Systems Corporation 1993 Stock Option Plan and Employee Stock Purchase Plan,

(5) Registration Statements (Form S-8 Nos. 333-32834 and 333-59051) pertaining to Credence Systems Corporation 1993 Stock Option Plan,

(6) Registration Statement (Form S-8 No. 333-38428) pertaining to the 1996 Stock Option Plan of TMT, Inc. (assumed by Credence Systems Corporation),

(7) Registration Statement (Form S-8 No. 333-50432) pertaining to Credence Systems Corporation Supplemental Stock Option Plan, 1993 Stock Option Plan and Employee Stock Purchase Plan,

(8) Registration Statement (Form S-8 No. 333-58100) pertaining to Credence Systems Corporation Supplemental Stock Option Plan,

(9) Registration Statement (Form S-8 No. 333-69584) pertaining to the 1995 Stock Incentive Plan, 1995 Stock Option Plan for Non-Employee Directors, 1995 Employee Stock Purchase Plan, and the 2000 Nonqualified Stock Option Plan of Integrated Measurement Systems, Inc. (each assumed by Credence Systems Corporation),

(10) Registration Statement (Form S-8 No. 333-74346) pertaining to the Fluence Technology, Inc. 1997 Stock Option Plan (assumed by Credence Systems Corporation), Opmaxx, Inc. 1997 Stock Option/Stock Issuance Plan (assumed by Credence Systems Corporation), Credence Systems Corporation 1993 Stock Option Plan and Credence Systems Corporation Supplemental Stock Option Plan,

(11) Registration Statement (Form S-8 No. 333-77007) pertaining to Credence Systems Corporation 1993 Stock Option Plan and 1994 Employee Stock Purchase Plan,

(12) Registration Statement (Form S-8 No. 333-102916) pertaining to Credence System Corporation 1993 Stock Option Plan, Employee Stock Purchase Plan, and the Optonics, Inc. 2001 Stock Option and Incentive Plan (assumed by Credence Systems Corporation),

(13) Registration Statement (Form S-3 No. 333-125722) pertaining to the registration of 615,157 shares of common stock,

(14) Registration Statement (Form S-3 No. 333-108069) pertaining to the Credence $180 million, 1.50% convertible subordinated notes and 15,915,119 shares of common stock,

(15) Registration Statement (Form S-4 No. 333-113990) pertaining to the registration of 33,201,258 shares of common stock and 203,036 non-voting convertible stock in connection with the acquisition of NPTest;

of our report dated January 11, 2006, with respect to the consolidated financial statements and schedule of Credence Systems Corporation, our report dated January 11, 2006, with respect to Credence System Corporation management’s assessment of the effectiveness of internal control over financial reporting and the effectiveness of internal control over financial reporting of Credence Systems Corporation included in this Annual Report (Form 10-K) for the year ended October 31, 2005.

/s/ Ernst & Young LLP

San Jose, California

January 11, 2006

EX-31.1

Exhibit 31.1

CERTIFICATION

I, David A. Ranhoff, certify that:

1.    I have reviewed this Annual Report on Form 10-K of Credence Systems Corporation;

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principals;

c)  Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)  Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/S/    DAVID A. RANHOFF        

David A. Ranhoff

President and Chief Executive Officer

Date:     January 17, 2006

EX-31.2

Exhibit 31.2

CERTIFICATION

I, John C. Batty, certify that:

1.    I have reviewed this Annual Report on Form 10-K of Credence Systems Corporation;

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principals;

c)  Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)  Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/S/    JOHN C. BATTY        

John C. Batty

Senior Vice President and

Chief Financial Officer

Date:     January 17, 2006

EX-32.1

Exhibit 32.1

CREDENCE SYSTEMS CORPORATION

CERTIFICATION

In connection with the Annual Report of Credence Systems Corporation (the “Company”) on Form 10-K for the period ended October 31, 2005 as filed with the Securities and Exchange Commission (the “Report”), I, David A. Ranhoff, President and Chief Executive Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

(1)    the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and

(2)    the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

This Certification has not been, and shall not be deemed, “filed” with the Securities and Exchange Commission.

Date:    January 17, 2006

/S/    DAVID A. RANHOFF        

David A. Ranhoff

President and Chief Executive Officer

EX-32.2

Exhibit 32.2

CREDENCE SYSTEMS CORPORATION

CERTIFICATION

In connection with the Annual Report of Credence Systems Corporation (the “Company”) on Form 10-K for the period ended October 31, 2005 as filed with the Securities and Exchange Commission (the “Report”), I, John C. Batty, Senior Vice President, Chief Financial Officer and Secretary of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

(1)    the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and

(2)    the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

This Certification has not been, and shall not be deemed, “filed” with the Securities and Exchange Commission.

Date:    January 17, 2006

/S/    JOHN C. BATTY        

John C. Batty

Senior Vice President,

Chief Financial Officer and Secretary